Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,0.9324687452030219,1.6300528561564909,0.0,0.20984485462238614,0.125,3/38,2.05%,Nfib;Nfia;Nfix
prerank,RNA Polymerase III Transcription Termination R-HSA-73980,0.9670288894827879,1.5707705036669377,0.0,0.6687297234949029,0.515,3/21,2.05%,Nfib;Nfia;Nfix
prerank,Late Phase Of HIV Life Cycle R-HSA-162599,0.728630868839749,1.5691297827301462,0.0,0.4679299057096886,0.53,14/125,7.31%,Sgip1;Nedd4l;Gtf2h2;Vps37b;Gtf2f2;Nmt1;Gtf2h5;Ccnh;Ndc1;Ssrp1;Xpo1;Nup93;Ncbp1;Ranbp2
prerank,Budding And Maturation Of HIV Virion R-HSA-162588,0.9020840266531625,1.564800286394699,0.00967741935483871,0.38923808522629383,0.571,3/27,3.55%,Sgip1;Nedd4l;Vps37b
prerank,EPHB-mediated Forward Signaling R-HSA-3928662,0.8692411511159498,1.5321583398630818,0.027210884353741496,0.699000446776638,0.828,12/32,5.41%,Kalrn;Grin2b;Tiam1;Itsn1;Ptk2;Actr3;Arpc2;Syngap1;Fyn;Gprin1;Src;Arhgef28
prerank,ER To Golgi Anterograde Transport R-HSA-199977,0.7024926887320178,1.5246780216634575,0.015337423312883436,0.6894328078110962,0.872,12/128,2.96%,Gria1;Ank3;Nsf;Sptb;Cnih3;Sptbn1;Tgfa;Sptbn4;Sec24d;Dync1i2;Ank2;Sptan1
prerank,Oxidative Stress Induced Senescence R-HSA-2559580,0.7505766176229652,1.511976409797981,0.005917159763313609,0.7828694740592139,0.935,19/78,7.67%,Tnik;Tnrc6c;Map2k6;Mapk1;Jun;Mapk10;Ago1;Tnrc6b;Mink1;Cbx6;Map2k4;Mapk3;Mapk14;Map3k5;Cbx4;Rbbp7;Phc2;Suz12;Ezh2
prerank,Neuronal System R-HSA-112316,0.6188463783645025,1.4984984752876889,0.0,0.8901823753916596,0.968,92/373,3.89%,Cacnb2;Gria1;Cacna1e;Kcnd2;Dlgap1;Lrrtm4;Grm1;Grin2a;Ppfia2;Il1rap;Dlgap2;Gabrb3;Nbea;Lrrc7;Il1rapl1;Ntrk3;Grin2b;Kcnj3;Kcnj6;Gabra2;Camk2a;Gabrb1;Nsf;Rims1;Camk2b;Gria2;Adcy1;Cacna2d1;Grik4;Gabra4;Ppm1e;Rasgrf1;Kcnh1;Gabrb2;Kcnab1;Adcy2;Gria3;Syt7;Rasgrf2;Plcb1;Grm5;Prkag2;Gabrg2;Kcnc3;Kcnd3;Sipa1l1;Gabbr2;Nlgn1;Syn2;Arhgef9;Epb41l1;Gng7;Gabra5;Gnal;Kcng2;Ncald;Kcnk10;Nptn;Tspan7;Mapk1;Slc17a7;Nrgn;Lrfn2;Adcy9;Camkk1;Syt10;Kcnc4;Gng2;Cacng8;Abcc8;Slc1a1;Kcnq3;Kcna4;Kcnk1;Rps6ka2;Camk2g;Syn3;Kcng1;Slitrk3;Kcng3;Kcna1;Slitrk2;Glra2;Ptprd;Calm1;Kcnab2;Actn2;Kcnmb4;Kcnma1;Grik5;Arhgef7;Syt1
prerank,COPII-mediated Vesicle Transport R-HSA-204005,0.7632982546468515,1.4958226071591685,0.023323615160349854,0.8337513955686376,0.975,5/63,2.33%,Gria1;Nsf;Cnih3;Tgfa;Sec24d
prerank,Transmission Across Chemical Synapses R-HSA-112315,0.6540062685317907,1.4924313300616452,0.004672897196261682,0.800546060335287,0.98,49/236,2.41%,Cacnb2;Gria1;Cacna1e;Grin2a;Ppfia2;Gabrb3;Nbea;Lrrc7;Grin2b;Kcnj3;Kcnj6;Gabra2;Camk2a;Gabrb1;Nsf;Rims1;Camk2b;Gria2;Adcy1;Cacna2d1;Grik4;Gabra4;Ppm1e;Rasgrf1;Gabrb2;Adcy2;Gria3;Rasgrf2;Plcb1;Prkag2;Gabrg2;Gabbr2;Syn2;Arhgef9;Epb41l1;Gng7;Gabra5;Gnal;Ncald;Nptn;Tspan7;Mapk1;Slc17a7;Nrgn;Adcy9;Camkk1;Gng2;Cacng8;Slc1a1
prerank,EPH-Ephrin Signaling R-HSA-2682334,0.7315824465400568,1.486016952219426,0.015772870662460567,0.8129569472439881,0.987,21/88,4.94%,Kalrn;Grin2b;Epha7;Tiam1;Epha4;Vav3;Epha6;Itsn1;Ptk2;Dnm1;Actr3;Arpc2;Nck2;Sdcbp;Syngap1;Arhgef7;Efnb3;Fyn;Psen1;Gprin1;Src
prerank,Signaling By NOTCH2 R-HSA-1980145,0.8588821484105713,1.483427257620233,0.02967359050445104,0.775863159810738,0.988,4/28,1.83%,Maml2;Maml3;Cntn1;Notch2
prerank,Signaling By NOTCH4 R-HSA-9013694,0.7242555990997686,1.459489005252609,0.01282051282051282,1.0,0.998,4/80,2.38%,Maml2;Maml3;Notch2;Smad3
prerank,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.6466421434973928,1.4517741994137565,0.011857707509881422,1.0,0.999,41/173,2.32%,Gria1;Grin2a;Gabrb3;Nbea;Lrrc7;Grin2b;Kcnj3;Kcnj6;Gabra2;Camk2a;Gabrb1;Nsf;Camk2b;Gria2;Adcy1;Grik4;Gabra4;Ppm1e;Rasgrf1;Gabrb2;Adcy2;Gria3;Rasgrf2;Plcb1;Prkag2;Gabrg2;Gabbr2;Arhgef9;Epb41l1;Gng7;Gabra5;Gnal;Ncald;Nptn;Tspan7;Mapk1;Nrgn;Adcy9;Camkk1;Gng2;Cacng8
prerank,Vpr-mediated Nuclear Import Of PICs R-HSA-180910,0.8364231083705049,1.450439614746423,0.03225806451612903,1.0,0.999,1/31,0.59%,Sgip1
prerank,Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,0.8281544454773605,1.4468053404575407,0.03559870550161812,0.985909015251728,0.999,1/33,0.59%,Sgip1
prerank,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,0.8374852177477338,1.4467342230666531,0.02711864406779661,0.9289784892765877,0.999,3/37,2.58%,Nr3c2;Fkbp5;Dync1i2
prerank,Protein-protein Interactions At Synapses R-HSA-6794362,0.7070164331225816,1.4400465841340733,0.022222222222222223,0.9559598932797592,1.0,19/86,2.11%,Gria1;Dlgap1;Lrrtm4;Grm1;Grin2a;Ppfia2;Il1rap;Dlgap2;Il1rapl1;Ntrk3;Grin2b;Gria3;Syt7;Grm5;Sipa1l1;Nlgn1;Epb41l1;Lrfn2;Syt10
prerank,Signaling By SCF-KIT R-HSA-1433557,-0.8462566216620406,-1.4341988623884567,0.020802377414561663,1.0,0.99,16/40,9.34%,Kit;Gab2;Stat5b;Ptpru;Pik3r1;Tec;Vav1;Fer;Lyn;Grb10;Fes;Jak2;Prkca;Grb7;Grap2;Stat5a
prerank,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,0.8542473503214516,1.4294330583235662,0.046822742474916385,1.0,1.0,1/27,0.35%,Ak5
prerank,Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.8627827492975353,1.4246887898685479,0.07119741100323625,1.0,1.0,4/20,0.27%,Ppfia2;Il1rap;Il1rapl1;Ntrk3
prerank,Signaling By ALK R-HSA-201556,-0.8632455058269636,-1.4208322426746585,0.024495677233429394,1.0,0.998,3/26,0.92%,Alk;Ptn;Pik3r1
prerank,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.7640717664945319,-1.4187035222844484,0.024566473988439308,1.0,0.999,4/85,4.21%,Ldb2;Runx1;Tcf7l1;Spi1
prerank,GABA Receptor Activation R-HSA-977443,0.7408600425960213,1.4178658520044614,0.05211726384364821,1.0,1.0,18/57,2.24%,Gabrb3;Kcnj3;Kcnj6;Gabra2;Gabrb1;Adcy1;Gabra4;Gabrb2;Adcy2;Gabrg2;Gabbr2;Arhgef9;Gng7;Gabra5;Gnal;Nptn;Adcy9;Gng2
prerank,Signaling By FGFR In Disease R-HSA-1226099,-0.8141783926327495,-1.4151169859901287,0.014245014245014245,1.0,0.999,6/59,2.08%,Gab2;Stat5b;Pik3r1;Fgf1;Cux1;Fgfr3
prerank,COPI-mediated Anterograde Transport R-HSA-6807878,0.7074621541280756,1.4061059025498257,0.05357142857142857,1.0,1.0,8/76,2.96%,Ank3;Nsf;Sptb;Sptbn1;Sptbn4;Dync1i2;Ank2;Sptan1
prerank,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,-0.8978653143155954,-1.4051381491084476,0.023154848046309694,1.0,1.0,1/16,0.37%,Enpp2
prerank,Interleukin-7 Signaling R-HSA-1266695,-0.8588802378208704,-1.4006382256405125,0.03074670571010249,1.0,1.0,3/25,0.92%,Socs2;Stat5b;Pik3r1
prerank,Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.8370755841372095,-1.3997912000253832,0.03982300884955752,1.0,1.0,8/28,9.34%,Gab2;Stat5b;Hck;Csf3r;Lyn;Jak2;Syk;Stat5a
prerank,Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,-0.8972395291132628,-1.3925391013743371,0.025936599423631124,1.0,1.0,4/17,1.30%,Gab2;Stat5b;Pik3r1;Cux1
prerank,Regulation Of Beta-Cell Development R-HSA-186712,0.7924369752695957,1.3911483486240552,0.05740181268882175,1.0,1.0,6/36,3.30%,Maml2;Maml3;Foxo1;Akt3;Onecut1;Neurod1
prerank,FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.859000523433505,-1.3904236240517343,0.02812939521800281,1.0,1.0,5/28,1.30%,Gab2;Stat5b;Pik3r1;Fgf1;Cux1
prerank,Arachidonic Acid Metabolism R-HSA-2142753,-0.815014629188946,-1.390323859239793,0.01925925925925926,1.0,1.0,10/41,7.80%,Fa2h;Tbxas1;Pla2g4a;Hpgd;Pon2;Ptgs1;Hpgds;Ggt5;Ptgds;Alox12b
prerank,Cargo Concentration In ER R-HSA-5694530,0.8114466573545915,1.3894818334213015,0.06707317073170732,1.0,1.0,4/29,2.33%,Gria1;Cnih3;Tgfa;Sec24d
prerank,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.7326026325167811,-1.3863169879208515,0.017735334242837655,1.0,1.0,33/119,10.71%,Pcdh7;Prkcb;Fn1;Phactr2;Igf1;Sparc;Cyrib;Itih3;Sgpp2;Vcl;Selenop;Prkcg;Sccpdh;Cd109;Tgfb1;Tmx3;App;Clu;Vegfa;Fermt3;Cd9;Endod1;Calu;Vegfd;Prkca;Plek;Scg3;Cd63;Pros1;Lamp2;Gas6;Pdgfb;Anxa5
prerank,Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,-0.8812038573427635,-1.3841516651383274,0.06069364161849711,1.0,1.0,3/15,0.92%,Gab2;Stat5b;Pik3r1
prerank,Spry Regulation Of FGF Signaling R-HSA-1295596,0.8333862473059236,1.3815644135507987,0.1360759493670886,1.0,1.0,4/16,4.94%,Mapk1;Cbl;Mapk3;Src
prerank,Signaling By FGFR1 In Disease R-HSA-5655302,-0.8471854982288636,-1.3811859376539835,0.017094017094017096,1.0,1.0,5/34,1.30%,Gab2;Stat5b;Pik3r1;Fgf1;Cux1
prerank,Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.7247987326830067,-1.3803141004558015,0.023529411764705882,1.0,1.0,32/107,10.06%,Mertk;Pik3r1;Mag;Fn1;Inpp5d;Selplg;Jam3;Jam2;Cd84;Itgam;Angpt1;Lyn;Slc7a11;Selenop;Cd44;Sirpa;Cxadr;F11r;Atp1b3;L1cam;Tgfb1;Itga6;Sdc4;Cav1;Slc7a7;Slc7a10;Itgb1;Slc16a1;Pros1;Grb7;Gas6;Itga3
prerank,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.8037403442720742,-1.3779681224524174,0.037091988130563795,1.0,1.0,10/45,8.26%,Runx1;Fli1;Klf5;Csf3r;Rara;Lef1;Spi1;E2f1;Tal1;Cdk2
prerank,Cardiac Conduction R-HSA-5576891,0.6545153439948118,1.3762133138023402,0.033846153846153845,1.0,1.0,25/120,2.94%,Fgf14;Cacnb2;Kcnip4;Ryr2;Kcnd2;Cacna1c;Camk2a;Camk2b;Scn3a;Kcnd3;Atp2b1;Slc8a2;Scn2a;Scn8a;Orai2;Kcnk10;Scn3b;Kcnip2;Atp2b3;Ryr1;Cacng8;Kcnk1;Atp1b1;Camk2g;Scn9a
prerank,Purine Catabolism R-HSA-74259,0.8281655472512958,1.3748499618145318,0.14715719063545152,1.0,1.0,2/15,2.69%,Gda;Nt5c2
prerank,Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.8297853918494046,-1.3742190526328215,0.048600883652430045,1.0,1.0,10/33,10.79%,Dlc1;Sparc;Colec12;Apoe;Masp1;Stab1;Col1a2;Col4a2;Col3a1;Col4a1
prerank,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.8113578334098347,-1.3729142014037952,0.03543913713405239,1.0,1.0,13/42,7.75%,Gab2;Stat5b;Pik3r1;Inpp5d;Tec;Hck;Vav1;Lyn;Clstn1;Inppl1;Jak2;Syk;Prkca
prerank,Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,-0.7862725604773758,-1.3719952959600825,0.04431314623338257,1.0,1.0,26/54,13.00%,Lama4;Col27a1;Col6a2;Col6a1;Col6a5;Ctss;Col8a1;Lamc2;Itga6;Mmp28;Col9a1;Col4a5;Col11a1;Col1a2;Col4a2;Col3a1;Col6a3;Pcolce;Col24a1;Col8a2;Dst;Loxl2;Col4a1;Cd151;Col2a1;Col11a2
prerank,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,-0.8470686616672398,-1.367680357533777,0.04190751445086705,1.0,1.0,4/28,2.15%,Flrt2;Pik3r1;Fgf1;Flrt1
prerank,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.8299208833438381,-1.3661648396743435,0.07163742690058479,1.0,1.0,7/23,9.34%,Stat5b;Hck;Csf3r;Lyn;Jak2;Syk;Stat5a
prerank,Complement Cascade R-HSA-166658,-0.8145703582820362,-1.3661080764641966,0.05113636363636364,1.0,1.0,11/40,11.46%,Cfh;Masp1;C1qa;C1qb;Cpne2;Cd81;Clu;C1qc;Vtn;Pros1;Cr2
prerank,Activation Of GABAB Receptors R-HSA-991365,0.7506053003238213,1.364721618541806,0.08517350157728706,1.0,1.0,9/40,2.24%,Kcnj3;Kcnj6;Adcy1;Adcy2;Gabbr2;Gng7;Gnal;Adcy9;Gng2
prerank,Initial Triggering Of Complement R-HSA-166663,-0.8822507922877845,-1.3620837604879728,0.07338129496402877,1.0,1.0,4/15,6.48%,Masp1;C1qa;C1qb;C1qc
prerank,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,0.8555988085488196,1.361879940687246,0.11643835616438356,1.0,1.0,6/16,7.03%,Map2k1;Tnip2;Btrc;Fbxw11;Map2k4;Cul1
prerank,Assembly Of HIV Virion R-HSA-175474,0.8229786966078112,1.35936814587661,0.12758620689655173,1.0,1.0,2/17,3.55%,Sgip1;Vps37b
prerank,Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.7076779374458725,-1.3583515227473013,0.040446304044630406,1.0,1.0,17/114,9.18%,Satb2;Maf;Runx1;Gli3;Wwtr1;Itgbl1;Smurf1;Dlx5;Esr1;Hdac4;Smad1;Gli2;Smad6;Ccnd1;Ucma;Sox9;Psmb8
prerank,Signaling By FLT3 Fusion Proteins R-HSA-9703465,-0.8624510827134648,-1.3580051144274996,0.08567208271787297,1.0,1.0,4/18,1.12%,Gab2;Stat5b;Pik3r1;Etv6
prerank,mRNA Capping R-HSA-72086,0.7786437350656376,1.3553441831839588,0.15282392026578073,1.0,1.0,8/28,10.98%,Gtf2h2;Gtf2f2;Gtf2h5;Ccnh;Ncbp1;Mnat1;Polr2e;Rngtt
prerank,Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,0.8310728219385435,1.3546439562601147,0.14840989399293286,1.0,1.0,2/15,3.55%,Sgip1;Vps37b
prerank,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,0.7824619181649112,1.3540628056523982,0.16666666666666666,1.0,1.0,7/26,10.98%,Gtf2h2;Gtf2f2;Gtf2h5;Ccnh;Mnat1;Polr2e;Rngtt
prerank,Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.807328080436763,-1.3531301288379798,0.04131054131054131,1.0,1.0,20/41,11.38%,Dmd;Lama4;Nrxn1;Ntn4;Itgb5;Lama2;Itga2;Lama1;Lamc2;Tgfb1;Itga6;Sdc4;Ddr2;Vtn;Prkca;Itgb1;Hspg2;Lamc3;Pdgfb;Ddr1
prerank,PTEN Regulation R-HSA-6807070,0.6160246172241702,1.348518604847226,0.03832752613240418,1.0,1.0,29/136,8.22%,Tnrc6c;Akt3;Mapk1;Chd4;Hdac7;Prex2;Chd3;Jun;Rragd;Cnot6l;Gatad2b;Ago1;Ago2;Nedd4;Tnrc6b;Hdac1;Tnks;Cbx6;Mapk3;Mta3;Cbx4;Rbbp7;Rptor;Phc2;Suz12;Ezh2;Rcor1;Mta2;Psmd13
prerank,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,-0.782077246936777,-1.3469305887351821,0.05028735632183908,1.0,1.0,17/53,6.07%,Gpc6;Xylt1;Ext1;Hs6st2;Gpc5;Hs3st2;Hs3st5;Hs6st3;Bcan;Ndst3;Hs3st4;Cspg4;Vcan;Cspg5;Dcn;Sdc4;Hs3st1
prerank,NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.6975099742787689,1.3425433938645894,0.09620991253644315,1.0,1.0,15/57,2.96%,Cacnb2;Cacna1c;Cacna1d;Gfra1;Ncam1;Sptb;Cacna1h;Mapk1;Sptbn1;Ptk2;Gfra2;Sptbn4;Ptpra;St8sia4;Sptan1
prerank,Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,0.8269034941051661,1.3411406268348807,0.18122977346278318,1.0,1.0,3/15,2.62%,Maml2;Maml3;Onecut1
prerank,PI-3K cascade:FGFR4 R-HSA-5654720,-0.8627570694392437,-1.3410550323957433,0.08498583569405099,1.0,1.0,2/17,1.29%,Pik3r1;Fgf1
prerank,Regulation Of Complement Cascade R-HSA-977606,-0.8139932514350986,-1.3410349633557488,0.07439198855507868,1.0,1.0,10/33,11.46%,Cfh;C1qa;C1qb;Cpne2;Cd81;Clu;C1qc;Vtn;Pros1;Cr2
prerank,PI-3K cascade:FGFR3 R-HSA-5654710,-0.859147068831632,-1.3406858648216604,0.08425414364640885,1.0,1.0,3/16,2.08%,Pik3r1;Fgf1;Fgfr3
prerank,Signaling By KIT In Disease R-HSA-9669938,-0.8579796892407445,-1.3401361523029816,0.06599713055954089,1.0,1.0,4/19,2.91%,Kit;Stat5b;Pik3r1;Lyn
prerank,Platelet Degranulation R-HSA-114608,-0.7076379538718454,-1.3352636075928919,0.03961748633879782,1.0,1.0,30/115,10.71%,Pcdh7;Fn1;Phactr2;Igf1;Sparc;Cyrib;Itih3;Sgpp2;Vcl;Selenop;Sccpdh;Cd109;Tgfb1;Tmx3;App;Clu;Vegfa;Fermt3;Cd9;Endod1;Calu;Vegfd;Plek;Scg3;Cd63;Pros1;Lamp2;Gas6;Pdgfb;Anxa5
prerank,Interleukin-1 Signaling R-HSA-9020702,0.6247692506136442,1.3340477914255897,0.049019607843137254,1.0,1.0,11/109,4.81%,Il1rap;Map2k6;Il1r1;Map2k1;Tnip2;Peli1;Btrc;Fbxw11;Peli2;Ripk2;Map2k4
prerank,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,-0.8517255607252975,-1.3336830370181418,0.11157601115760112,1.0,1.0,4/15,7.75%,Prkcb;Prkcg;Ap2b1;Prkca
prerank,Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,0.8126483543399668,1.3329883254041421,0.1779935275080906,1.0,1.0,1/18,0.58%,Cyp7b1
prerank,Muscle Contraction R-HSA-397014,0.5955034887825682,1.3317514567935735,0.04152249134948097,1.0,1.0,34/186,3.72%,Fgf14;Cacnb2;Kcnip4;Ryr2;Kcnd2;Cacna1c;Camk2a;Sorbs1;Camk2b;Scn3a;Kcnd3;Atp2b1;Slc8a2;Scn2a;Scn8a;Orai2;Cald1;Cacna1h;Kcnk10;Scn3b;Kcnip2;Atp2b3;Ryr1;Cacng8;Kcnk1;Atp1b1;Camk2g;Anxa6;Scn9a;Tmod1;Calm1;Actn2;Gucy1b1;Itpr1
prerank,FLT3 Signaling In Disease R-HSA-9682385,-0.8161999459681392,-1.3308783598343639,0.10746268656716418,1.0,1.0,4/26,1.12%,Gab2;Stat5b;Pik3r1;Etv6
prerank,Interleukin Receptor SHC Signaling R-HSA-912526,-0.822731680828055,-1.3305963871951259,0.07309941520467836,1.0,1.0,6/25,6.94%,Gab2;Pik3r1;Inpp5d;Clstn1;Inppl1;Jak2
prerank,"Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",-0.8278804745781044,-1.328889235766955,0.08746355685131195,1.0,1.0,6/23,10.58%,Tcf7l2;Pcsk1;C1qtnf1;Ucma;Ffar4;Dpp4
prerank,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,-0.8236612249781289,-1.3283864249031558,0.09141274238227147,1.0,1.0,4/22,1.99%,Satb2;Maf;Gli3;Wwtr1
prerank,PKA-mediated Phosphorylation Of CREB R-HSA-111931,0.820721960706574,1.3271880647006817,0.16095890410958905,1.0,1.0,5/18,3.50%,Nbea;Adcy1;Adcy2;Adcy9;Calm1
prerank,Activation Of Matrix Metalloproteinases R-HSA-1592389,0.7900544593229993,1.3260486263232467,0.16013071895424835,1.0,1.0,3/20,1.77%,Mmp16;Spock3;Mmp17
prerank,Other Interleukin Signaling R-HSA-449836,-0.8256429618507667,-1.3243706887391997,0.10014513788098693,1.0,1.0,4/20,2.59%,Il34;Csf1r;Stx1a;Csf3r
prerank,FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,0.8532462092544706,1.323456954714438,0.15878378378378377,1.0,1.0,2/15,1.89%,Foxo1;Bcl6
prerank,"Synthesis, Secretion, And Inactivation Of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771",-0.8326234401670641,-1.3220928432779695,0.08452722063037249,1.0,1.0,5/20,10.58%,Tcf7l2;Pcsk1;Ucma;Ffar4;Dpp4
prerank,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,0.7374787651642212,1.3212082439636492,0.12,1.0,1.0,11/41,12.04%,Gtf2h2;Gtf2f2;Gtf2h5;Ccnh;Ssrp1;Ncbp1;Mnat1;Ccnt2;Polr2e;Ccnk;Cdk9
prerank,Signaling By PDGFR In Disease R-HSA-9671555,-0.8367712675515693,-1.3208041641020059,0.11320754716981132,1.0,1.0,5/19,5.92%,Pik3r1;Etv6;Pdgfra;Kank1;Bin2
prerank,Formation Of Early Elongation Complex R-HSA-113418,0.7506468094711107,1.319611346446567,0.16838487972508592,1.0,1.0,7/31,9.84%,Gtf2h2;Gtf2f2;Gtf2h5;Ccnh;Ncbp1;Mnat1;Polr2e
prerank,Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.8262923334053413,-1.3195089971271319,0.07647907647907648,1.0,1.0,3/25,2.22%,Elmo1;Dock2;Hck
prerank,Signaling By FGFR3 In Disease R-HSA-5655332,-0.8460171987963179,-1.3190330878836332,0.08484005563282336,1.0,1.0,3/19,2.08%,Pik3r1;Fgf1;Fgfr3
prerank,Interaction Between L1 And Ankyrins R-HSA-445095,0.7781254151064375,1.3189134118457018,0.15060240963855423,1.0,1.0,13/29,2.96%,Ank3;Nrcam;Scn3a;Scn2a;Scn8a;Sptb;Scn3b;Sptbn1;Sptbn4;Kcnq3;Ank2;Scn9a;Sptan1
prerank,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,0.8173067508284764,1.3180711635796798,0.1751592356687898,1.0,1.0,4/19,2.38%,Maml2;Maml3;Notch2;Smad3
prerank,IRS-related Events Triggered By IGF1R R-HSA-2428928,-0.7738846151319536,-1.3173928956075691,0.07342143906020558,1.0,1.0,5/47,2.53%,Gab2;Pik3r1;Fgf1;Fgfr3;Igf1
prerank,Downstream Signaling Of Activated FGFR3 R-HSA-5654708,-0.8318767782465913,-1.31493298255649,0.07790368271954674,1.0,1.0,3/22,2.08%,Pik3r1;Fgf1;Fgfr3
prerank,Zinc Transporters R-HSA-435354,0.8248327938553255,1.3138894355631217,0.15960912052117263,1.0,1.0,2/17,2.30%,Slc39a6;Slc30a3
prerank,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,0.7305615378721607,1.3124032447735836,0.13333333333333333,1.0,1.0,8/39,9.84%,Gtf2h2;Gtf2f2;Gtf2h5;Ccnh;Ssrp1;Ncbp1;Mnat1;Polr2e
prerank,IGF1R Signaling Cascade R-HSA-2428924,-0.7673566710457906,-1.310617485956631,0.08112094395280237,1.0,1.0,5/48,2.53%,Gab2;Pik3r1;Fgf1;Fgfr3;Igf1
prerank,Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,-0.766628215596683,-1.310157080221129,0.08247422680412371,1.0,1.0,5/49,2.53%,Gab2;Pik3r1;Fgf1;Fgfr3;Igf1
prerank,Downstream Signaling Of Activated FGFR4 R-HSA-5654716,-0.828312942967103,-1.3097122797378908,0.09312320916905444,1.0,1.0,2/23,1.29%,Pik3r1;Fgf1
prerank,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,0.7744865796297582,1.3090885583307525,0.1757188498402556,1.0,1.0,7/27,4.34%,Map2k6;Pdzd2;Akt3;Chd4;Chd3;Gatad2b;Hdac1
prerank,SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.7485731711417873,-1.3076470793081725,0.08199121522693997,1.0,1.0,3/50,4.64%,Satb2;Satb1;Hdac4
prerank,RUNX2 Regulates Bone Development R-HSA-8941326,-0.7986599270966037,-1.3071569426190157,0.11079545454545454,1.0,1.0,8/28,5.99%,Satb2;Maf;Gli3;Wwtr1;Hdac4;Smad1;Gli2;Smad6
prerank,Basigin Interactions R-HSA-210991,-0.7941600226416421,-1.3048305131421667,0.12927191679049035,1.0,1.0,11/24,10.06%,Mag;Slc7a11;Atp1b3;L1cam;Itga6;Cav1;Slc7a7;Slc7a10;Itgb1;Slc16a1;Itga3
prerank,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.6674473605140196,1.304225000727298,0.09491525423728814,1.0,1.0,19/72,2.81%,Gria1;Grin2a;Nbea;Lrrc7;Grin2b;Camk2a;Camk2b;Gria2;Adcy1;Ppm1e;Rasgrf1;Gria3;Rasgrf2;Prkag2;Mapk1;Nrgn;Camkk1;Rps6ka2;Camk2g
prerank,Pre-NOTCH Transcription And Translation R-HSA-1912408,0.7015674019865923,1.3036603977553496,0.13994169096209913,1.0,1.0,8/49,3.98%,Maml2;Maml3;Tnrc6c;Notch2;Jun;Ago1;Ago2;Tnrc6b
prerank,RHOJ GTPase Cycle R-HSA-9013409,-0.7481563985472397,-1.303629784738077,0.09327217125382263,1.0,1.0,15/53,6.06%,Fnbp1l;Cpne8;Pik3r1;Dock8;Arhgap26;Fnbp1;Prex1;Gja1;Fmnl3;Rhoj;Syde1;Wwp2;Cdc42ep1;Ophn1;Cav1
prerank,Inflammasomes R-HSA-622312,-0.8224200424905955,-1.302351128309261,0.12215909090909091,1.0,1.0,6/19,10.74%,Bcl2;P2rx7;Casp1;App;Txnip;Nlrp3
prerank,Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.6228488349630034,-1.302019133559397,0.04533678756476684,1.0,1.0,62/263,12.65%,Chrm3;Rxfp1;Htr1f;Htr2c;Adra1a;Chrm2;Lpar1;Htr7;Tacr3;Qrfpr;Ccr5;Htr2a;Cckbr;Drd2;S1pr1;P2ry6;Cx3cr1;Ptger3;Oprk1;Npsr1;Ednrb;Adra1b;P2ry13;Ntsr1;Adrb3;Gpr37l1;App;Gpr17;Hrh2;P2ry12;Lhcgr;Adora2b;Ntsr2;P2ry1;Hrh3;Opn3;Npffr1;Chrm5;Hcrt;Lpar6;Tac1;Ucma;Gpr55;Prok2;Plppr3;Bdkrb2;Ffar4;Sst;Adrb1;Nlrp3;Tacr2;Htr1b;Npbwr1;Cxcr4;Ccl28;Nmbr;Tacr1;Adra2a;Rxfp3;Chga;Pnoc;Tshb
prerank,Signaling By NTRK2 (TRKB) R-HSA-9006115,0.7656642387036503,1.3018164632932994,0.16783216783216784,1.0,1.0,7/22,4.94%,Grin2b;Tiam1;Ntf3;Dock3;Cdk5r1;Fyn;Src
prerank,PI3K Cascade R-HSA-109704,-0.7741190270271899,-1.2996950325097019,0.09912536443148688,1.0,1.0,4/40,2.08%,Gab2;Pik3r1;Fgf1;Fgfr3
prerank,N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,-0.8041056157411828,-1.298414203664356,0.1044349070100143,1.0,1.0,5/24,2.71%,St6gal1;Mgat4c;Chst8;Man2a1;Mgat5
prerank,IRS-mediated Signaling R-HSA-112399,-0.7674620696377015,-1.2953989515451587,0.08905109489051095,1.0,1.0,4/43,2.08%,Gab2;Pik3r1;Fgf1;Fgfr3
prerank,HIV Life Cycle R-HSA-162587,0.5896966249416227,1.2951795878402121,0.07857142857142857,1.0,1.0,14/138,7.31%,Sgip1;Nedd4l;Gtf2h2;Vps37b;Gtf2f2;Nmt1;Gtf2h5;Ccnh;Ndc1;Ssrp1;Xpo1;Nup93;Ncbp1;Ranbp2
prerank,Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.8083461188680492,-1.2948137777436173,0.13525179856115108,1.0,1.0,9/23,12.94%,Entpd1;P2rx7;Casp1;P2rx4;Txnip;Il1a;Nlrp3;Il18;Entpd5
prerank,Scavenging By Class A Receptors R-HSA-3000480,-0.824241777398708,-1.2948107897620567,0.12173913043478261,1.0,1.0,7/17,10.79%,Colec12;Apoe;Masp1;Col1a2;Col4a2;Col3a1;Col4a1
prerank,Interleukin-20 Family Signaling R-HSA-8854691,-0.82277262409689,-1.2947733951526792,0.10885341074020319,1.0,1.0,4/18,9.34%,Stat5b;Jak2;Ifnlr1;Stat5a
prerank,"FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",0.7670191239880797,1.2941234237101624,0.1540983606557377,1.0,1.0,3/26,2.38%,Plxna4;Foxo1;Smad3
prerank,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.766929539401287,-1.2940633638486445,0.10104011887072809,1.0,1.0,8/40,6.66%,Tbl1x;Hmgcs1;Hmgcr;Smarcd3;Srebf2;Elovl6;Sqle;Fdft1
prerank,Synaptic Adhesion-Like Molecules R-HSA-8849932,0.7883741589175144,1.2935731351028277,0.1836734693877551,1.0,1.0,5/21,2.00%,Gria1;Grin2a;Grin2b;Gria3;Lrfn2
prerank,Signaling By Erythropoietin R-HSA-9006335,-0.7951914892576972,-1.2901385112422454,0.12354651162790697,1.0,1.0,8/24,6.94%,Stat5b;Pik3r1;Vav1;Lyn;Pik3r5;Clstn1;Pik3cg;Jak2
prerank,PKA Activation R-HSA-163615,0.8262092907450529,1.2894671654734011,0.18050541516245489,1.0,1.0,5/16,3.50%,Nbea;Adcy1;Adcy2;Adcy9;Calm1
prerank,Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.7486577237876627,1.2889176757697112,0.20440251572327045,1.0,1.0,6/25,0.44%,Grin2a;Nbea;Lrrc7;Grin2b;Camk2a;Camk2b
prerank,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.7647778080688693,1.2871169603938295,0.18360655737704917,1.0,1.0,3/22,3.93%,Erc2;Jun;Cdk5r1
prerank,Peptide Ligand-Binding Receptors R-HSA-375276,-0.6508333431048633,-1.285343988523288,0.08550724637681159,1.0,1.0,40/153,16.56%,Rxfp1;Tacr3;Qrfpr;Ccr5;Cckbr;Cx3cr1;Oprk1;Npsr1;Ednrb;Ntsr1;Gpr37l1;App;Ntsr2;Npffr1;Hcrt;Tac1;Ucma;Prok2;Bdkrb2;Sst;Nlrp3;Tacr2;Npbwr1;Cxcr4;Ccl28;Nmbr;Tacr1;Rxfp3;Pnoc;Gper1;Oprd1;Cxcr2;Npy;Edn3;Cxcl16;Npffr2;Edn1;Nln;Ccr2;Avpr1b
prerank,Nicotinamide Salvaging R-HSA-197264,-0.8226860165418489,-1.2852235782115538,0.1485148514851485,1.0,1.0,2/18,1.80%,Parp8;Parp4
prerank,"Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",0.7863869311303153,1.2823641763258857,0.22321428571428573,1.0,1.0,4/21,2.94%,Grm1;Scn3a;Scn2a;Scn9a
prerank,FGFR2 Alternative Splicing R-HSA-6803529,0.7677092176246266,1.2806670946228307,0.19207317073170732,1.0,1.0,7/25,9.84%,Rbfox2;Gtf2f2;Hnrnpm;Ncbp1;Hnrnph1;Tia1;Polr2e
prerank,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,0.6936825447312885,1.2799945720551922,0.14240506329113925,1.0,1.0,7/47,3.00%,Maml2;Nbea;Maml3;Tle1;Ncor1;Hdac7;Tle4
prerank,Degradation Of DVL R-HSA-4641258,0.6778356243433583,1.2799357378704421,0.13564668769716087,1.0,1.0,1/55,0.65%,Hecw1
prerank,Inwardly Rectifying K+ Channels R-HSA-1296065,0.7234325351789904,1.2795833418114062,0.1717171717171717,1.0,1.0,6/33,2.33%,Kcnj3;Kcnj6;Gabbr2;Gng7;Gng2;Abcc8
prerank,Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.8112882082193806,-1.276918488242573,0.14166666666666666,1.0,1.0,3/20,6.74%,Stx1a;App;Cyb5a
prerank,FOXO-mediated Transcription R-HSA-9614085,0.6554068361436096,1.273980333102386,0.13003095975232198,1.0,1.0,9/61,4.77%,Plxna4;Foxo1;Akt3;Bcl6;Smad3;Btg1;Ywhaz;Hdac1;Ywhab
prerank,"Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",0.7591657416671534,1.2734013148774541,0.22073578595317725,1.0,1.0,8/21,0.70%,Gria1;Grin2a;Lrrc7;Grin2b;Camk2a;Camk2b;Gria2;Gria3
prerank,VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.8021522542581058,-1.2733153242263042,0.1463768115942029,1.0,1.0,5/18,7.75%,Itpr2;Prkcb;Prkcd;Vegfa;Prkca
prerank,Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,-0.7409859338847168,-1.272992123480282,0.10741301059001512,1.0,1.0,6/53,2.50%,Pcdh15;Whrn;Epb41l3;Kcnn2;Myo1e;Gsn
prerank,PI-3K cascade:FGFR2 R-HSA-5654695,-0.8021063925627002,-1.2714342117900141,0.15330520393811534,1.0,1.0,2/21,1.29%,Pik3r1;Fgf1
prerank,Serotonin Neurotransmitter Release Cycle R-HSA-181429,0.7762281614467039,1.2708322088144512,0.22115384615384615,1.0,1.0,6/18,4.24%,Ppfia2;Rims1;Syn2;Syn3;Syt1;Tspoap1
prerank,Meiotic Synapsis R-HSA-1221632,0.697321914427046,1.2693213671106953,0.15315315315315314,0.9989680684365403,1.0,1/46,0.47%,Syne1
prerank,Peptide Hormone Metabolism R-HSA-2980736,-0.7004386150816871,-1.2690150581434945,0.11798561151079137,1.0,1.0,23/79,14.21%,Tcf7l2;Cpe;Pcsk1;Stx1a;Igf1;Kif5a;Ctsd;Ctsz;C1qtnf1;Pla2g7;Ucma;Aopep;Ffar4;Ache;Dpp4;Anpep;Inhbb;Chga;Tshb;Cpb1;Atp6ap2;Mboat4;Enpep
prerank,Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.7664650477032223,1.2689223489589492,0.21548821548821548,0.9867425774700556,1.0,3/20,3.93%,Erc2;Jun;Cdk5r1
prerank,VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.7966850795547809,-1.268913201274969,0.15607734806629833,1.0,1.0,1/21,0.19%,Asap1
prerank,Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,-0.7917848311054673,-1.2685480490062955,0.14064697609001406,1.0,1.0,7/27,8.86%,Sall1;Sox2;Smad2;Epas1;Nr6a1;Pbx1;Hhex
prerank,Post NMDA Receptor Activation Events R-HSA-438064,0.6649878891426023,1.268227320166977,0.15100671140939598,0.9755705818426708,1.0,16/59,2.81%,Gria1;Grin2a;Lrrc7;Grin2b;Camk2a;Camk2b;Gria2;Adcy1;Rasgrf1;Rasgrf2;Prkag2;Mapk1;Nrgn;Camkk1;Rps6ka2;Camk2g
prerank,Signaling By PDGF R-HSA-186797,-0.7306499871862779,-1.2658704835976464,0.14114114114114115,1.0,1.0,19/52,11.06%,Stat5b;Pik3r1;Pdgfra;Col6a2;Col6a1;Col6a5;Col9a1;Col4a5;Pdgfd;Stat6;Pdgfrb;Thbs4;Col4a2;Col6a3;Grb7;Stat5a;Pdgfb;Col4a1;Pik3ca
prerank,TP53 Regulates Metabolic Genes R-HSA-5628897,0.6195953735029064,1.264316270162828,0.13804713804713806,0.980878251906101,1.0,12/79,6.03%,Tnrc6c;Prkag2;Akt3;Rragd;Ago1;Ago2;Ywhaz;Tnrc6b;Ywhab;Txnrd1;Ywhae;Ywhah
prerank,FRS-mediated FGFR3 Signaling R-HSA-5654706,-0.810287513888784,-1.2639712562391165,0.16459197786998617,1.0,1.0,2/17,2.08%,Fgf1;Fgfr3
prerank,Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.5888149437977818,-1.2638576712153182,0.05402010050251256,1.0,1.0,52/340,18.42%,Gatm;Folh1;Slc6a7;Aspa;Carns1;Glul;Slc25a13;Gadl1;Smox;Sqor;Dio2;Aass;Ass1;Bcat1;Atat1;Asrgl1;Ckb;Dhtkd1;Pcbd1;Cdo1;Qdpr;Psmb8;Heca;Rpl3l;Bckdhb;Hnmt;Bbox1;Soat1;Glud1;Gpt2;Chga;Psma8;Agxt2;Tshb;Slc38a1;Amdhd1;Psat1;Ftcd;Slc25a21;Gls2;Tph1;Serinc2;Slc6a11;Naalad2;Ldhd;Slc45a2;Ckm;Chdh;Psme4;Acadsb;Psme2;Papss2
prerank,Cholesterol Biosynthesis R-HSA-191273,-0.7818618092625336,-1.2636967402441057,0.16911764705882354,1.0,1.0,7/25,9.51%,Hmgcs1;Msmo1;Hmgcr;Srebf2;Sqle;Fdft1;Dhcr24
prerank,Sensory Perception Of Taste R-HSA-9717189,0.7525778899399385,1.263374215148074,0.21301775147928995,0.9714624352892592,1.0,5/26,4.17%,Grm1;Scn3a;Scn2a;Scn9a;Scnn1a
prerank,Processing Of SMDT1 R-HSA-8949664,0.7559116533017141,1.2624824541784798,0.2347266881028939,0.962626420430119,1.0,3/15,3.94%,Mcu;Micu1;Yme1l1
prerank,HS-GAG Biosynthesis R-HSA-2022928,-0.7807049280464083,-1.2610238785525116,0.13582089552238805,1.0,1.0,9/30,1.64%,Gpc6;Ext1;Hs6st2;Gpc5;Hs3st2;Hs3st5;Hs6st3;Ndst3;Hs3st4
prerank,"Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",0.6262690366093915,1.2609100514511336,0.12585034013605442,0.9580965595158764,1.0,10/73,1.48%,Kalrn;Tiam1;Plekhg5;Vav3;Rasgrf2;Abr;Itsn1;Arhgef9;Fgd4;Arhgef4
prerank,Diseases Of Programmed Cell Death R-HSA-9645723,0.6535211907536317,1.2595741896631052,0.15561959654178675,0.9520756882716042,1.0,3/57,3.93%,Erc2;Jun;Cdk5r1
prerank,Downstream TCR Signaling R-HSA-202424,-0.6850718883027475,-1.2593398785297294,0.10344827586206896,1.0,1.0,3/83,1.22%,Prkcq;Pik3r1;Inpp5d
prerank,PI-3K cascade:FGFR1 R-HSA-5654689,-0.8015279938390031,-1.2585758277325114,0.18194640338504936,1.0,1.0,2/19,1.29%,Pik3r1;Fgf1
prerank,Activation Of G Protein Gated Potassium Channels R-HSA-1296041,0.724823753253987,1.2559164867057877,0.20344827586206896,0.9572623785843117,1.0,5/27,2.24%,Kcnj3;Kcnj6;Gabbr2;Gng7;Gng2
prerank,Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,0.7562696795503225,1.2547705503356412,0.2375,0.9505381606726824,1.0,2/18,0.43%,Ppfia2;Rims1
prerank,N-Glycan Antennae Elongation R-HSA-975577,-0.7944153728021317,-1.2544904269526085,0.1867816091954023,1.0,1.0,4/15,5.28%,St6gal1;Mgat4c;Mgat5;St8sia6
prerank,Mitochondrial Calcium Ion Transport R-HSA-8949215,0.7361586736808583,1.2539584156285057,0.22611464968152867,0.9421717592035855,1.0,3/21,3.94%,Mcu;Micu1;Yme1l1
prerank,Expression And Translocation Of Olfactory Receptors R-HSA-9752946,-0.6763458154491804,-1.25375786395414,0.12954876273653565,1.0,1.0,12/95,11.46%,Ldb2;Or51d1;Or52i2;Or51e1;Or52k2;Or2t6;Or52m1;Reep1;Ebf1;Or51e2;Or1n2;Or2t1
prerank,Growth Hormone Receptor Signaling R-HSA-982772,-0.768954424307873,-1.2520074219297506,0.18950437317784258,1.0,1.0,8/21,9.87%,Socs2;Stat5b;Lyn;Cish;Jak2;Adam17;Stat5a;Prlr
prerank,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.7431581564927462,-1.2504838820534103,0.17524339360222532,1.0,1.0,12/41,8.52%,Tcf7l2;Sox6;Tcf7l1;Tle3;Sox2;Lef1;Sox4;Tle2;Ctnnbip1;Bcl9;Sox9;Sox13
prerank,Downstream Signaling Of Activated FGFR2 R-HSA-5654696,-0.7721870350868624,-1.2501388036658858,0.16101694915254236,1.0,1.0,2/27,1.29%,Pik3r1;Fgf1
prerank,NLRP3 Inflammasome R-HSA-844456,-0.8033747296668826,-1.2487127039954524,0.20142857142857143,1.0,1.0,5/15,10.74%,P2rx7;Casp1;App;Txnip;Nlrp3
prerank,SHC-mediated cascade:FGFR3 R-HSA-5654704,-0.7989803832625061,-1.2463357610187398,0.20608575380359612,1.0,1.0,2/15,2.08%,Fgf1;Fgfr3
prerank,Interleukin-1 Family Signaling R-HSA-446652,0.5699848961515132,1.24366930815276,0.09352517985611511,0.9801109147150794,1.0,10/140,2.99%,Il1rap;Il1rapl1;Map2k6;Il1r1;Map2k1;Tnip2;Smad3;Peli1;Btrc;Fbxw11
prerank,Hedgehog Ligand Biogenesis R-HSA-5358346,-0.6911813030328099,-1.2427391059409376,0.1619718309859155,1.0,1.0,4/64,9.18%,Gpc5;Shh;Adam17;Psmb8
prerank,Fatty Acid Metabolism R-HSA-8978868,-0.6330430426928678,-1.2424247189073419,0.1271186440677966,1.0,1.0,32/147,14.22%,Fa2h;Elovl7;Tbxas1;Pla2g4a;Hpgd;Pon2;Ptgs1;Prkab2;Prkaa2;Hpgds;Acsl3;Ggt5;Elovl6;Acadl;Phyh;Crot;Ptgds;Hsd17b12;Acsbg1;Alox12b;Acsf2;Acot11;Acot9;Cpt1a;Acaca;Pctp;Abcd1;Decr1;Abcc1;Ptges;Ltc4s;Dbi
prerank,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,-0.76581488742487,-1.242282102597447,0.18722786647314948,1.0,1.0,10/27,6.58%,Sox10;Utrn;Mag;Wwtr1;Lama2;Pou3f2;Hmgcr;Srebf2;Adgrg6;Pou3f1
prerank,Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,-0.7507962016577259,-1.2410851405809042,0.1791044776119403,1.0,1.0,7/34,6.78%,Kit;Apoe;Esr1;Kctd1;Egfr;Wwox;Vegfa
prerank,Dopamine Neurotransmitter Release Cycle R-HSA-212676,0.7376808069779015,1.2392583110920927,0.19935691318327975,0.9887255710263411,1.0,7/23,4.51%,Ppfia2;Rims1;Syn2;Syn3;Syt1;Tspoap1;Lin7c
prerank,Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.6194414729414628,-1.2382640636067612,0.11772853185595568,1.0,1.0,22/171,11.02%,Gpc6;Enpp2;Gpc5;Akr1b10;Parp8;Parp4;Prkg2;Apoe;Tcn2;Bco2;Aldh1l1;Aox1;Sdc4;Cyb5a;Hspg2;Ldlrap1;Acaca;Sp8;Tpk1;Mthfd1l;Cd38;Lpl
prerank,Glutamate Neurotransmitter Release Cycle R-HSA-210500,0.7150861162161001,1.238137421685893,0.24477611940298508,0.9817030731224431,1.0,6/23,4.24%,Ppfia2;Rims1;Slc17a7;Slc1a1;Syt1;Tspoap1
prerank,Amine Ligand-Binding Receptors R-HSA-375280,-0.7422343696046942,-1.2380686330629223,0.17688022284122562,1.0,1.0,13/34,7.72%,Chrm3;Htr1f;Htr2c;Adra1a;Chrm2;Htr7;Htr2a;Drd2;Adra1b;Adrb3;Hrh2;Hrh3;Chrm5
prerank,Cellular Senescence R-HSA-2559583,0.5732165425706569,1.237800417250346,0.09507042253521127,0.9710423991498086,1.0,24/138,7.67%,Tnik;Tnrc6c;Map2k6;Mapk1;Jun;Rps6ka2;Mapk10;Ago1;Tnrc6b;Mink1;Cbx6;Map2k4;Mapk3;Rad50;Hira;Ehmt1;Mapk14;Map3k5;Cbx4;Rbbp7;Phc2;Cebpb;Suz12;Ezh2
prerank,ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,0.7333606202372449,1.2375802331392176,0.24477611940298508,0.9602152276833716,1.0,4/25,7.38%,Atf6;Khsrp;Exosc8;Cebpb
prerank,Phase 0 - Rapid Depolarisation R-HSA-5576892,0.7139876191022149,1.2360588772657248,0.23053892215568864,0.9555191444967966,1.0,12/32,2.94%,Fgf14;Cacnb2;Cacna1c;Camk2a;Camk2b;Scn3a;Scn2a;Scn8a;Scn3b;Cacng8;Camk2g;Scn9a
prerank,Signaling By FGFR2 In Disease R-HSA-5655253,-0.7368354429072552,-1.2359443082213892,0.17280453257790368,1.0,1.0,2/40,1.29%,Pik3r1;Fgf1
prerank,Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.7722449091899096,-1.2356587341024732,0.17333333333333334,1.0,1.0,5/24,7.19%,Elovl7;Acsl3;Elovl6;Hsd17b12;Acsbg1
prerank,CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,0.7373054866308288,1.235511155269382,0.22972972972972974,0.9464267115974064,1.0,11/26,3.61%,Lrrc7;Grin2b;Camk2a;Camk2b;Rasgrf1;Rasgrf2;Mapk1;Rps6ka2;Camk2g;Calm1;Actn2
prerank,Neurexins And Neuroligins R-HSA-6794361,0.6496684369259657,1.2354861223404847,0.17307692307692307,0.9353632211616502,1.0,12/55,2.11%,Dlgap1;Lrrtm4;Grm1;Grin2a;Dlgap2;Grin2b;Syt7;Grm5;Sipa1l1;Nlgn1;Epb41l1;Syt10
prerank,FCERI Mediated NF-kB Activation R-HSA-2871837,-0.6766858051653615,-1.235345770093026,0.15208034433285508,1.0,1.0,6/76,9.18%,Prkcq;Rasgrp1;Lyn;Rasgrp2;Bcl10;Psmb8
prerank,NCAM1 Interactions R-HSA-419037,0.6904564304633845,1.2338977981890389,0.22028985507246376,0.9317509807321038,1.0,8/37,2.46%,Cacnb2;Cacna1c;Cacna1d;Gfra1;Ncam1;Cacna1h;Gfra2;St8sia4
prerank,Laminin Interactions R-HSA-3000157,-0.7761251218469977,-1.232971342640657,0.18607954545454544,1.0,1.0,12/22,11.80%,Lama4;Lama2;Itga2;Lama1;Lamc2;Itga6;Itgb1;Hspg2;Itga1;Itga3;Lamc3;Nid2
prerank,Regulation Of Signaling By CBL R-HSA-912631,-0.7787439047528605,-1.2314234083344706,0.19578313253012047,1.0,1.0,6/18,7.53%,Pik3r1;Hck;Vav1;Lyn;Clstn1;Syk
prerank,"Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",0.7140687833701105,1.230614492357819,0.27514792899408286,0.9357350522905886,1.0,5/27,2.24%,Cacnb2;Cacna1c;Cacna1d;Gng7;Gng2
prerank,Syndecan Interactions R-HSA-3000170,-0.7771369574359688,-1.230403436233239,0.19688385269121814,1.0,1.0,8/20,8.24%,Itgb5;Itga2;Tgfb1;Itga6;Sdc4;Vtn;Prkca;Itgb1
prerank,Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.6055557154467918,-1.2285840755128623,0.12985274431057564,1.0,1.0,15/184,6.01%,Ldb2;Prkcq;Prkcb;Runx1;Tcf7l1;Nr4a3;Kat2b;Nfatc2;Spi1;Esr1;Ccnd3;Hipk2;Smarcd3;Zfpm1;Pcgf5
prerank,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.6504135514914824,-1.228557620909736,0.13884785819793205,1.0,1.0,18/113,14.49%,Enpp2;Parp8;Parp4;Tcn2;Aldh1l1;Aox1;Cyb5a;Ldlrap1;Acaca;Sp8;Tpk1;Mthfd1l;Cd38;Parp14;Abcc1;Acp5;Folr2;Enpp3
prerank,LDL Clearance R-HSA-8964038,-0.7771974159153099,-1.2265314857822978,0.2323943661971831,1.0,1.0,6/16,14.62%,Ap2b1;Ldlrap1;Soat1;Npc2;Ldlr;Cltc
prerank,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,0.6658272326219775,1.2259047164241006,0.1620795107033639,0.9459189887504137,1.0,5/48,0.64%,Epha7;Tiam1;Epha4;Vav3;Epha6
prerank,NRAGE Signals Death Thru JNK R-HSA-193648,0.6336376288262088,1.2254102025206295,0.2054794520547945,0.9375536385424431,1.0,10/56,1.48%,Kalrn;Tiam1;Plekhg5;Vav3;Rasgrf2;Abr;Itsn1;Arhgef9;Fgd4;Arhgef4
prerank,Pre-NOTCH Expression And Processing R-HSA-1912422,0.6274259603896689,1.2249950436151278,0.16619718309859155,0.9288381828228172,1.0,9/65,3.98%,Maml2;Maml3;Tnrc6c;Notch2;B4galt1;Jun;Ago1;Ago2;Tnrc6b
prerank,Metabolism Of Nucleotides R-HSA-15869,0.5936489419054382,1.2249513344552114,0.16013071895424835,0.9188034562407105,1.0,6/86,3.00%,Ak5;Dpyd;Gda;Nt5c2;Adk;Upp2
prerank,Metabolism Of Carbohydrates R-HSA-71387,-0.5894216781491438,-1.2245956929010071,0.11009174311926606,1.0,1.0,40/263,8.53%,Gpc6;Xylt1;Ext1;Hs6st2;Gpc5;Hs3st2;Hs3st5;Hs6st3;Bcan;Pfkp;Ndst3;Aldh1a1;Hs3st4;Ugp2;St3gal6;Cspg4;Phkb;Vcan;Slc25a13;Chst3;Cspg5;Cd44;Gbe1;Dcn;Pck2;Manba;Pfkfb3;Has2;Map4k2;Sdc4;Hs3st1;Phkg1;Pfkfb4;Pgm2;Prkca;Gys1;Slc35d2;Gusb;Ndst1;Prelp
prerank,MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,0.7627077644914004,1.223395523770365,0.2762237762237762,0.9152790754275515,1.0,4/18,2.26%,Grin2a;Grin2b;Gria2;Fkbp5
prerank,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.7630726738908765,-1.2231995137238185,0.2231638418079096,1.0,1.0,2/22,4.53%,Tubb3;Tubb4a
prerank,mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,0.7488669605475644,1.2220094944594202,0.283987915407855,0.9114803572919465,1.0,6/15,11.52%,Dcp1b;Edc3;Lsm7;Edc4;Dcp1a;Lsm4
prerank,Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.7673398810931736,-1.221861084587985,0.20555555555555555,1.0,1.0,1/19,1.29%,Fgf1
prerank,"Synthesis, Secretion, And Deacylation Of Ghrelin R-HSA-422085",-0.7710242928342254,-1.2202290279322026,0.2326241134751773,1.0,1.0,5/17,13.99%,Pcsk1;Igf1;Pla2g7;Ache;Mboat4
prerank,FRS-mediated FGFR4 Signaling R-HSA-5654712,-0.780942057940278,-1.220083543712159,0.22284908321579688,1.0,1.0,1/18,1.29%,Fgf1
prerank,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,-0.6488102644992109,-1.2189459467770747,0.15976331360946747,1.0,1.0,19/110,13.04%,Tbl1x;Hmgcs1;Arnt2;Npas2;Abca1;Fhl2;Cdk19;Hmgcr;Smarcd3;Srebf2;Fdft1;Hmgcs2;Ncoa3;Pparg;Cpt1a;Ppargc1a;Angptl4;Nrf1;G0s2
prerank,Collagen Formation R-HSA-1474290,-0.664956175875561,-1.2189341126174038,0.16152716593245228,1.0,1.0,32/86,10.79%,Adamts2;Col26a1;Lama4;Col27a1;P4ha3;Col6a2;P3h2;Col6a1;Col6a5;Ctss;Col8a1;Lamc2;Itga6;Mmp28;Col9a1;Col4a5;Col16a1;Col12a1;Col11a1;Col19a1;Plod1;Col1a2;Col4a2;Col3a1;Col6a3;Pcolce;Col14a1;Col24a1;Col8a2;Dst;Loxl2;Col4a1
prerank,Signaling By NTRKs R-HSA-166520,0.569342101967532,1.21797954988434,0.12121212121212122,0.9191681902489369,1.0,17/129,3.25%,Ntrk3;Grin2b;Tiam1;Bcl11b;Pcsk5;Ntf3;Mapk1;Rit2;Map2k1;Adcyap1r1;Chd4;Dock3;Dnm1;Rps6ka2;Mef2c;Mef2d;Pik3cb
prerank,Stimuli-sensing Channels R-HSA-2672351,0.5941424599624902,1.2179354440579044,0.1505016722408027,0.9096323782887148,1.0,13/91,3.50%,Trpm3;Ryr2;Ano3;Trpc6;Nedd4l;Unc79;Unc80;Ano2;Ryr1;Best3;Nalcn;Ano6;Calm1
prerank,Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.7264303953808876,-1.2177359655864928,0.18653576437587657,1.0,1.0,10/40,5.44%,Kcnc2;Itpr2;Kcns3;Gng4;Rapgef3;Prkar1b;Gng12;Iqgap1;Gnas;Gnb4
prerank,GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,-0.7695598746135478,-1.2175319043786068,0.2143884892086331,1.0,1.0,9/26,5.96%,Gpc6;Xylt1;Gpc5;Bcan;Cspg4;Vcan;Cspg5;Dcn;Sdc4
prerank,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.7154594144669583,-1.2168036208796114,0.21585903083700442,1.0,1.0,2/46,2.55%,Myo1e;Kat2b
prerank,PPARA Activates Gene Expression R-HSA-1989781,-0.6506092454670369,-1.2164207586006108,0.16840536512667661,1.0,1.0,19/108,13.04%,Tbl1x;Hmgcs1;Arnt2;Npas2;Abca1;Fhl2;Cdk19;Hmgcr;Smarcd3;Srebf2;Fdft1;Hmgcs2;Ncoa3;Pparg;Cpt1a;Ppargc1a;Angptl4;Nrf1;G0s2
prerank,Striated Muscle Contraction R-HSA-390522,-0.737634320613633,-1.2163936064065675,0.20987654320987653,1.0,1.0,7/32,8.22%,Dmd;Tnni1;Myh6;Tnnt2;Tcap;Tmod3;Neb
prerank,Surfactant Metabolism R-HSA-5683826,-0.7567267272390004,-1.2156970342041526,0.21428571428571427,1.0,1.0,12/22,20.45%,Zdhhc2;Lmcd1;Ctsh;Adora2b;Adgrf5;Adra2a;Slc34a1;Csf2rb;Abca3;Sftpb;Sftpc;Gata6
prerank,RHOBTB1 GTPase Cycle R-HSA-9013422,-0.7533108916508198,-1.2147095171374784,0.23504273504273504,1.0,1.0,3/23,2.79%,Pde5a;Myo6;Rhobtb1
prerank,Regulation Of KIT Signaling R-HSA-1433559,-0.7832433168400583,-1.2136495772363018,0.23829787234042554,1.0,1.0,2/15,2.91%,Kit;Lyn
prerank,Signaling By WNT In Cancer R-HSA-4791275,-0.7451670074471649,-1.212157394386806,0.18439716312056736,1.0,1.0,7/32,10.25%,Tcf7l2;Ppp2r5a;Rnf43;Dkk2;Lrp5;Ppp2r5c;Fzd6
prerank,RA Biosynthesis Pathway R-HSA-5365859,-0.7761872963004763,-1.211244289318717,0.21304347826086956,1.0,1.0,3/17,6.99%,Aldh1a1;Cyp26b1;Dhrs3
prerank,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,0.6709369079476972,1.208784303624218,0.254601226993865,0.9390632619658755,1.0,13/29,11.94%,Ube2w;Ube2e3;Ube2g2;Ube2k;Ube2b;Ube2r2;Ube2d1;Ube2q2;Uchl3;Usp7;Ube2t;Ube2h;Uba52
prerank,Nuclear Envelope Breakdown R-HSA-2980766,-0.6978327769447285,-1.208567014750416,0.2052401746724891,1.0,1.0,2/49,0.97%,Prkcb;Vrk2
prerank,Phototransduction Cascade R-HSA-2514856,-0.7348940694511785,-1.2082060799226013,0.23407407407407407,1.0,1.0,6/28,9.16%,Prkcq;Camkmt;Slc24a1;Gucy2f;Prkca;Nmt2
prerank,Metabolism Of Porphyrins R-HSA-189445,-0.7604648764904074,-1.2078224231135894,0.2301013024602026,1.0,1.0,2/22,8.40%,Slco2b1;Gusb
prerank,Depolymerisation Of Nuclear Lamina R-HSA-4419969,-0.7806774736421225,-1.2074575998632717,0.2409288824383164,1.0,1.0,2/15,7.75%,Prkcb;Prkca
prerank,Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,-0.7244084648300276,-1.2053532320639435,0.20605187319884727,1.0,1.0,10/39,5.96%,Gpc6;Ext1;Gpc5;Bcan;Cspg4;Vcan;Chst3;Cspg5;Dcn;Sdc4
prerank,TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,-0.7557545672243509,-1.2035783464556349,0.2791666666666667,1.0,1.0,9/16,21.37%,Tnfrsf11a;Birc3;Ltbr;Traf3;Ltb;Tnfsf12;Cd40;Cd40lg;Tnfsf11
prerank,Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.7287715908208753,-1.2023020072165094,0.22627737226277372,1.0,1.0,7/35,6.80%,Agbl4;Ttll7;Tubb3;Tubb4a;Ttl;Ttll8;Vash2
prerank,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,0.6894081318174219,1.2013151076030062,0.25825825825825827,0.9606637268697659,1.0,12/32,10.57%,Chd4;Chd3;Gatad2b;Hdac1;Mta3;Rbbp7;Cbx3;Mta2;H2bc4;H2az1;H2ac6;H2ax
prerank,Signaling By Nuclear Receptors R-HSA-9006931,-0.581743100975183,-1.2000608277288847,0.13545816733067728,1.0,1.0,34/229,8.45%,Erbb4;Pik3r1;Tbl1x;Runx1;Bcl2;Aldh1a1;Arl4c;Gng4;Abca1;Kcnh8;Tle3;Kank1;Kat2b;Rara;Apoe;Rxrg;Gng12;Ctsd;Nrip1;Esr1;Gnai1;Apod;Esr2;Gnb4;Egfr;Cav1;Kdm3a;Cyp26b1;Gnai2;Dhrs3;Cav2;Ccnd1;Greb1;Ncoa3
prerank,TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.7417325831739154,-1.1986696501520633,0.263768115942029,1.0,1.0,8/22,15.62%,Trim25;App;Ifih1;Map3k1;Rnf135;Rigi;S100b;Nkiras1
prerank,SLC Transporter Disorders R-HSA-5619102,0.5761598402281058,1.1952807333745588,0.20123839009287925,0.9766055487906369,1.0,3/91,2.41%,Slc4a4;Slc24a4;Slc1a1
prerank,SHC-mediated cascade:FGFR4 R-HSA-5654719,-0.7639996452036256,-1.1948845876987058,0.2556179775280899,1.0,1.0,1/16,1.29%,Fgf1
prerank,FLT3 Signaling R-HSA-9607240,-0.7115630671740668,-1.1947472352011688,0.24312590448625182,1.0,1.0,5/36,2.22%,Socs2;Gab2;Stat5b;Pik3r1;Hck
prerank,Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,0.7373299519090564,1.193049832216608,0.30357142857142855,0.9770223426958804,1.0,6/19,0.82%,Lrrc7;Grin2b;Camk2a;Camk2b;Rasgrf1;Rasgrf2
prerank,"Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.7235813122629922,-1.191611550858628,0.26284875183553597,1.0,1.0,5/27,9.16%,Prkcq;Camkmt;Gucy2f;Prkca;Nmt2
prerank,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.6418890280936488,-1.190590104116944,0.19247467438494936,1.0,1.0,6/87,9.18%,Enpp2;Zfp36l1;Prkcd;Mapk11;Prkca;Psmb8
prerank,"Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",-0.7415680743666448,-1.1904145781879192,0.26061493411420206,1.0,1.0,3/17,13.41%,Tcn2;Ldlrap1;Abcc1
prerank,Glycogen Metabolism R-HSA-8982491,-0.7370080161510955,-1.1882067167801358,0.2614942528735632,1.0,1.0,5/22,8.20%,Ugp2;Phkb;Gbe1;Phkg1;Gys1
prerank,Signaling By FGFR1 R-HSA-5654736,-0.6900882959783402,-1.1874909556177013,0.245014245014245,1.0,1.0,4/46,2.15%,Flrt2;Pik3r1;Fgf1;Flrt1
prerank,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,0.6088552454289916,1.1863259659649301,0.2180232558139535,0.9971007408315886,1.0,25/59,21.17%,Utp4;Rcl1;Sppl2a;Dkc1;Nop58;Heatr1;Wdr75;Wdr43;Utp15;Nop56;Wdr36;Mphosph10;Emg1;Tbl3;Rps9;Utp6;Nol6;Krr1;Dhx37;Thumpd1;Tsr3;Dcaf13;Utp20;Rrp9;Utp25
prerank,Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,0.7307641627690618,1.1857917577666062,0.3072100313479624,0.9898076350897961,1.0,2/17,0.43%,Ppfia2;Rims1
prerank,Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.7220307597571332,-1.1857173937777654,0.24848484848484848,1.0,1.0,6/33,10.22%,Elovl7;Acsl3;Elovl6;Hsd17b12;Acsbg1;Acaca
prerank,Signaling By FGFR R-HSA-190236,-0.6544367968187252,-1.1856549566660508,0.21128798842257598,1.0,1.0,5/80,2.15%,Flrt2;Pik3r1;Fgf1;Fgfr3;Flrt1
prerank,Notch-HLH Transcription Pathway R-HSA-350054,0.6899532200035352,1.182969610002638,0.27134146341463417,0.9926011601534787,1.0,5/28,2.06%,Maml2;Maml3;Ncor1;Notch2;Hdac7
prerank,Insulin Processing R-HSA-264876,-0.736339215986392,-1.1791114100015505,0.23347398030942335,1.0,1.0,4/26,4.13%,Cpe;Pcsk1;Stx1a;Kif5a
prerank,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.6892587880538251,-1.1790562398590556,0.22287390029325513,1.0,1.0,10/51,5.64%,Khdrbs3;Dock1;Erbb4;Elmo1;Nrg1;Erbb3;Epas1;Lrrk2;Arap1;Egfr
prerank,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,0.660785570068382,1.1778976059576436,0.2687074829931973,1.0,1.0,13/34,4.99%,Wipf3;Wasf1;Baiap2;Nckap1;Abi2;Mapk1;Ptk2;Actr3;Arpc2;Abi1;Cyfip2;Mapk3;Cyfip1
prerank,Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.7169132721108282,-1.1770584606172287,0.26744186046511625,1.0,1.0,9/30,7.94%,Itpr2;Pik3r1;Pik3ap1;Vav1;Lyn;Dapp1;Clstn1;Syk;Btk
prerank,Formation Of RNA Pol II Elongation Complex R-HSA-112382,0.6232069918024234,1.176289770311402,0.23248407643312102,1.0,1.0,14/53,12.04%,Gtf2h2;Gtf2f2;Gtf2h5;Ccnh;Ssrp1;Ncbp1;Mnat1;Rtf1;Ccnt2;Aff4;Polr2e;Ccnk;Skic8;Cdk9
prerank,Biological Oxidations R-HSA-211859,-0.6030770421942617,-1.1749381929155573,0.20317002881844382,1.0,1.0,14/141,6.93%,Acss1;Aldh1a1;Arnt2;Ugp2;Tbxas1;Ptgs1;Smox;Slc38a3;Hpgds;Ggt5;Maob;Cyp26b1;Cyp27a1;Fmo1
prerank,Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,-0.6620508499472129,-1.174900584942727,0.22492836676217765,1.0,1.0,16/72,5.64%,Kit;Erbb4;Gab2;Pik3r1;Nrg1;Fgf1;Pik3ap1;Fgfr3;Vav1;Pdgfra;Erbb3;Cd86;Esr1;Esr2;Clstn1;Egfr
prerank,Telomere Extension By Telomerase R-HSA-171319,-0.7271997293345959,-1.1731982033214632,0.2643171806167401,1.0,1.0,3/22,12.46%,Ankrd28;Cdk2;Pif1
prerank,RAS Processing R-HSA-9648002,-0.7417140749382818,-1.169820521280529,0.2948539638386648,1.0,1.0,2/17,3.25%,Prkcq;Prkg2
prerank,Signaling By Hippo R-HSA-2028269,-0.7405230758595482,-1.1691907324529296,0.28551724137931034,1.0,1.0,5/20,9.10%,Lats2;Wwtr1;Tjp2;Amot;Amotl2
prerank,Collagen Chain Trimerization R-HSA-8948216,-0.682429315951249,-1.1691585434807994,0.25360230547550433,1.0,1.0,20/43,10.79%,Col26a1;Col27a1;Col6a2;Col6a1;Col6a5;Col8a1;Col9a1;Col4a5;Col16a1;Col12a1;Col11a1;Col19a1;Col1a2;Col4a2;Col3a1;Col6a3;Col14a1;Col24a1;Col8a2;Col4a1
prerank,RHOB GTPase Cycle R-HSA-9013026,-0.656162388209822,-1.168492254455793,0.25327510917030566,1.0,1.0,15/68,7.06%,Pcdh7;Dlc1;Vav2;Pik3r1;Arhgap26;Mcf2;Anln;Prex1;Akap13;Arhgef11;Mcam;Ophn1;Arhgef10;Cav1;Tjp2
prerank,G Alpha (12/13) Signaling Events R-HSA-416482,0.5750111820874645,1.167994286151559,0.20521172638436483,1.0,1.0,12/76,2.24%,Kalrn;Tiam1;Plekhg5;Vav3;Rasgrf2;Abr;Itsn1;Arhgef9;Fgd4;Gng7;Arhgef4;Gng2
prerank,Integrin Signaling R-HSA-354192,-0.7278874721321649,-1.1673957124440097,0.28125,1.0,1.0,7/26,7.53%,Apbb1ip;Fn1;Rasgrp1;Rapgef3;Rasgrp2;Rap1b;Syk
prerank,ISG15 Antiviral Mechanism R-HSA-1169408,0.6074911534057674,1.1649247164119176,0.24662162162162163,1.0,1.0,9/69,7.31%,Sgip1;Pdzd2;Nedd4;Mapk3;Eif4e3;Ndc1;Eif4g2;Nup93;Ranbp2
prerank,RAB Geranylgeranylation R-HSA-8873719,-0.6619750064539796,-1.1635278444179704,0.28011611030478956,1.0,1.0,3/57,2.61%,Rab3c;Rab31;Rab3b
prerank,Platelet Aggregation (Plug Formation) R-HSA-76009,-0.7060333987412754,-1.1634600398332822,0.24158125915080528,1.0,1.0,7/35,7.53%,Apbb1ip;Fn1;Rasgrp1;Rapgef3;Rasgrp2;Rap1b;Syk
prerank,Phase I - Functionalization Of Compounds R-HSA-211945,-0.6585532717366477,-1.1624130531215047,0.25806451612903225,1.0,1.0,10/63,6.93%,Acss1;Aldh1a1;Arnt2;Tbxas1;Ptgs1;Smox;Maob;Cyp26b1;Cyp27a1;Fmo1
prerank,Insulin Receptor Signaling Cascade R-HSA-74751,-0.6787777026339252,-1.1615219453970345,0.2821270310192024,1.0,1.0,5/48,5.15%,Gab2;Pik3r1;Fgf1;Fgfr3;Grb10
prerank,Signaling By ERBB2 ECD Mutants R-HSA-9665348,-0.7502802369996528,-1.1606803599527056,0.31444759206798867,1.0,1.0,6/15,17.85%,Pik3r1;Egfr;Pik3ca;Erbin;Shc1;Erbb2
prerank,Clathrin-mediated Endocytosis R-HSA-8856828,-0.5962159455566478,-1.1596467373688293,0.22349570200573066,1.0,1.0,18/131,7.29%,Fnbp1l;Synj2;Chrm2;Syt9;Hip1;Cftr;Grk3;Eps15;Dab2;Hip1r;Fnbp1;Dnm3;Egfr;Pacsin3;Stam2;Ap2b1;Sh3gl2;Syt12
prerank,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.7357111311343785,-1.1588002996150588,0.29312762973352036,1.0,1.0,2/20,4.53%,Tubb3;Tubb4a
prerank,PERK Regulates Gene Expression R-HSA-381042,0.6721040266800256,1.1580886885136887,0.27696793002915454,1.0,1.0,4/29,7.38%,Atf6;Khsrp;Exosc8;Cebpb
prerank,Ion Channel Transport R-HSA-983712,0.5211665951020993,1.1574650528907027,0.20567375886524822,1.0,1.0,22/162,3.50%,Trpm3;Ryr2;Ano3;Trpc6;Camk2a;Camk2b;Nedd4l;Unc79;Unc80;Atp2b1;Atp2b3;Atp6v1a;Ano2;Ryr1;Best3;Atp8a1;Atp1b1;Camk2g;Nalcn;Atp2c1;Ano6;Calm1
prerank,HIV Elongation Arrest And Recovery R-HSA-167287,0.6706264773940193,1.1567351367450682,0.31561461794019935,1.0,1.0,10/29,17.86%,Gtf2f2;Ssrp1;Ccnt2;Polr2e;Ccnk;Cdk9;Polr2k;Gtf2f1;Ctdp1;Tcea1
prerank,RORA Activates Gene Expression R-HSA-1368082,-0.7362460477169064,-1.156416416931494,0.3318777292576419,1.0,1.0,3/18,10.15%,Tbl1x;Smarcd3;Cpt1a
prerank,PI3K/AKT Signaling In Cancer R-HSA-2219528,-0.6200422013234733,-1.1562357832638015,0.25312934631432543,1.0,1.0,18/99,5.64%,Kit;Erbb4;Gab2;Pik3r1;Nr4a1;Nrg1;Fgf1;Pik3ap1;Fgfr3;Vav1;Pdgfra;Erbb3;Cd86;Esr1;Prr5;Esr2;Clstn1;Egfr
prerank,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.6309493854939403,-1.1561744739599469,0.23579545454545456,1.0,1.0,6/84,4.69%,Tcf7l2;Tcf7l1;Tle3;Lef1;Ppp2r5a;Tle2
prerank,Signaling By Retinoic Acid R-HSA-5362517,-0.6870653560522676,-1.1553819288294778,0.2903703703703704,1.0,1.0,8/35,13.62%,Aldh1a1;Rara;Rxrg;Cyp26b1;Dhrs3;Cpt1a;Pdk4;Aldh1a2
prerank,Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,-0.7395653672253666,-1.1552876929446887,0.30346820809248554,1.0,1.0,8/20,5.96%,Gpc6;Gpc5;Bcan;Cspg4;Vcan;Cspg5;Dcn;Sdc4
prerank,RND2 GTPase Cycle R-HSA-9696270,-0.671183343358565,-1.1549123776203543,0.2829912023460411,1.0,1.0,10/41,12.14%,Pik3r1;Prag1;Fnbp1;Plxnd1;Cav1;Depdc1b;Ptpn13;Dst;Arhgap5;Arhgap1
prerank,WNT Ligand Biogenesis And Trafficking R-HSA-3238698,-0.7145510328578861,-1.1543241066527685,0.30638297872340425,1.0,1.0,4/25,9.05%,Wls;Wnt2;Wnt5b;Wnt10a
prerank,Pyroptosis R-HSA-5620971,-0.7373923670248927,-1.1535073663194444,0.3049645390070922,1.0,1.0,5/20,11.85%,Casp1;Casp4;Irf2;Il1a;Il18
prerank,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,0.693089767687802,1.153498769621808,0.3408360128617363,1.0,1.0,5/20,5.92%,Cntn1;Notch2;Psen1;Jag1;Mib1
prerank,Nephrin Family Interactions R-HSA-373753,0.6875561152986709,1.1532229072645694,0.34782608695652173,1.0,1.0,11/21,5.73%,Kirrel3;Magi2;Sptbn1;Nck2;Sptan1;Pik3cb;Actn2;Actn1;Fyn;Actn4;Cd2ap
prerank,Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.653652119893336,-1.1529227743528208,0.26323529411764707,1.0,1.0,7/57,2.71%,St6gal1;Mgat4c;Parp8;Parp4;Man2a1;Zdhhc2;Mgat5
prerank,Gap Junction Trafficking R-HSA-190828,-0.7223859515550473,-1.1517894312272527,0.31798561151079136,1.0,1.0,6/20,9.55%,Dab2;Myo6;Gja3;Gja1;Gjb6;Gjc2
prerank,Sema3A PAK Dependent Axon Repulsion R-HSA-399954,0.7158444579223342,1.150965453133833,0.3687707641196013,1.0,1.0,4/16,4.17%,Plxna4;Nrp1;Arhgef7;Fyn
prerank,Long-term Potentiation R-HSA-9620244,0.6899401852430661,1.1507910602138867,0.328719723183391,1.0,1.0,7/23,0.44%,Gria1;Grin2a;Lrrc7;Grin2b;Camk2a;Camk2b;Gria2
prerank,Plasma Lipoprotein Clearance R-HSA-8964043,-0.6920817415272279,-1.1505609302532198,0.3033381712626996,1.0,1.0,8/33,14.62%,Apoe;Ap2b1;Ldlrap1;Mylip;Soat1;Npc2;Ldlr;Cltc
prerank,MET Promotes Cell Motility R-HSA-8875878,-0.7044383823410983,-1.1503796879991837,0.2994428969359331,1.0,1.0,10/28,10.60%,Lama4;Lama2;Itga2;Lama1;Tns3;Lamc2;Rap1b;Itgb1;Itga3;Lamc3
prerank,Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,0.6919997527152537,1.150340132181342,0.32764505119453924,1.0,1.0,6/21,0.61%,Grin2a;Lrrc7;Grin2b;Camk2a;Camk2b;Ppm1e
prerank,Visual Phototransduction R-HSA-2187338,-0.6333409163657506,-1.1500134877351043,0.2606774668630339,1.0,1.0,15/83,9.16%,Gpc6;Prkcq;Gpc5;Akr1b10;Apoe;Bco2;Rlbp1;Camkmt;Sdc4;Slc24a1;Gucy2f;Dhrs3;Prkca;Hspg2;Nmt2
prerank,Signaling By NOTCH1 R-HSA-1980143,0.591289035268318,1.1484097353029166,0.24920127795527156,1.0,1.0,8/72,3.00%,Maml2;Nbea;Maml3;Cntn1;Tle1;Ncor1;Hdac7;Tle4
prerank,Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,-0.7375232714440136,-1.1454788498758568,0.3183791606367583,1.0,1.0,8/20,5.96%,Gpc6;Gpc5;Bcan;Cspg4;Vcan;Cspg5;Dcn;Sdc4
prerank,"Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",-0.7386346062865334,-1.1448028690090724,0.3193033381712627,1.0,1.0,8/20,5.96%,Gpc6;Gpc5;Bcan;Cspg4;Vcan;Cspg5;Dcn;Sdc4
prerank,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.7200232826795154,-1.1444631737226305,0.3184438040345821,1.0,1.0,1/19,0.97%,Vrk2
prerank,Synthesis Of PC R-HSA-1483191,0.6832807700334705,1.1437884748141536,0.32802547770700635,1.0,1.0,1/27,0.48%,Slc44a5
prerank,Downstream Signal Transduction R-HSA-186763,-0.7177496135319958,-1.1432710177549978,0.31277533039647576,1.0,1.0,9/28,11.06%,Stat5b;Pik3r1;Pdgfra;Stat6;Pdgfrb;Grb7;Stat5a;Pdgfb;Pik3ca
prerank,Glycosaminoglycan Metabolism R-HSA-1630316,-0.6077449665708214,-1.142615081330526,0.2615606936416185,1.0,1.0,21/117,6.07%,Gpc6;Xylt1;Ext1;Hs6st2;Gpc5;Hs3st2;Hs3st5;Hs6st3;Bcan;Ndst3;Hs3st4;St3gal6;Cspg4;Vcan;Chst3;Cspg5;Cd44;Dcn;Has2;Sdc4;Hs3st1
prerank,Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.7288450204308577,-1.1423762210621498,0.3300423131170663,1.0,1.0,2/18,5.64%,Pik3r1;Egfr
prerank,Common Pathway Of Fibrin Clot Formation R-HSA-140875,-0.7166994053708484,-1.1418073692482686,0.3333333333333333,1.0,1.0,2/19,9.03%,Serpine2;Pros1
prerank,TCR Signaling R-HSA-202403,-0.605222826534216,-1.140982587263097,0.2577464788732394,1.0,1.0,5/104,2.09%,Prkcq;Pik3r1;Lcp2;Inpp5d;Ptprc
prerank,Activated Point Mutants Of FGFR2 R-HSA-2033519,-0.7297696100133688,-1.140316810108689,0.33194444444444443,1.0,1.0,3/15,12.43%,Fgf1;Fgf23;Fgfr2
prerank,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,0.6086515470398052,1.1402794174479958,0.2698412698412698,1.0,1.0,4/56,2.06%,Maml2;Maml3;Ncor1;Hdac7
prerank,Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,-0.6426403639190432,-1.1402407848633507,0.276218611521418,1.0,1.0,24/66,9.85%,Adamts2;Col26a1;Col27a1;P4ha3;Col6a2;P3h2;Col6a1;Col6a5;Col8a1;Col9a1;Col4a5;Col16a1;Col12a1;Col11a1;Col19a1;Plod1;Col1a2;Col4a2;Col3a1;Col6a3;Pcolce;Col14a1;Col24a1;Col8a2
prerank,FGFR2 Ligand Binding And Activation R-HSA-190241,-0.7286068083451571,-1.1398403130559787,0.3352112676056338,1.0,1.0,3/17,12.43%,Fgf1;Fgf23;Fgfr2
prerank,Intracellular Signaling By Second Messengers R-HSA-9006925,0.4686790615294252,1.1384464845857807,0.11363636363636363,1.0,1.0,37/294,3.98%,Prkce;Il1rap;Pip5k1b;Nbea;Camk2a;Camk2b;Adcy1;Nrg2;Nrg3;Adcy2;Foxo1;Tnrc6c;Akt3;Mapk1;Pde1b;Tgfa;Adcy9;Chd4;Hdac7;Camkk1;Prex2;Chd3;Jun;Flt3;Rragd;Pip5k1a;Camk2g;Cnot6l;Gatad2b;Pik3cb;Ago1;Calm1;Itpr1;Fgf5;Ago2;Nedd4;Tnrc6b
prerank,Phospholipase C-mediated Cascade; FGFR2 R-HSA-5654221,-0.7270429486229572,-1.137958054286194,0.3301104972375691,1.0,1.0,3/16,12.43%,Fgf1;Fgf23;Fgfr2
prerank,Regulation Of Gene Expression In Beta Cells R-HSA-210745,0.733182142444117,1.137930085138508,0.3684210526315789,1.0,1.0,3/17,3.30%,Foxo1;Akt3;Neurod1
prerank,mRNA Splicing - Minor Pathway R-HSA-72165,0.6102157581424955,1.1371135709252396,0.2875,1.0,1.0,16/49,15.52%,Gtf2f2;Eftud2;Srsf1;Snrnp40;Ncbp1;Sf3b3;Ybx1;Ddx42;Polr2e;Snrpd3;Snrnp48;Srsf7;Snrpb;Polr2k;Snrnp25;Gtf2f1
prerank,Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.7071694249646673,-1.1369114737557484,0.32724719101123595,1.0,1.0,11/29,15.66%,Unc93b1;Tlr3;Traf3;Btk;Tlr5;S100a1;Tlr1;Ticam1;Tirap;Tlr2;Tlr6
prerank,RHOC GTPase Cycle R-HSA-9013106,-0.6348484881958416,-1.1366015557992923,0.2852897473997028,1.0,1.0,18/72,7.06%,Dlc1;Vav2;Pik3r1;Arhgap26;Mcf2;Arhgap18;Anln;Prex1;Akap13;Fmnl3;Iqgap1;Arhgef40;Arhgef11;Mcam;Ophn1;Arhgef10;Cav1;Tjp2
prerank,Nicotinate Metabolism R-HSA-196807,-0.6943196715906151,-1.1361959713464165,0.34281650071123754,1.0,1.0,2/30,1.80%,Parp8;Parp4
prerank,Signaling To RAS R-HSA-167044,-0.7281229550030418,-1.1360649727698153,0.3452722063037249,1.0,1.0,5/19,10.89%,Ngf;Shc3;Mapk11;Ralb;Rala
prerank,Regulation Of PTEN Gene Transcription R-HSA-8943724,0.5898878855427433,1.135222919731912,0.2682119205298013,1.0,1.0,19/58,8.01%,Mapk1;Chd4;Hdac7;Chd3;Jun;Rragd;Gatad2b;Hdac1;Cbx6;Mapk3;Mta3;Cbx4;Rbbp7;Rptor;Phc2;Suz12;Ezh2;Rcor1;Mta2
prerank,MET Activates PTK2 Signaling R-HSA-8874081,-0.7200886568154796,-1.1348876650743536,0.32608695652173914,1.0,1.0,8/17,10.60%,Lama4;Lama2;Itga2;Lama1;Lamc2;Itgb1;Itga3;Lamc3
prerank,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",-0.7063504146451574,-1.1340877082575744,0.33768115942028987,1.0,1.0,3/25,4.55%,Tbl1x;Npas2;Smarcd3
prerank,Signaling By FGFR3 R-HSA-5654741,-0.6821728975418525,-1.1340324839853126,0.335243553008596,1.0,1.0,3/37,2.08%,Pik3r1;Fgf1;Fgfr3
prerank,NRIF Signals Cell Death From Nucleus R-HSA-205043,-0.7151572533925371,-1.133466321622433,0.34048640915593703,1.0,1.0,2/16,8.40%,Ngf;Mapk8
prerank,mRNA Splicing - Major Pathway R-HSA-72163,-0.5650077610318047,-1.1321026977086746,0.26943699731903487,1.0,1.0,2/180,2.68%,Elavl2;Colec12
prerank,Deadenylation-dependent mRNA Decay R-HSA-429914,0.6108561132830037,1.130124621304791,0.29793510324483774,1.0,1.0,20/54,11.52%,Cnot2;Cnot6l;Dcp1b;Pan3;Edc3;Lsm7;Exosc8;Eif4b;Nt5c3b;Cnot4;Cnot1;Eif4a2;Eif4a1;Pabpc1;Edc4;Dcp1a;Eif4e;Cnot3;Skic8;Lsm4
prerank,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.71421510506849,-1.1301103337133018,0.3437057991513437,1.0,1.0,2/17,4.53%,Tubb3;Tubb4a
prerank,Costimulation By CD28 Family R-HSA-388841,-0.637173508528625,-1.1288983347466457,0.31689088191330345,1.0,1.0,12/56,12.56%,Pik3r1;Vav1;Cd86;Lyn;Ppp2r5a;Prr5;Cd80;Ppp2r5c;Grap2;Pik3ca;Icos;Pkn2
prerank,Platelet Sensitization By LDL R-HSA-432142,-0.7195593663012979,-1.1279898083368574,0.36070381231671556,1.0,1.0,5/17,17.27%,Pla2g4a;Ppp2r5a;Ppp2r5c;Ptpn6;Ppp2r5e
prerank,Antigen processing-Cross Presentation R-HSA-1236975,-0.6104371962809843,-1.1272981645296622,0.30858806404657935,1.0,1.0,21/93,18.78%,Itgb5;Ncf2;Ctss;Btk;S100a1;Psmb8;Tlr1;Mrc1;Ncf1;Ncf4;Psma8;Cyba;Tirap;Tapbp;Tlr2;Tlr6;Ctsl;Psme4;Vamp8;Psme2;B2m
prerank,P75 NTR Receptor-Mediated Signaling R-HSA-193704,0.54204545345043,1.1269997254167736,0.24567474048442905,1.0,1.0,10/94,1.48%,Kalrn;Tiam1;Plekhg5;Vav3;Rasgrf2;Abr;Itsn1;Arhgef9;Fgd4;Arhgef4
prerank,Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.6866466751793986,-1.1266319673315723,0.3539325842696629,1.0,1.0,8/26,7.04%,Plcb4;Plch2;Inpp5d;Plcb2;Inppl1;Pld4;Plch1;Plcd3
prerank,Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,-0.7150088795743776,-1.1266275206624474,0.3488700564971751,1.0,1.0,2/19,9.03%,Serpine2;Pros1
prerank,Interleukin-2 Family Signaling R-HSA-451927,-0.6651260815447562,-1.1256264298653251,0.3231240428790199,1.0,1.0,12/40,7.53%,Gab2;Stat5b;Pik3r1;Inpp5d;Havcr2;Il15;Lgals9;Clstn1;Inppl1;Il21r;Jak2;Syk
prerank,Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.6322246786808745,-1.123986156972344,0.30959302325581395,1.0,1.0,3/65,4.53%,Vrk2;Tubb3;Tubb4a
prerank,RHOV GTPase Cycle R-HSA-9013424,-0.6618619181484456,-1.1218378312855533,0.3469387755102041,1.0,1.0,5/35,5.11%,Sh3rf1;Pik3r1;Peak1;Iqgap1;Ccp110
prerank,p75NTR Signals Via NF-kB R-HSA-193639,-0.7231666206509908,-1.1212478620872133,0.34008683068017365,1.0,1.0,1/16,1.80%,Ngf
prerank,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.6475871271346282,-1.1212398242958694,0.32831325301204817,1.0,1.0,8/53,6.66%,Tbl1x;Hmgcs1;Hmgcr;Smarcd3;Srebf2;Elovl6;Sqle;Fdft1
prerank,SARS-CoV-2 Infection R-HSA-9694516,-0.5396777750858872,-1.1200946774042664,0.2457516339869281,1.0,1.0,21/252,7.32%,Gpc6;St6gal1;Mgat4c;Gpc5;Parp8;Parp4;Man2a1;Zdhhc2;Mgat5;Gja1;Masp1;Irak2;Trim25;Tlr7;Il17ra;Ywhaq;Sdc4;Cav1;Sting1;Traf3;Ifih1
prerank,Sulfur Amino Acid Metabolism R-HSA-1614635,-0.6941641746023373,-1.1191615580742502,0.34992679355783307,1.0,1.0,3/25,8.03%,Gadl1;Sqor;Cdo1
prerank,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,0.6739460897333371,1.1182604923283492,0.3535714285714286,1.0,1.0,5/17,1.66%,Gria1;Nsf;Gria2;Gria3;Tspan7
prerank,CRMPs In Sema3A Signaling R-HSA-399956,0.6828868390690017,1.1163963330462883,0.391304347826087,1.0,1.0,2/16,0.85%,Plxna4;Nrp1
prerank,mRNA Splicing R-HSA-72172,-0.5577585898280852,-1.116307583981752,0.2918918918918919,1.0,1.0,2/188,2.68%,Elavl2;Colec12
prerank,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,0.5668063422806157,1.1158687741509228,0.2971246006389776,1.0,1.0,10/75,7.31%,Sgip1;Pdzd2;Nedd4;Mapk3;Eif4e3;Ndc1;Eif4g2;Abce1;Nup93;Ranbp2
prerank,Death Receptor Signaling R-HSA-73887,0.5134344353461996,1.1152805047485865,0.2689393939393939,1.0,1.0,11/134,2.17%,Kalrn;Tiam1;Plekhg5;Vav3;Rasgrf2;Abr;Itsn1;Arhgef9;Fgd4;Arhgef4;Usp2
prerank,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.6669489182791598,-1.1145968795298506,0.35871156661786235,1.0,1.0,9/41,15.62%,Alpk1;Irak2;Casp8;App;S100b;Nod1;Nod2;Usp14;Nkiras1
prerank,GPCR Ligand Binding R-HSA-500792,-0.5187697134986762,-1.1121977174782507,0.22857142857142856,1.0,1.0,97/358,14.53%,Chrm3;Rxfp1;Htr1f;Htr2c;Grm8;Grm3;Adra1a;Chrm2;Lpar1;Htr7;Tacr3;Gng4;Qrfpr;Ccr5;Htr2a;Cckbr;Drd2;S1pr1;P2ry6;Cx3cr1;Ptger3;Oprk1;Npsr1;Ednrb;Gng12;Grm4;Smox;Adra1b;P2ry13;Fzd2;Gnas;Ntsr1;Adrb3;Wnt2;Gpr37l1;App;Gnb4;Adgre1;Gpr17;Hrh2;P2ry12;Lhcgr;Shh;C1qtnf1;Adora2b;Ntsr2;P2ry1;Hrh3;Opn3;Npffr1;Chrm5;Hcrt;Crhbp;Crhr1;Lpar6;Tac1;Ucma;Gpr55;Wnt10a;Pth2r;Prok2;Plppr3;Bdkrb2;Ffar4;Sctr;Fzd6;Sst;Adrb1;Nlrp3;Tacr2;Htr1b;Npbwr1;Cxcr4;Ccl28;Nmbr;Tacr1;Adra2a;Rxfp3;Adm;Chga;Pnoc;Tshb;Calcr;Gng3;Wnt3a;Calcb;Gngt2;Ptgdr;Cmklr1;Gper1;Calcrl;Oprd1;Cxcr2;Npy;Edn3;Cysltr1;Cxcl16
prerank,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.6499889344054797,-1.112058530232916,0.3381712626995646,1.0,1.0,5/47,4.69%,Tcf7l2;Tcf7l1;Tle3;Lef1;Tle2
prerank,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.6505702976697006,-1.110910404351353,0.34507042253521125,1.0,1.0,2/50,4.16%,Asap1;Smox
prerank,Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.6942245952923108,-1.110576389825026,0.3883357041251778,1.0,1.0,1/20,2.43%,Cdc14a
prerank,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.6404077971289863,-1.1102371661833033,0.32805755395683456,1.0,1.0,15/50,12.52%,Bcl2;P2rx7;Casp1;Irak2;Casp8;Mapk11;App;Birc3;Casp4;Cyld;Txnip;Nlrp3;Tnfaip3;Nod1;Nod2
prerank,Gene Silencing By RNA R-HSA-211000,0.540309518746296,1.1096285939487278,0.29508196721311475,1.0,1.0,8/92,7.31%,Tnrc6c;Ago1;Ago2;Tnrc6b;Dicer1;Ndc1;Nup93;Ranbp2
prerank,Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.6574997906207192,-1.109495314893358,0.3652173913043478,1.0,1.0,6/41,5.96%,Gpc6;Gpc5;Akr1b10;Apoe;Bco2;Sdc4
prerank,PKA Activation In Glucagon Signaling R-HSA-164378,0.6961473356745378,1.10929951443954,0.39862542955326463,1.0,1.0,3/15,2.01%,Adcy1;Adcy2;Adcy9
prerank,CD28 Co-Stimulation R-HSA-389356,-0.6620653122484191,-1.1083438265088033,0.3454810495626822,1.0,1.0,9/33,12.56%,Pik3r1;Vav1;Cd86;Lyn;Prr5;Cd80;Grap2;Pik3ca;Pkn2
prerank,Retinoid Metabolism And Transport R-HSA-975634,-0.6633430721370059,-1.1041602509457644,0.3855072463768116,1.0,1.0,6/37,5.96%,Gpc6;Gpc5;Akr1b10;Apoe;Bco2;Sdc4
prerank,Estrogen-dependent Gene Expression R-HSA-9018519,-0.5877714191092489,-1.1040753172293303,0.30416068866571017,1.0,1.0,9/103,4.26%,Erbb4;Runx1;Bcl2;Tle3;Kank1;Kat2b;Ctsd;Nrip1;Esr1
prerank,RHOBTB GTPase Cycle R-HSA-9706574,-0.6586423609536659,-1.103409364699956,0.37175792507204614,1.0,1.0,5/35,7.68%,Pde5a;Myo6;Rhobtb1;Msi2;Tmod3
prerank,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,-0.6063489064844013,-1.1031802267123447,0.33915574963609896,1.0,1.0,13/80,11.15%,Tbl1x;Klf5;Cdk19;Ccnd3;Smarcd3;Srebf2;Tgfb1;Nr2f2;Ncoa3;Pparg;Ebf1;Lpl;Ppargc1a
prerank,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,0.6453583760021637,1.1019330331087582,0.36577181208053694,1.0,1.0,8/27,17.86%,Gtf2f2;Ssrp1;Polr2e;Cdk9;Polr2k;Gtf2f1;Ctdp1;Tcea1
prerank,Gap Junction Trafficking And Regulation R-HSA-157858,-0.6875505394920043,-1.1009529023724538,0.37052932761087265,1.0,1.0,5/22,5.47%,Dab2;Myo6;Gja3;Gja1;Gjb6
prerank,Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.6069781792872205,-1.100660496699419,0.33861671469740634,1.0,1.0,25/73,21.35%,Lair1;Colec12;Cd33;Cxadr;Cd81;Nectin2;Itgb1;Tyrobp;Kir3dl2;Clec2d;Slamf6;Itgb2;Trem2;Vcam1;Cd200;Slamf7;Ifitm1;Cd300a;Cd200r1;B2m;Cd40;Treml4;Icam1;Cd300e;Cd40lg
prerank,RNA Polymerase I Transcription Termination R-HSA-73863,0.6299780382463487,1.1005721717951231,0.3838383838383838,1.0,1.0,9/30,14.14%,Gtf2h2;Gtf2h5;Ccnh;Ubtf;Mnat1;Polr2e;Taf1c;Polr2k;Polr1h
prerank,CD28 Dependent PI3K/Akt Signaling R-HSA-389357,-0.6724972669340423,-1.0986687948652634,0.36894586894586895,1.0,1.0,4/22,7.37%,Pik3r1;Cd86;Prr5;Cd80
prerank,MAPK6/MAPK4 Signaling R-HSA-5687128,0.5461972308701161,1.0983379463203826,0.27722772277227725,1.0,1.0,8/87,3.98%,Kalrn;Foxo1;Tnrc6c;Jun;Ago1;Ago2;Arhgef7;Tnrc6b
prerank,RHOQ GTPase Cycle R-HSA-9013406,-0.6223752317991185,-1.0969307033373212,0.3726993865030675,1.0,1.0,20/58,8.81%,Cpne8;Dlc1;Srgap2;Cdc42ep3;Arhgap26;Cftr;Fnbp1;Rhoq;Prex1;Gja1;Syde1;Iqgap1;Wwp2;Cdc42ep1;Ophn1;Cav1;Slc1a5;Arhgap33;Depdc1b;Cdc42ep2
prerank,SARS-CoV Infections R-HSA-9679506,-0.5137553609625212,-1.0967599684747114,0.26362484157160965,1.0,1.0,36/332,9.00%,Gpc6;St6gal1;Mgat4c;Gpc5;Parp8;Parp4;Atp1a2;Vav1;Man2a1;S1pr1;Zdhhc2;Mgat5;Gja1;Masp1;Irak2;Trim25;Tlr7;Il17ra;Ywhaq;Atp1b3;Sdc4;Cav1;Fxyd7;Ap2b1;Sting1;Vegfa;Jak2;Nfe2l2;Traf3;Ifih1;Syk;Btk;Itgb1;Mgat4a;Fxyd1;Hspg2
prerank,Paracetamol ADME R-HSA-9753281,-0.6904313113830021,-1.0960811042759167,0.39705882352941174,1.0,1.0,7/21,15.60%,Slc38a3;Ggt5;Abcc1;Slc38a1;Abcc3;Abcc5;Gstt1
prerank,Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.6058206493776752,-1.095812681038455,0.3584637268847795,1.0,1.0,5/66,9.18%,Prkcb;Rel;Bcl10;Nfkbie;Psmb8
prerank,TRP Channels R-HSA-3295583,0.6491749073065157,1.095460755989124,0.4019933554817276,1.0,1.0,2/24,0.27%,Trpm3;Trpc6
prerank,Extracellular Matrix Organization R-HSA-1474244,-0.5210429174481507,-1.0920574860589782,0.27979274611398963,1.0,1.0,86/269,10.79%,Adamts16;Adamts2;Scube1;Col26a1;Dmd;Lama4;Nrxn1;Itga9;Fn1;Col27a1;Bcan;Ntn4;Lrp4;Itgb5;Ltbp1;Jam3;P4ha3;Lama2;Jam2;Col6a2;Itgam;Adam19;Sparc;Vcan;Mmp14;P3h2;Adamts4;Itga2;Lama1;Htra1;Col6a1;Bmp4;Cd44;Ctsd;Col6a5;Ctss;F11r;Timp2;Col8a1;Ltbp3;Dcn;Lamc2;Tgfb1;Itga6;Hapln1;Capn2;Tnn;Mmp28;Col9a1;Bmp7;Col4a5;Sdc4;Col16a1;Ddr2;Fbln5;Col12a1;Fbln2;Col11a1;Adam12;Vtn;Col19a1;Prkca;Adam17;Plod1;Col1a2;Itgb1;Klk7;Col4a2;Hspg2;Col3a1;Adam10;Col6a3;Pcolce;Col14a1;Efemp2;Col24a1;Col8a2;Itga1;Itga3;Mmp15;Adamts5;Lamc3;Pdgfb;Dst;Loxl2;Col4a1
prerank,Signaling By FGFR4 R-HSA-5654743,-0.6496001641669769,-1.088452925701745,0.3985611510791367,1.0,1.0,2/37,1.29%,Pik3r1;Fgf1
prerank,Interleukin-37 Signaling R-HSA-9008059,-0.6779021621327048,-1.0882382265919683,0.40863309352517985,1.0,1.0,6/20,9.53%,Ptpn14;Casp1;Ptpn9;Ptpn5;Ptpn13;Ptpn4
prerank,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.6941559854303795,-1.088108782497617,0.4066265060240964,1.0,1.0,2/18,1.15%,Alk;Fn1
prerank,Acyl Chain Remodelling Of PG R-HSA-1482925,-0.690740949930643,-1.0880488391576952,0.40915593705293274,1.0,1.0,3/17,12.72%,Pla2g4a;Lpgat1;Pla2r1
prerank,Gluconeogenesis R-HSA-70263,-0.6762880862550098,-1.0864968786182876,0.4065281899109792,1.0,1.0,7/27,19.04%,Slc25a13;Pck2;Aldoc;Fbp1;G6pc3;Eno1;Slc37a2
prerank,Impaired BRCA2 Binding To PALB2 R-HSA-9709603,-0.6760780924074044,-1.0861878964345177,0.3950795947901592,1.0,1.0,5/23,13.33%,Rbbp8;Rad51b;Top3a;Wrn;Artn
prerank,Hedgehog On State R-HSA-5632684,-0.5847629449565842,-1.0847153169767123,0.36,1.0,1.0,12/85,10.03%,Gpr161;Gli3;Hhip;Dzip1;Smurf1;Smox;Gli2;Numb;Shh;Psmb8;Kif7;Gas1
prerank,Extension Of Telomeres R-HSA-180786,-0.6245176066579903,-1.084599069761672,0.3738738738738739,1.0,1.0,6/49,13.04%,Ankrd28;Lrig1;Cdk2;Pif1;Pold4;Wrn
prerank,Signaling By Insulin Receptor R-HSA-74752,-0.6012486353382802,-1.0829131300562151,0.3919308357348703,1.0,1.0,5/70,5.15%,Gab2;Pik3r1;Fgf1;Fgfr3;Grb10
prerank,FRS-mediated FGFR2 Signaling R-HSA-5654700,-0.6754299306509843,-1.0828889306134306,0.430939226519337,1.0,1.0,3/22,12.43%,Fgf1;Fgf23;Fgfr2
prerank,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.6804125343729046,-1.0828591467575952,0.39462517680339465,1.0,1.0,2/26,4.53%,Tubb3;Tubb4a
prerank,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.6820989689595288,-1.0795892737694759,0.39290780141843973,1.0,1.0,2/24,4.53%,Tubb3;Tubb4a
prerank,Neutrophil Degranulation R-HSA-6798695,-0.4965152678807394,-1.0793833326301223,0.2744360902255639,1.0,1.0,78/395,12.04%,Dlc1;Dock2;Rab31;Arhgap45;Lair1;Padi2;Ptprc;Nckap1l;Gsn;Itgam;Cst3;Tmem63a;Ostf1;Frmpd3;Vcl;Cd33;Tnfrsf1b;Ptprn2;Cd44;Ctsd;Iqgap1;Ctss;Sirpa;Prkcd;Timp2;Ctsh;Ctsc;Manba;Tarm1;Nfam1;Tspan14;Mmp28;Abca13;Irag2;Cd53;Bin2;Ctsz;Cd93;Tom1;Rap1b;Tmbim1;Ampd3;Qpct;Tnfaip6;Sting1;Trpm2;Ptprb;Asah1;Tbc1d10c;Syngr1;Pgm2;Fuca1;Gusb;Aifm2;Plekho2;Cd63;Adam10;Rab37;Lamp2;Gca;Crispld2;Plppr3;Slc2a5;Rcan1;Adgrg3;Tyrobp;Dnajc13;Plau;Lamp1;Stbd1;Ghdc;Anpep;Dync1h1;Itgb2;Npc2;Glyat;Stom;Cda
prerank,Olfactory Signaling Pathway R-HSA-381753,-0.5741335800282386,-1.0791012260119393,0.3357142857142857,1.0,1.0,12/103,11.46%,Ldb2;Or51d1;Or52i2;Or51e1;Or52k2;Or2t6;Or52m1;Reep1;Ebf1;Or51e2;Or1n2;Or2t1
prerank,Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.6493797294581708,-1.0790144860987019,0.39574468085106385,1.0,1.0,12/33,27.48%,Serpine2;F3;Pros1;Tfpi;Vwf;Thbd;Procr;F13b;Gp9;F9;F7;Proc
prerank,MAPK Family Signaling Cascades R-HSA-5683057,0.44514666703000655,1.0750003579377487,0.26046511627906976,1.0,1.0,45/300,4.00%,Kalrn;Lrrc7;Grin2b;Camk2a;Camk2b;Rasal2;Nrg2;Rasgrf1;Nrg3;Foxo1;Tnrc6c;Rasgrf2;Cnksr2;Gfra1;Rapgef2;Ncam1;Sptb;Mapk1;Ksr2;Map2k1;Sptbn1;Ptpn3;Tgfa;Ptk2;Gfra2;Ppp1cb;Sptbn4;Ptpra;Rasgef1a;Jun;Flt3;Camk2g;Sptan1;Pik3cb;Ago1;Calm1;Syngap1;Actn2;Fgf5;Ago2;Abhd17c;Arhgef7;Ksr1;Tnrc6b;Spred2
prerank,Aquaporin-mediated Transport R-HSA-445717,0.5882105224525497,1.0746026807689164,0.396875,1.0,1.0,6/42,2.24%,Adcy1;Adcy2;Myo5b;Gng7;Adcy9;Gng2
prerank,Signaling By MET R-HSA-6806834,-0.6053762166354969,-1.0720550074811028,0.37916666666666665,1.0,1.0,17/63,11.69%,Pik3r1;Lama4;Lama2;Eps15;Itga2;Lama1;Tns3;Lamc2;Stam2;Rap1b;Sh3gl2;Lrig1;Itgb1;Itga3;Lamc3;Pik3ca;Ptpn1
prerank,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.49787943418675706,-1.0713231703456516,0.3076923076923077,1.0,1.0,58/409,7.83%,Camk2d;Kit;Tcf7l2;Erbb4;Alk;Gab2;Dusp10;Rrbp1;Stat5b;Pik3r1;Apbb1ip;Tbl1x;Etv6;Fn1;Qki;Nr4a1;Nrg1;Fgf1;Cux1;Pik3ap1;Fgfr3;Hip1;Vav1;Pdgfra;Kank1;Erbb3;Kat2b;Cd86;Lyn;Smad2;Tgfbr2;Dusp16;Dusp6;Nf1;Vcl;Ppp2r5a;Esr1;Iqgap1;Prr5;Hdac4;Tgfb1;Esr2;Clstn1;Notch1;Egfr;Bin2;Rap1b;Zc3hav1;Spred3;Shh;Jak2;Jag2;Hes5;Cd80;Rnf43;Msn;Adam17;Spred1
prerank,ESR-mediated Signaling R-HSA-8939211,-0.5384923766189239,-1.0712671659952298,0.3356643356643357,1.0,1.0,23/168,8.45%,Erbb4;Pik3r1;Runx1;Bcl2;Gng4;Kcnh8;Tle3;Kank1;Kat2b;Gng12;Ctsd;Nrip1;Esr1;Gnai1;Esr2;Gnb4;Egfr;Cav1;Gnai2;Cav2;Ccnd1;Greb1;Ncoa3
prerank,ABC Transporters In Lipid Homeostasis R-HSA-1369062,-0.683085148538704,-1.0711888313255982,0.4248175182481752,1.0,1.0,5/17,14.92%,Abca9;Abca7;Abca6;Abcd1;Abca3
prerank,Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,0.5940979995046467,1.0700496421754335,0.4185303514376997,1.0,1.0,6/38,2.24%,Adcy1;Adcy2;Myo5b;Gng7;Adcy9;Gng2
prerank,Signaling By Interleukins R-HSA-449147,-0.4896733087818367,-1.0675508284437465,0.306832298136646,1.0,1.0,65/407,9.61%,Socs2;Gab2;Stat5b;Pik3r1;Il34;Fn1;Inpp5d;Csf1r;Bcl2;Ptpn14;Tec;Ccr5;Kcnh8;Hck;Stx1a;Il10ra;Vav1;Sox2;Itgam;S1pr1;Csf3r;Cd86;Havcr2;Lyn;Alpk1;Il15;Casp1;Dusp6;Irak2;Il1rl2;Tnfrsf1b;Il17re;Il17ra;Casp8;Ptpn9;Lgals9;Mapk11;Tgfb1;App;Irak3;Rps6ka5;Clstn1;Inppl1;Il21r;Cish;Rap1b;Vegfa;Stat6;Jak2;Ptpn5;Cd80;Syk;Ccnd1;Msn;Prkca;Col1a2;Itgb1;Ebi3;Mapk8;Ptpn13;Psmb8;Ifnlr1;Stat5a;Ptpn4;Il1a
prerank,Effects Of PIP2 Hydrolysis R-HSA-114508,0.6294084199951917,1.0658102055064236,0.4011299435028249,1.0,1.0,6/27,2.08%,Dgkh;Prkce;Trpc6;Dgki;Dgkg;Dagla
prerank,Phase II - Conjugation Of Compounds R-HSA-156580,-0.588512302427139,-1.065106644224855,0.4011713030746706,1.0,1.0,17/74,20.84%,Ugp2;Slc38a3;Hpgds;Ggt5;As3mt;Podxl2;Glyat;Ugdh;Slc38a1;Gsta3;Gstt1;Papss2;Sult6b1;Mgst3;Gstm2;Mat1a;Ggt1
prerank,Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,-0.6605871104768481,-1.0649386026230456,0.42358078602620086,1.0,1.0,5/24,13.33%,Rbbp8;Rad51b;Top3a;Wrn;Artn
prerank,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.5753653719653394,-1.0642124318525596,0.3787661406025825,1.0,1.0,14/95,8.24%,Pik3r1;Fn1;Bcl2;Sox2;Itgam;S1pr1;Tnfrsf1b;Tgfb1;Vegfa;Stat6;Jak2;Ccnd1;Col1a2;Itgb1
prerank,mTORC1-mediated Signaling R-HSA-166208,0.6115657461944806,1.0638098391667796,0.4,1.0,1.0,7/24,11.12%,Rragd;Ywhab;Eif4b;Rptor;Eif4e;Slc38a9;Rragb
prerank,Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.6490339208812509,-1.062734407741536,0.42042042042042044,1.0,1.0,8/30,16.20%,Ncf2;Atp7a;Gpx8;Ncf1;Glyat;Ncf4;Cyba;Sod3
prerank,Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.5550203966382173,-1.0617230978318295,0.3709449929478138,1.0,1.0,12/108,3.87%,Itpr2;Prkcb;Pik3r1;Rasgrp3;Rasgrp1;Nfatc1;Pik3ap1;Vav1;Lyn;Nfatc2;Dapp1;Rel
prerank,Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.6426441648838606,-1.0611594665254054,0.4328147100424328,1.0,1.0,4/37,10.28%,Kif13a;Fkbp9;Kifc3;Arfgef2
prerank,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,0.6345364512266416,1.0603669130727444,0.45,1.0,1.0,6/21,16.65%,Gtf2f2;Ncbp1;Polr2e;Polr2k;Gtf2f1;Ctdp1
prerank,TBC/RABGAPs R-HSA-8854214,-0.6239303712035883,-1.0592486278805922,0.4038748137108793,1.0,1.0,7/42,20.32%,Optn;Tbc1d10c;Rab43;Rab7b;Rab6b;Rab6a;Rabgap1
prerank,FRS-mediated FGFR1 Signaling R-HSA-5654693,-0.6739468683889006,-1.0584815426019365,0.45892351274787535,1.0,1.0,1/20,1.29%,Fgf1
prerank,Signaling By NOTCH R-HSA-157118,0.4777879172380439,1.0584471456569864,0.30078125,1.0,1.0,17/186,3.98%,Maml2;Nbea;Maml3;Tnrc6c;Cntn1;Tle1;Ncor1;Notch2;Hdac7;B4galt1;Smad3;Jun;Tle4;Ago1;Ago2;Ywhaz;Tnrc6b
prerank,HS-GAG Degradation R-HSA-2024096,-0.6686163647769131,-1.0578892761284187,0.4398826979472141,1.0,1.0,2/21,0.64%,Gpc6;Gpc5
prerank,Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.6550648885745984,-1.057518121529378,0.4447632711621234,1.0,1.0,6/28,13.26%,Ppp2r5a;Fzd2;Cav1;Lrp5;Ppp2r5c;Wnt3a
prerank,Neurotransmitter Release Cycle R-HSA-112310,0.5645357844434166,1.056608378049547,0.38317757009345793,1.0,1.0,9/50,4.51%,Ppfia2;Rims1;Syn2;Slc17a7;Slc1a1;Syn3;Syt1;Tspoap1;Lin7c
prerank,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.5145972125549958,-1.0565239049921429,0.36026490066225164,1.0,1.0,2/237,2.68%,Elavl2;Colec12
prerank,Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,-0.6479708513406464,-1.0537172594245712,0.4402332361516035,1.0,1.0,8/26,20.36%,Rbbp8;Rad51b;Top3a;Wrn;Artn;Bard1;Xrcc2;Xrcc3
prerank,Meiotic Recombination R-HSA-912446,-0.6272296977247791,-1.0534887076739903,0.44511278195488724,1.0,1.0,6/42,17.50%,Rbbp8;Cdk2;Top3a;Artn;H3c7;H2aj
prerank,SHC-mediated cascade:FGFR2 R-HSA-5654699,-0.6621346230060474,-1.0530489796855957,0.469187675070028,1.0,1.0,1/20,1.29%,Fgf1
prerank,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,-0.6110381243744182,-1.0526260503555498,0.41944847605224966,1.0,1.0,5/54,4.91%,Prkcq;Runx1;Nr4a3;Kat2b;Zfpm1
prerank,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.6008160391363924,-1.0520512636725956,0.44155844155844154,1.0,1.0,6/53,3.77%,Alk;Rrbp1;Pik3r1;Fn1;Hip1;Vcl
prerank,Transcriptional Regulation By MECP2 R-HSA-8986944,0.5491459849540624,1.0496384063109359,0.3980891719745223,1.0,1.0,15/60,3.98%,Grin2a;Grin2b;Camk2a;Camk2b;Gria2;Rbfox1;Tnrc6c;Ncor1;Fkbp5;Mef2c;Camk2g;Ago1;Calm1;Ago2;Tnrc6b
prerank,Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,-0.6692892281342776,-1.0494266093184215,0.459802538787024,1.0,1.0,5/17,13.74%,Ccnd3;E2f1;Ccnd1;Cdk2;Cdkn1c
prerank,Chemokine Receptors Bind Chemokines R-HSA-380108,-0.6369335739771803,-1.0486500128113583,0.43191800878477304,1.0,1.0,7/35,16.39%,Ccr5;Cx3cr1;Cxcr4;Ccl28;Cxcr2;Cxcl16;Ccr2
prerank,FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,0.6490133712464494,1.0484325822019653,0.44594594594594594,1.0,1.0,3/17,3.33%,Foxo1;Smad3;Btg1
prerank,Deadenylation Of mRNA R-HSA-429947,0.6255767140865823,1.0478599411255818,0.44680851063829785,1.0,1.0,11/24,10.20%,Cnot2;Cnot6l;Pan3;Eif4b;Cnot4;Cnot1;Eif4a2;Eif4a1;Pabpc1;Eif4e;Cnot3
prerank,RHO GTPase Cycle R-HSA-9012999,-0.4808617407198751,-1.0469268444634043,0.35098522167487683,1.0,1.0,78/426,6.52%,Fnbp1l;Dock1;Cpne8;Srgap1;Pcdh7;Dlc1;Plekhg1;Sh3rf1;Arap2;Vav2;Dock2;Arhgef26;Arhgap22;Farp1;Pik3r1;Wipf1;Vrk2;Arhgap31;Prag1;Srgap2;Stmn2;Arhgap23;Arhgap45;Dock8;Cdc42ep3;Dock5;Homer2;Peak1;Arhgap26;Pde5a;Nckap1l;Cftr;Mcf2;Vav1;Arhgap18;Garre1;Myo6;Anln;Dock6;Rhobtb1;Plxna1;Rnd3;Fnbp1;Ncf2;Rhoq;Arhgap25;Prex1;Arhgap42;Swap70;Rhoh;Gja1;Akap12;Akap13;Fmnl3;Rhoj;Plxnd1;Syde1;Arhgef6;Iqgap1;Wwp2;Arhgef40;Arhgap28;Arhgef19;Arhgap24;Ccp110;Cdc42ep1;Baiap2l2;Arhgef11;Arhgap6;Fgd5;Arap1;Mcam;Ophn1;Arhgef10;Cav1;Arhgap11a;Stam2;Plekhg2
prerank,Signaling By ERBB4 R-HSA-1236394,0.5433647614968219,1.046091171190697,0.3662420382165605,1.0,1.0,7/56,1.80%,Gabrb3;Gabrb1;Nrg2;Gabrb2;Nrg3;Gabrg2;Ncor1
prerank,Integration Of Energy Metabolism R-HSA-163685,0.5018708039485098,1.0458724052500092,0.3630769230769231,1.0,1.0,15/102,2.54%,Cacnb2;Cacna1e;Cacna1c;Adcy1;Adcy2;Plcb1;Prkag2;Cacna1d;Gng7;Kcng2;Gnaq;Adcy9;Gng2;Abcc8;Rapgef4
prerank,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.586629144170965,1.0452425945232096,0.40836012861736337,1.0,1.0,10/31,2.81%,Gria1;Camk2a;Nsf;Camk2b;Gria2;Gria3;Epb41l1;Tspan7;Cacng8;Camk2g
prerank,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,0.5376882327028804,1.044968525565388,0.37540453074433655,1.0,1.0,12/56,10.49%,Jun;Gtf2h2;Gtf2f2;Cdk12;Gtf2h5;Ccnh;Ssrp1;Mnat1;Ccnt2;Polr2e;Atm;Ccnk
prerank,Signaling By TGF-beta Receptor Complex R-HSA-170834,0.5251579812141416,1.0440091689806386,0.376865671641791,1.0,1.0,14/91,4.34%,Itga8;Nedd4l;Pard3;Mapk1;Ncor1;Ppp1cb;Smad3;Tgfbr1;Itgb8;Usp15;Ski;Tgfb2;Cbl;Hdac1
prerank,ABC-family Proteins Mediated Transport R-HSA-382556,-0.5533318783072179,-1.0424210293790057,0.4248927038626609,1.0,1.0,16/97,18.32%,Abca9;Cftr;Abca7;Abca6;Abcb9;Psmb8;Abcd1;Psma8;Abcc1;Abcc3;Abca3;Abcb5;Abcc5;Sel1l;Psme4;Psme2
prerank,Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,0.5353501362290575,1.041790307911508,0.38782051282051283,1.0,1.0,14/70,13.09%,Cdc40;Srsf9;Thoc2;Srsf11;Srsf1;Ndc1;Nup93;Ncbp1;Ranbp2;Fyttd1;Srsf7;Nup160;Nup155;Thoc3
prerank,MyD88 Deficiency (TLR2/4) R-HSA-5602498,-0.6781091945819929,-1.0413145780078996,0.4794908062234795,1.0,1.0,6/16,15.66%,Btk;S100a1;Tlr1;Tirap;Tlr2;Tlr6
prerank,Diseases Of DNA Repair R-HSA-9675135,-0.6024334121987892,-1.040209378670707,0.4590643274853801,1.0,1.0,10/49,19.36%,Rbbp8;Rad51b;Neil3;Top3a;Wrn;Artn;Nthl1;Bard1;Rrad;Xrcc2
prerank,Formation Of Incision Complex In GG-NER R-HSA-5696395,0.5602116526861649,1.0399342793615365,0.423841059602649,1.0,1.0,8/42,8.58%,Gtf2h2;Ercc4;Gtf2h5;Ccnh;Sumo2;Parp1;Pias1;Mnat1
prerank,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.5634709623237372,-1.0386692552484953,0.4146341463414634,1.0,1.0,19/94,16.51%,Masp1;Irak2;Trim25;Tlr7;Il17ra;Sting1;Traf3;Ifih1;Tlr1;Rnf135;Nlrp3;Rigi;Nod1;Nod2;Irf3;Sec24a;Tlr2;Ptpn6;Il17f
prerank,Interleukin-10 Signaling R-HSA-6783783,-0.6251223857521035,-1.0385325698095709,0.467438494934877,1.0,1.0,7/35,11.85%,Ccr5;Il10ra;Cd86;Tnfrsf1b;Cd80;Il1a;Il18
prerank,FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.6301891616273727,-1.0382168946607595,0.4533898305084746,1.0,1.0,1/31,1.29%,Fgf1
prerank,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,0.6361510555109997,1.0375148887869212,0.49032258064516127,1.0,1.0,2/24,0.42%,Maml2;Maml3
prerank,TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.5163215357733244,-1.0374035765780685,0.39945652173913043,1.0,1.0,26/182,9.18%,Tcf7l2;Sox6;Rspo2;Cxxc4;Tcf7l1;Ccdc88c;Tle3;Sox2;Lef1;Ppp2r5a;Fzd2;Sox4;Tle2;Wif1;Lgr5;Cav1;Ctnnbip1;Rnf43;Bcl9;Dkk2;Sox9;Sox13;Lrp5;Rspo1;Ppp2r5c;Psmb8
prerank,Metabolism Of Steroids R-HSA-8957322,-0.5278882200273243,-1.0369306608196438,0.39914163090128757,1.0,1.0,20/136,11.36%,Osbpl1a;Tbl1x;Hmgcs1;Lgmn;Msmo1;Stard4;Hmgcr;Smarcd3;Srebf2;Elovl6;Sqle;Cyp27a1;Fdft1;Hsd17b12;Dhcr24;Ldlrap1;Acaca;Osbpl9;Insig1;Osbpl3
prerank,Apoptotic Execution Phase R-HSA-75153,-0.6059956575329237,-1.036796064951273,0.45569620253164556,1.0,1.0,9/44,9.90%,Prkcq;Gsn;Satb1;Prkcd;Casp8;Gas2;Tjp2;Casp7;Mapt
prerank,RHO GTPase Effectors R-HSA-195258,0.4409491034423396,1.0358380025998597,0.3276595744680851,1.0,1.0,35/249,6.24%,Iqgap2;Diaph2;Wipf3;Wasf1;Baiap2;Nckap1;Pdzd2;Abi2;Mrtfa;Mapk1;Cenpp;Ppp1r12b;Ptk2;Ppp1cb;Actr3;Arpc2;Dync1i2;Fmnl2;Abi1;Diaph1;Calm1;Arhgef7;Ywhaz;Cyfip2;Ywhab;Mapk3;Src;Cyfip1;Taok1;Mapk14;Ywhae;Ywhah;Wasf3;Ctnnb1;Arpc1a
prerank,SHC-mediated cascade:FGFR1 R-HSA-5654688,-0.6612277735193399,-1.0353982295048665,0.49645390070921985,1.0,1.0,1/18,1.29%,Fgf1
prerank,Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,0.5913940116318592,1.0344198703850696,0.44516129032258067,1.0,1.0,3/23,2.10%,Dapk1;Dcc;Unc5a
prerank,rRNA Processing In Nucleus And Cytosol R-HSA-8868773,0.45794009135147296,1.0318692205794082,0.3623693379790941,1.0,1.0,62/182,18.15%,Utp4;Bop1;Rcl1;Sppl2a;Rpl15;Mtrex;Exosc8;Dkc1;Nop58;Xrn2;Heatr1;Rbm28;Nol12;Pelp1;Rrp1b;Rplp1;Wdr75;Wdr12;Rpl10a;Rplp0;Rpl4;Tsr1;Nob1;Dnajc5;Riok3;Rpl3;Gnl3;Rpsa;Wdr43;Mrpl13;Utp15;Senp3;Riok2;Rpl36a;Nop56;Wdr36;Rpl8;Ebna1bp2;Rps28;Rsl24d1;Uba52;Mphosph10;Rpl18;Emg1;Eri1;Rps21;Exosc2;Tbl3;Rps3;Rps8;Nip7;Exosc1;Rpl6;Bysl;Rps9;Rpl31;Utp6;Nol6;Krr1;Dhx37;Rpl7;Thumpd1
prerank,Inositol Phosphate Metabolism R-HSA-1483249,-0.600117768712396,-1.0318160607541111,0.459915611814346,1.0,1.0,8/47,7.04%,Plcb4;Plch2;Inpp5d;Plcb2;Inppl1;Pld4;Plch1;Plcd3
prerank,Transcriptional Regulation By VENTX R-HSA-8853884,-0.6169532406488997,-1.0313432821034851,0.45494186046511625,1.0,1.0,3/37,3.58%,Tcf7l2;Csf1r;Lef1
prerank,Interferon Alpha/Beta Signaling R-HSA-909733,-0.5944860128510248,-1.0296687070895083,0.4525862068965517,1.0,1.0,20/48,23.90%,Egr1;Irf8;Rnasel;Irf2;Psmb8;Xaf1;Mx2;Ptpn1;Ifi27;Irf3;Ifitm1;Ptpn6;Oas2;Isg20;Ifitm3;Ifit3;Irf6;Irf4;Ifit2;Bst2
prerank,G Alpha (I) Signaling Events R-HSA-418594,-0.4969885331150331,-1.0296546087071365,0.4007989347536618,1.0,1.0,40/246,5.58%,Pde4b;Camk2d;Rgs20;Plcb4;Htr1f;Itpr2;Pde4d;Grm8;Grm3;Chrm2;Camk4;Rgs12;Lpar1;Pde1a;Gng4;Ccr5;Rgs3;Pde1c;Pla2g4a;Rgs6;Cx3cr1;Ptger3;Prkar1b;Oprk1;Gna15;Rgs10;Rgsl1;Gng12;Grm4;Plcb2;P2ry13;Prkcg;Gnas;Gnai1;Prkcd;Gpr37l1;App;Gnb4;Adcy7;Rgs16
prerank,Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,-0.6228625314189439,-1.0294093801656956,0.47406340057636887,1.0,1.0,9/36,9.90%,Prkcq;Gsn;Satb1;Prkcd;Casp8;Gas2;Tjp2;Casp7;Mapt
prerank,DAG And IP3 Signaling R-HSA-1489509,0.5817981122677904,1.028679463922552,0.45565749235474007,1.0,1.0,12/38,3.72%,Prkce;Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Pde1b;Adcy9;Camkk1;Camk2g;Calm1;Itpr1
prerank,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,0.45994163874421834,1.028349584537637,0.35986159169550175,1.0,1.0,3/161,1.72%,Slit3;Robo2;Lhx9
prerank,Collagen Degradation R-HSA-1442490,-0.6156740687277124,-1.0283262111284812,0.4750733137829912,1.0,1.0,12/34,10.17%,Col26a1;Mmp14;Ctsd;Mmp28;Col9a1;Col16a1;Col12a1;Col19a1;Adam17;Adam10;Col14a1;Mmp15
prerank,Cell-extracellular Matrix Interactions R-HSA-446353,-0.6613409058965756,-1.026930405475421,0.49273255813953487,1.0,1.0,6/16,16.28%,Lims1;Arhgef6;Itgb1;Lims2;Flna;Flnc
prerank,Signaling By NOTCH3 R-HSA-9012852,0.5641461795629465,1.0264164512435074,0.45625,1.0,1.0,2/47,0.42%,Maml2;Maml3
prerank,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.5328470350251824,-1.0262430393711286,0.4400564174894217,1.0,1.0,12/127,3.06%,Itpr2;Prkcq;Gab2;Vav2;Pik3r1;Lcp2;Rasgrp1;Nfatc1;Tec;Vav1;Lyn;Nfatc2
prerank,SLC-mediated Transmembrane Transport R-HSA-425407,0.4399976914024624,1.0259492172062918,0.3781818181818182,1.0,1.0,17/227,2.41%,Slc4a4;Ahcyl2;Slc2a13;Slc44a5;Slc8a2;Slc16a2;Slc29a4;Slc16a7;Slc16a10;Slc39a6;Slc4a7;Slc17a7;Slc6a15;Slc24a4;Slc4a10;Slc30a3;Slc1a1
prerank,RNA Polymerase I Transcription Initiation R-HSA-73762,0.5571420794109423,1.0248262214839239,0.4069400630914827,1.0,1.0,12/45,8.58%,Chd4;Chd3;Gatad2b;Gtf2h2;Hdac1;Gtf2h5;Ccnh;Ubtf;Mta3;Rbbp7;Mta2;Mnat1
prerank,Antimicrobial Peptides R-HSA-6803157,-0.6123425098335767,-1.0243119600104138,0.48034934497816595,1.0,1.0,9/33,16.97%,Clu;Atp7a;Tlr1;Chga;Trim21;Ro60;Tlr2;Ccr2;Ltf
prerank,RHOA GTPase Cycle R-HSA-8980692,-0.5218030950183769,-1.0238125405989544,0.42937062937062936,1.0,1.0,34/144,6.31%,Srgap1;Pcdh7;Dlc1;Arap2;Vav2;Dock2;Arhgap22;Farp1;Pik3r1;Arhgap31;Arhgap23;Arhgap45;Arhgap26;Mcf2;Vav1;Arhgap18;Anln;Prex1;Arhgap42;Akap13;Fmnl3;Iqgap1;Arhgef40;Arhgap28;Arhgef19;Arhgap24;Arhgef11;Arhgap6;Arap1;Mcam;Ophn1;Arhgef10;Cav1;Arhgap11a
prerank,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,0.458051165287305,1.0196455640353668,0.39862542955326463,1.0,1.0,60/172,18.06%,Utp4;Bop1;Rcl1;Sppl2a;Rpl15;Mtrex;Exosc8;Nop58;Xrn2;Heatr1;Rbm28;Nol12;Pelp1;Rrp1b;Rplp1;Wdr75;Wdr12;Rpl10a;Rplp0;Rpl4;Tsr1;Nob1;Dnajc5;Riok3;Rpl3;Gnl3;Rpsa;Wdr43;Mrpl13;Utp15;Senp3;Riok2;Rpl36a;Nop56;Wdr36;Rpl8;Ebna1bp2;Rps28;Rsl24d1;Uba52;Mphosph10;Rpl18;Emg1;Eri1;Rps21;Exosc2;Tbl3;Rps3;Rps8;Nip7;Exosc1;Rpl6;Bysl;Rps9;Rpl31;Utp6;Nol6;Krr1;Dhx37;Rpl7
prerank,Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.6159464564786542,1.019171225100296,0.45483870967741935,1.0,1.0,2/16,4.53%,Mtmr12;Inpp4a
prerank,Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.6217188265668407,-1.018950621040202,0.5030395136778115,1.0,1.0,9/34,17.22%,Acadl;Acsf2;Acot11;Acot9;Pctp;Decr1;Dbi;Acsm3;Acot7
prerank,Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.612023624916448,-1.0186682870734045,0.4963072378138848,1.0,1.0,8/38,19.36%,Rbbp8;Rad51b;Top3a;Wrn;Artn;Bard1;Rrad;Xrcc2
prerank,Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.6126072257217895,-1.0180496873498681,0.49262536873156343,1.0,1.0,8/39,19.36%,Rbbp8;Rad51b;Top3a;Wrn;Artn;Bard1;Rrad;Xrcc2
prerank,Interferon Signaling R-HSA-913531,0.45832824030068664,1.017832193913527,0.41533546325878595,1.0,1.0,10/153,3.91%,Camk2a;Camk2b;Bcl11b;Sgip1;Pdzd2;Ncam1;Camk2g;Trim2;Nedd4;Trim46
prerank,Beta-catenin Independent WNT Signaling R-HSA-3858494,0.46647887274485395,1.0175596910071338,0.3942652329749104,1.0,1.0,15/141,3.98%,Ppp3ca;Prkg1;Camk2a;Tnrc6c;Plcb1;Prickle1;Gng7;Gng2;Ppp3r1;Ago1;Calm1;Vangl2;Itpr1;Ago2;Tnrc6b
prerank,Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.6068323841834907,-1.0173870895950345,0.5,1.0,1.0,11/41,23.61%,Rbbp8;Rad51b;Top3a;Wrn;Artn;Bard1;Rrad;Xrcc2;Xrcc3;Rfc2;Sem1
prerank,RNA Polymerase I Promoter Clearance R-HSA-73854,0.5151746266804365,1.0158458841716573,0.4012539184952978,1.0,1.0,19/65,10.57%,Chd4;Chd3;Gatad2b;Gtf2h2;Hdac1;Mapk3;Gtf2h5;Ccnh;Ubtf;Mta3;Rbbp7;Cbx3;Mta2;Mnat1;H2bc4;Polr2e;H2az1;H2ac6;H2ax
prerank,Potassium Channels R-HSA-1296071,0.4803992459202413,1.0153520487112968,0.41946308724832215,1.0,1.0,23/99,3.71%,Kcnd2;Kcnj3;Kcnj6;Kcnh1;Kcnab1;Kcnc3;Kcnd3;Gabbr2;Gng7;Kcng2;Kcnk10;Kcnc4;Gng2;Abcc8;Kcnq3;Kcna4;Kcnk1;Kcng1;Kcng3;Kcna1;Kcnab2;Kcnmb4;Kcnma1
prerank,RAF-independent MAPK1/3 Activation R-HSA-112409,-0.6361444793542238,-1.0144686645362542,0.5141158989598811,1.0,1.0,5/21,6.94%,Dusp10;Dusp5;Dusp16;Dusp6;Jak2
prerank,Regulation Of FZD By Ubiquitination R-HSA-4641263,-0.6323887045458282,-1.013870151756771,0.5157593123209169,1.0,1.0,6/20,10.25%,Rspo2;Lgr5;Rnf43;Lrp5;Rspo1;Fzd6
prerank,Glucose Metabolism R-HSA-70326,-0.5541125719425642,-1.0138397593725985,0.46755162241887904,1.0,1.0,7/79,7.75%,Pfkp;Slc25a13;Pck2;Pfkfb3;Map4k2;Pfkfb4;Prkca
prerank,GAB1 Signalosome R-HSA-180292,-0.6500274125685673,-1.0107927949287323,0.4985835694050991,1.0,1.0,3/16,6.23%,Pik3r1;Egfr;Pag1
prerank,CDC42 GTPase Cycle R-HSA-9013148,-0.5139264751488715,-1.010634107162226,0.44397759103641454,1.0,1.0,35/144,6.06%,Fnbp1l;Cpne8;Srgap1;Dlc1;Plekhg1;Arap2;Vav2;Arhgef26;Arhgap22;Farp1;Pik3r1;Wipf1;Arhgap31;Srgap2;Arhgap45;Dock8;Cdc42ep3;Arhgap26;Mcf2;Dock6;Fnbp1;Prex1;Arhgap42;Fmnl3;Syde1;Arhgef6;Iqgap1;Arhgef19;Arhgap24;Cdc42ep1;Arhgef11;Arap1;Ophn1;Arhgef10;Cav1
prerank,Signaling By TGFB Family Members R-HSA-9006936,0.47562842201301675,1.0094346654835036,0.40344827586206894,1.0,1.0,18/116,4.88%,Itga8;Nedd4l;Pard3;Acvr2a;Mapk1;Ncor1;Ppp1cb;Smad3;Tgfbr1;Itgb8;Usp15;Ski;Bmpr1a;Tgfb2;Cbl;Hdac1;Acvr1c;Mapk3
prerank,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",0.617154873026319,1.0088314755573518,0.4794520547945205,1.0,1.0,3/21,4.93%,Sec24d;Sec14l2;Sec23a
prerank,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,-0.6472048923921946,-1.0068775144338253,0.5057803468208093,1.0,1.0,3/15,6.75%,Eps15;Stam2;Sh3gl2
prerank,Metal Ion SLC Transporters R-HSA-425410,0.5933408432490537,1.0048493653382076,0.4681528662420382,1.0,1.0,2/26,2.30%,Slc39a6;Slc30a3
prerank,Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.6084545752055011,-1.0046320888603988,0.5167394468704513,1.0,1.0,7/30,9.04%,Dner;Notch1;Numb;Jag2;Adam17;Dlk1;Adam10
prerank,Chaperone Mediated Autophagy R-HSA-9613829,-0.6292044112088213,-1.0045875484757714,0.5257731958762887,1.0,1.0,6/19,20.05%,Cftr;Ift88;Lamp2;Gfap;Pcnt;Plin3
prerank,Cyclin D Associated Events In G1 R-HSA-69231,-0.5810362324700004,-1.0041417633052712,0.5192878338278932,1.0,1.0,8/46,13.74%,Lyn;Ccnd3;E2f1;Jak2;Ccnd1;Cdk2;Cdkn2c;Cdkn1c
prerank,Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.5172180583385773,1.0038275267695158,0.44837758112094395,1.0,1.0,6/63,1.83%,Thsd7a;Sema5a;Adamts17;Spon1;Adamts3;Notch2
prerank,RNA Polymerase I Promoter Escape R-HSA-73772,0.5382282330999608,1.0030160300675806,0.44155844155844154,1.0,1.0,15/47,14.14%,Gtf2h2;Gtf2h5;Ccnh;Ubtf;Cbx3;Mnat1;H2bc4;Polr2e;H2az1;H2ac6;H2ax;H2ac4;Taf1c;Polr2k;Polr1h
prerank,MTOR Signaling R-HSA-165159,0.5417032954828376,1.002447432730452,0.45017182130584193,1.0,1.0,6/41,7.03%,Prkag2;Rragd;Strada;Ywhab;Eif4b;Rptor
prerank,Resolution Of D-Loop Structures R-HSA-5693537,-0.6106177038946881,-1.0017544006894081,0.5274074074074074,1.0,1.0,9/32,20.36%,Rbbp8;Rad51b;Top3a;Wrn;Artn;Eme1;Bard1;Xrcc2;Xrcc3
prerank,IRAK4 Deficiency (TLR2/4) R-HSA-5603041,-0.6515173831029496,-1.0015092639144314,0.5352112676056338,1.0,1.0,6/17,15.66%,Btk;S100a1;Tlr1;Tirap;Tlr2;Tlr6
prerank,rRNA Processing R-HSA-72312,0.4443367993044977,1.0013611770963744,0.4296028880866426,1.0,1.0,62/192,18.15%,Utp4;Bop1;Rcl1;Sppl2a;Rpl15;Mtrex;Exosc8;Dkc1;Nop58;Xrn2;Heatr1;Rbm28;Nol12;Pelp1;Rrp1b;Rplp1;Wdr75;Wdr12;Rpl10a;Rplp0;Rpl4;Tsr1;Nob1;Dnajc5;Riok3;Rpl3;Gnl3;Rpsa;Wdr43;Mrpl13;Utp15;Senp3;Riok2;Rpl36a;Nop56;Wdr36;Rpl8;Ebna1bp2;Rps28;Rsl24d1;Uba52;Mphosph10;Rpl18;Emg1;Eri1;Rps21;Exosc2;Tbl3;Rps3;Rps8;Nip7;Exosc1;Rpl6;Bysl;Rps9;Rpl31;Utp6;Nol6;Krr1;Dhx37;Rpl7;Thumpd1
prerank,Sensory Perception R-HSA-9709957,-0.4773094070878756,-1.0010260122473238,0.46469833119383824,1.0,1.0,33/280,7.87%,Ldb2;Gpc6;Pcdh15;Whrn;Prkcq;Gpc5;Epb41l3;Kcnn2;Akr1b10;Myo1e;Cacna2d2;Stx1a;Gsn;Apoe;Trpm4;Or51d1;Or52i2;Grm4;Plcb2;Bco2;Rlbp1;Or51e1;Camkmt;Or52k2;Cabp1;Sdc4;Clic5;Slc24a1;Gucy2f;Dhrs3;Msn;Prkca;Ezr
prerank,Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.6108033552478649,-1.0006032220308985,0.5273264401772526,1.0,1.0,9/31,20.36%,Rbbp8;Rad51b;Top3a;Wrn;Artn;Eme1;Bard1;Xrcc2;Xrcc3
prerank,Cellular Response To Heat Stress R-HSA-3371556,0.484066429443725,1.0005929067984367,0.45733788395904434,1.0,1.0,15/92,7.34%,Camk2a;Camk2b;Mapk1;Camk2g;Bag4;Hspa2;Mapk3;Dnajb6;Ywhae;Ndc1;Crebbp;Nup93;Rptor;Ranbp2;Eef1a1
prerank,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.47905341841539734,1.0002486106932797,0.45484949832775917,1.0,1.0,12/102,3.68%,Slc4a4;Ahcyl2;Slc8a2;Slc16a10;Slc4a7;Slc17a7;Slc6a15;Slc24a4;Slc4a10;Slc1a1;Calm1;Slc6a6
prerank,Host Interactions Of HIV Factors R-HSA-162909,-0.5213974834138801,-0.9992457352457377,0.46965317919075145,1.0,1.0,3/122,2.22%,Elmo1;Dock2;Hck
prerank,Transcription Of HIV Genome R-HSA-167172,0.5155672731841374,0.9981546302866713,0.44802867383512546,1.0,1.0,12/64,12.04%,Gtf2h2;Gtf2f2;Gtf2h5;Ccnh;Ssrp1;Ncbp1;Mnat1;Ccnt2;Polr2e;Ccnk;Rngtt;Cdk9
prerank,Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.6168171161947633,-0.9977586977468589,0.5177809388335705,1.0,1.0,3/28,2.23%,Sv2b;Stx1a;Antxr1
prerank,RAF/MAP Kinase Cascade R-HSA-5673001,0.4216760162574779,0.9976803480743197,0.44144144144144143,1.0,1.0,38/257,4.17%,Lrrc7;Grin2b;Camk2a;Camk2b;Rasal2;Nrg2;Rasgrf1;Nrg3;Rasgrf2;Cnksr2;Gfra1;Rapgef2;Ncam1;Sptb;Mapk1;Ksr2;Map2k1;Sptbn1;Ptpn3;Tgfa;Ptk2;Gfra2;Ppp1cb;Sptbn4;Ptpra;Rasgef1a;Flt3;Camk2g;Sptan1;Pik3cb;Calm1;Syngap1;Actn2;Fgf5;Abhd17c;Ksr1;Spred2;Fyn
prerank,Metalloprotease DUBs R-HSA-5689901,-0.6190519315939514,-0.9961276329953733,0.5488505747126436,1.0,1.0,3/27,10.74%,Kat2b;Stambpl1;Nlrp3
prerank,Ca2+ Pathway R-HSA-4086398,0.5225516134799165,0.9956280378919447,0.49216300940438873,1.0,1.0,13/60,3.98%,Ppp3ca;Prkg1;Camk2a;Tnrc6c;Plcb1;Gng7;Gng2;Ppp3r1;Ago1;Calm1;Itpr1;Ago2;Tnrc6b
prerank,Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.6031187860011185,-0.9955051065938588,0.5313868613138686,1.0,1.0,6/33,18.54%,Rbbp8;Top3a;Wrn;Artn;Bard1;Rrad
prerank,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,0.5397172080595697,0.9933017460533571,0.4784172661870504,1.0,1.0,9/44,4.21%,Itga8;Nedd4l;Ppp1cb;Smad3;Tgfbr1;Itgb8;Usp15;Tgfb2;Cbl
prerank,Disorders Of Transmembrane Transporters R-HSA-5619115,0.44166192751699807,0.9921935644788173,0.47038327526132406,1.0,1.0,4/168,2.41%,Slc4a4;Slc24a4;Abcc8;Slc1a1
prerank,MAPK1/MAPK3 Signaling R-HSA-5684996,0.42037267443577847,0.9921402110740678,0.4675925925925926,1.0,1.0,38/262,4.17%,Lrrc7;Grin2b;Camk2a;Camk2b;Rasal2;Nrg2;Rasgrf1;Nrg3;Rasgrf2;Cnksr2;Gfra1;Rapgef2;Ncam1;Sptb;Mapk1;Ksr2;Map2k1;Sptbn1;Ptpn3;Tgfa;Ptk2;Gfra2;Ppp1cb;Sptbn4;Ptpra;Rasgef1a;Flt3;Camk2g;Sptan1;Pik3cb;Calm1;Syngap1;Actn2;Fgf5;Abhd17c;Ksr1;Spred2;Fyn
prerank,Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,0.5583875715955592,0.9920583839958247,0.4586206896551724,1.0,1.0,3/29,4.21%,Prkag2;Rragd;Strada
prerank,PCP/CE Pathway R-HSA-4086400,-0.5392055012117546,-0.9915996040516902,0.5051094890510949,1.0,1.0,12/88,12.47%,Prkcb;Smurf1;Prkcg;Fzd2;Ap2b1;Prkca;Wnt5b;Ncoa3;Psmb8;Fzd6;Rac2;Psma8
prerank,HCMV Early Events R-HSA-9609690,-0.5411768731688744,-0.9901898367762938,0.4978038067349927,1.0,1.0,5/80,8.24%,Tbl1x;Pcsk1;Kcnh8;Egfr;Itgb1
prerank,Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,-0.5826548776138676,-0.9889395761871367,0.5242165242165242,1.0,1.0,10/48,5.96%,Gpc6;Xylt1;Gpc5;Bcan;Cspg4;Vcan;Chst3;Cspg5;Dcn;Sdc4
prerank,RNA Polymerase I Transcription R-HSA-73864,0.5006534172858285,0.9867339642913833,0.44375,1.0,1.0,19/66,10.57%,Chd4;Chd3;Gatad2b;Gtf2h2;Hdac1;Mapk3;Gtf2h5;Ccnh;Ubtf;Mta3;Rbbp7;Cbx3;Mta2;Mnat1;H2bc4;Polr2e;H2az1;H2ac6;H2ax
prerank,Triglyceride Metabolism R-HSA-8979227,-0.5991035918636066,-0.9859029888984527,0.5389048991354467,1.0,1.0,4/30,8.69%,Agmo;Cav1;Prkca;Fabp7
prerank,Glucagon Signaling In Metabolic Regulation R-HSA-163359,0.5690889294893284,0.9846695169061448,0.5134228187919463,1.0,1.0,5/31,2.24%,Adcy1;Adcy2;Gng7;Adcy9;Gng2
prerank,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,0.5652098699254349,0.9819239850897941,0.5166666666666667,1.0,1.0,7/31,4.88%,Nedd4l;Mapk1;Ncor1;Smad3;Ski;Hdac1;Mapk3
prerank,CaM Pathway R-HSA-111997,0.5746483742308042,0.9818925178954405,0.536741214057508,1.0,1.0,10/32,3.50%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Pde1b;Adcy9;Camkk1;Camk2g;Calm1
prerank,Cellular Response To Chemical Stress R-HSA-9711123,-0.48595051930378547,-0.9815804797656691,0.4786206896551724,1.0,1.0,29/174,18.32%,Tbl1x;Ncf2;Slc7a11;Smarcd3;Prkcd;Notch1;Mafg;Atp7a;Nfe2l2;Gpx8;Txnip;Cox16;Psmb8;Nlrp3;Ncf1;Glyat;Ncf4;Psma8;Trim21;Abcc1;Cyba;Stat3;Gsta3;Idh1;Sod3;Mafk;Psme4;Ep300;Psme2
prerank,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.4939231410548972,-0.980753144525352,0.5,1.0,1.0,11/164,4.54%,Kif21b;Akr1b10;Cux1;Kif26a;Kif6;Usp6nl;Man2a1;Pla2g4a;Golim4;Kif5a;Kif13b
prerank,Transport To Golgi And Subsequent Modification R-HSA-948021,0.435759928943558,0.9804242854223364,0.47572815533980584,1.0,1.0,15/156,2.96%,Gria1;Ank3;Nsf;Sptb;Cnih3;Sptbn1;Tgfa;B4galt1;B4galt5;Sptbn4;Sec24d;Dync1i2;Ank2;Fut8;Sptan1
prerank,Acyl Chain Remodelling Of PS R-HSA-1482801,-0.6104120078058397,-0.9800864909671367,0.5527859237536656,1.0,1.0,10/21,18.06%,Mboat1;Pla2g4a;Osbpl10;Plaat3;Osbpl5;Pla2r1;Lpcat3;Pla1a;Osbpl8;Pla2g5
prerank,G Alpha (Q) Signaling Events R-HSA-416476,0.4314277709047787,0.9784926986755935,0.49429657794676807,1.0,1.0,17/193,2.74%,Dgkh;Grm1;Kalrn;Prkce;Trpc6;Dgki;Dgkg;Plcb1;Grm5;Gng7;Gnaq;Mapk1;Arhgef25;Dagla;Gng2;Chrm1;Rps6ka2
prerank,Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.540114129035058,-0.977901502039416,0.5375722543352601,1.0,1.0,7/77,5.62%,St6gal1;St8sia5;St3gal6;St6gal2;Neu4;St8sia6;Uap1
prerank,Processive Synthesis On Lagging Strand R-HSA-69183,-0.6252901449140287,-0.9775439975307731,0.5530085959885387,1.0,1.0,4/15,26.29%,Lrig1;Pold4;Prim2;Dna2
prerank,Mismatch Repair R-HSA-5358508,-0.6316411109097434,-0.9774959828050443,0.5521126760563381,1.0,1.0,2/15,12.61%,Lrig1;Pold4
prerank,Ca-dependent Events R-HSA-111996,0.5676961539774658,0.9754242432475335,0.5474683544303798,1.0,1.0,10/34,2.81%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Mapk1;Pde1b;Adcy9;Camkk1;Camk2g
prerank,SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.5745611739868229,0.974660360472583,0.47368421052631576,1.0,1.0,3/20,0.63%,Prkce;Nrg2;Nrg3
prerank,CD209 (DC-SIGN) Signaling R-HSA-5621575,-0.6191827004067235,-0.9737142853095119,0.559322033898305,1.0,1.0,4/16,7.75%,Lyn;Relb;Rps6ka5;Prkca
prerank,Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.5407346003483019,-0.971990329667823,0.5476878612716763,1.0,1.0,14/69,7.53%,Pik3r1;Bcl2;Gng4;Kcnh8;Gng12;Esr1;Gnai1;Esr2;Gnb4;Egfr;Cav1;Gnai2;Cav2;Ccnd1
prerank,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,0.5804372614608523,0.971379288334451,0.5182724252491694,1.0,1.0,1/20,2.06%,B4galt1
prerank,NoRC Negatively Regulates rRNA Expression R-HSA-427413,0.4982385264910196,0.9713273995793879,0.501577287066246,1.0,1.0,19/62,14.79%,Gtf2h2;Hdac1;Gtf2h5;Ccnh;Ubtf;Mnat1;H2bc4;Polr2e;Smarca5;H2az1;H2ac6;H2ax;Sin3b;H2ac4;Taf1c;Polr2k;Polr1h;Baz2a;Sap30bp
prerank,O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.54395838923549,0.9710746692301858,0.496875,1.0,1.0,5/38,0.94%,Thsd7a;Sema5a;Adamts17;Spon1;Adamts3
prerank,Semaphorin Interactions R-HSA-373755,0.49155487121517805,0.9707946022923051,0.5015290519877675,1.0,1.0,4/64,1.27%,Plxna4;Sema5a;Nrp1;Sema6d
prerank,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,0.5178586166631943,0.970730287671939,0.48355263157894735,1.0,1.0,7/51,4.88%,Nedd4l;Mapk1;Ncor1;Smad3;Ski;Hdac1;Mapk3
prerank,TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,-0.618328669556393,-0.9702938143966805,0.5486968449931413,1.0,1.0,2/15,12.17%,Irak2;Ticam1
prerank,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.5980525019949264,-0.9700666021580284,0.5815295815295816,1.0,1.0,2/27,2.08%,Fgf1;Fgfr3
prerank,Acyl Chain Remodelling Of PE R-HSA-1482839,-0.5959304483637264,-0.9692917638599593,0.5761973875181422,1.0,1.0,9/26,14.29%,Mboat1;Pla2g4a;Pla2g4c;Plaat3;Plaat1;Pla2g6;Pnpla8;Pla2r1;Lpcat3
prerank,Asparagine N-linked Glycosylation R-HSA-446203,0.4068031966421623,0.967200753378836,0.548936170212766,1.0,1.0,18/273,2.96%,Gria1;Ank3;St6galnac3;Nsf;St6galnac5;Sptb;Cnih3;Sptbn1;Tgfa;B4galt1;B4galt5;Sptbn4;Sec24d;St8sia4;Dync1i2;Ank2;Fut8;Sptan1
prerank,Defective B3GALTL Causes PpS R-HSA-5083635,0.5439855693045392,0.9661965769982137,0.5079365079365079,1.0,1.0,5/37,0.94%,Thsd7a;Sema5a;Adamts17;Spon1;Adamts3
prerank,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.5148506874261832,-0.9657464109435889,0.5263157894736842,1.0,1.0,10/96,9.18%,Tnfrsf11a;Relb;Tnfrsf1b;Tnfrsf13b;Birc3;Ltbr;Edaradd;Traf3;Tnfrsf11b;Psmb8
prerank,Mitotic Prophase R-HSA-68875,-0.5301129378341038,-0.9655924408073366,0.5570776255707762,1.0,1.0,2/95,0.97%,Prkcb;Vrk2
prerank,MAP Kinase Activation R-HSA-450294,0.5025265359110622,0.9654305056451957,0.5130718954248366,1.0,1.0,15/61,5.94%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Rps6ka2;Mef2c;Btrc;Fbxw11;Mapk10;Ripk2;Map2k4;Mapk3;Mapk14;Dusp4
prerank,Sema4D In Semaphorin Signaling R-HSA-400685,-0.6008997175095552,-0.9642480413294666,0.5552367288378766,1.0,1.0,8/24,19.37%,Arhgef11;Plxnb1;Myh14;Limk1;Myl6;Rras;Erbb2;Myh10
prerank,"Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.4687375822343849,-0.9640326610240489,0.5393858477970628,1.0,1.0,53/241,7.75%,Pcdh7;Itpr2;Prkcq;Prkcb;Vav2;Trpc3;Pik3r1;Apbb1ip;Fn1;Lcp2;Rasgrp1;Phactr2;Gng4;Rapgef3;Vav1;Trpc7;Igf1;Pla2g4a;Sparc;Cyrib;Lyn;Itih3;Pik3r5;Sgpp2;Gna15;Vcl;Selenop;Gng12;Prkcg;Sccpdh;Gnai1;Prkcd;Cd109;Tgfb1;Tmx3;Rasgrp2;App;Gnb4;Prkch;Clu;Rap1b;P2ry12;Vegfa;Pik3cg;Gnai2;Fermt3;P2ry1;Cd9;Endod1;Calu;Syk;Vegfd;Prkca
prerank,Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.5460726657812641,-0.9636719181470416,0.554904831625183,1.0,1.0,7/63,5.62%,St6gal1;St8sia5;St3gal6;St6gal2;Neu4;St8sia6;Uap1
prerank,Cell-Cell Communication R-HSA-1500931,0.4604207995718383,0.9628950280004852,0.5164473684210527,1.0,1.0,20/111,4.33%,Cdh9;Kirrel3;Cadm2;Cdh8;Ptk2b;Cdh12;Pard3;Magi2;Sptbn1;Ptk2;Cdh13;Nck2;Cdh2;Sptan1;Cadm1;Pik3cb;Actn2;Actn1;Fyn;Pals1
prerank,HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.5451154708949898,-0.9628022344942883,0.564963503649635,1.0,1.0,14/64,23.68%,Rbbp8;Rad51b;Pold4;Top3a;Wrn;Artn;Eme1;Bard1;Rrad;Xrcc2;Xrcc3;Rfc2;Sem1;Polk
prerank,Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.48513864237107135,0.9623044750540254,0.512987012987013,1.0,1.0,16/79,13.09%,Cdc40;Srsf9;Thoc2;Srsf11;Srsf1;Ndc1;Nup93;Ncbp1;Ranbp2;Fyttd1;Eif4e;Wdr33;Srsf7;Nup160;Nup155;Thoc3
prerank,Cilium Assembly R-HSA-5617833,-0.4804009263787491,-0.9607704005703979,0.546079779917469,1.0,1.0,32/183,19.64%,Asap1;Sclt1;Smox;Tubb4a;Ccp110;Nde1;Nedd1;Cep83;Atat1;Bbs9;Prkca;Plk4;Ift88;Bbs2;Alms1;Dync1h1;Akap9;Bbs5;Cep43;Cnga4;Rho;Csnk1e;Cep164;Cep290;Rpgrip1l;Pafah1b1;Dynlrb2;Pcnt;Cep97;Kif24;Ift172;Cntrl
prerank,GPVI-mediated Activation Cascade R-HSA-114604,-0.5826436668007294,-0.9598365265246304,0.5595054095826894,1.0,1.0,6/32,3.01%,Vav2;Pik3r1;Lcp2;Vav1;Lyn;Pik3r5
prerank,Signaling By FGFR2 R-HSA-5654738,-0.5396067576549631,-0.9584140065528532,0.577259475218659,1.0,1.0,2/68,1.29%,Pik3r1;Fgf1
prerank,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,-0.6047709878664682,-0.9569425613589168,0.5835694050991501,1.0,1.0,7/20,19.37%,Arhgef11;Plxnb1;Myh14;Limk1;Myl6;Erbb2;Myh10
prerank,RHO GTPases Activate CIT R-HSA-5625900,0.5770662516293948,0.9565167194303851,0.5272108843537415,1.0,1.0,2/19,2.19%,Ppp1r12b;Ppp1cb
prerank,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,0.49014409037146306,0.9558122197652967,0.5477707006369427,1.0,1.0,19/65,14.79%,Gtf2h2;Hdac1;Gtf2h5;Ccnh;Ubtf;Mnat1;H2bc4;Polr2e;Smarca5;H2az1;H2ac6;H2ax;Sin3b;H2ac4;Taf1c;Polr2k;Polr1h;Baz2a;Sap30bp
prerank,Activation Of HOX Genes During Differentiation R-HSA-5619507,-0.5399067276705778,-0.955067121840115,0.5688350983358548,1.0,1.0,5/69,8.45%,Meis1;Rara;Mafb;Pbx1;Ncoa3
prerank,MicroRNA (miRNA) Biogenesis R-HSA-203927,0.5684192494847866,0.9526861618329814,0.5303514376996805,1.0,1.0,4/24,9.84%,Ago1;Ago2;Dicer1;Polr2e
prerank,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.5381507083639377,-0.9514425324159058,0.5730659025787965,1.0,1.0,6/60,18.32%,Cftr;Psmb8;Psma8;Sel1l;Psme4;Psme2
prerank,Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.5754875732660963,-0.951220142249555,0.5953757225433526,1.0,1.0,2/35,0.64%,Gpc6;Gpc5
prerank,Early Phase Of HIV Life Cycle R-HSA-162594,0.5971883461697474,0.9508943375710653,0.5617283950617284,1.0,1.0,1/15,0.59%,Sgip1
prerank,Metabolism Of Polyamines R-HSA-351202,-0.5401839773301756,-0.9504169745235699,0.5781021897810219,1.0,1.0,9/57,23.61%,Smox;Psmb8;Psma8;Slc38a1;Slc25a21;Psme4;Psme2;Psma1;Sem1
prerank,Ion Homeostasis R-HSA-5578775,0.5178342701398679,0.9503971157340035,0.5382165605095541,1.0,1.0,12/48,3.72%,Ryr2;Camk2a;Camk2b;Atp2b1;Slc8a2;Orai2;Atp2b3;Ryr1;Atp1b1;Camk2g;Calm1;Itpr1
prerank,PIP3 Activates AKT Signaling R-HSA-1257604,0.39757055713286577,0.9502509629823972,0.6233183856502242,1.0,1.0,31/257,4.94%,Il1rap;Pip5k1b;Nrg2;Nrg3;Foxo1;Tnrc6c;Akt3;Mapk1;Tgfa;Chd4;Hdac7;Prex2;Chd3;Jun;Flt3;Rragd;Pip5k1a;Cnot6l;Gatad2b;Pik3cb;Ago1;Fgf5;Ago2;Nedd4;Tnrc6b;Fyn;Hdac1;Tnks;Cbx6;Mapk3;Src
prerank,Translation Of Structural Proteins R-HSA-9683701,-0.573170750862425,-0.9495944431239686,0.5747800586510264,1.0,1.0,3/29,1.80%,St6gal1;Parp8;Parp4
prerank,RHOU GTPase Cycle R-HSA-9013420,-0.5561221567465324,-0.9493712105024789,0.5651515151515152,1.0,1.0,11/39,9.06%,Pik3r1;Arhgap31;Srgap2;Peak1;Myo6;Arhgef6;Iqgap1;Wwp2;Stam2;Depdc1b;Arhgap30
prerank,Transcriptional Regulation By TP53 R-HSA-3700989,0.3906333516876363,0.9480751028934761,0.6267942583732058,1.0,1.0,38/330,6.44%,Tnrc6c;Prkag2;Map2k6;Ppp1r13b;Pdzd2;Akt3;Bcl6;Chd4;Usp2;Chd3;Cnot2;Jun;Rragd;Cnot6l;Gatad2b;Gtf2h2;Ago1;Steap3;Ago2;Ywhaz;Cdk5r1;Tnrc6b;Gtf2f2;Hdac1;Cdk12;Ywhab;Rad50;Kmt5a;Gtf2h5;Ccnh;Txnrd1;Ehmt1;Smyd2;Mapk14;Ywhae;Ywhah;Ssrp1;Crebbp
prerank,Toll-like Receptor Cascades R-HSA-168898,-0.48580602131917094,-0.9442454102434324,0.5774647887323944,1.0,1.0,36/152,14.20%,Ly86;Kcnh8;Itgam;Lgmn;Alpk1;Cd180;Unc93b1;Dusp6;Irak2;Tlr7;Ctss;Casp8;Mapk11;App;Irak3;Birc3;Rps6ka5;Dnm3;Tlr3;Traf3;Map3k1;Btk;Tlr5;Mapk8;S100a1;Ptpn4;Tlr1;Itgb2;S100b;Nod1;Ticam1;Nod2;Irf3;Rps6ka1;Tirap;Usp14
prerank,MHC Class II Antigen Presentation R-HSA-2132295,-0.5137943271970674,-0.9421875823105812,0.5796460176991151,1.0,1.0,19/85,14.62%,Osbpl1a;Kif26a;Lgmn;Kif5a;Ctsd;Ctss;Ctsh;Ctsc;Dnm3;Ap2b1;Sh3gl2;Lag3;Dync1h1;Cd74;Ctso;Dync1li2;Sec24a;Klc3;Cltc
prerank,Synthesis Of PA R-HSA-1483166,-0.5627129150008511,-0.9417816582928145,0.5947521865889213,1.0,1.0,4/37,12.72%,Pla2g4a;Gpat3;Pld2;Pla2r1
prerank,RHOD GTPase Cycle R-HSA-9013405,-0.5515403741173878,-0.9415814715234103,0.5780346820809249,1.0,1.0,9/49,7.02%,Cpne8;Pik3r1;Vrk2;Arhgap26;Plxna1;Akap12;Mcam;Cav1;Plxnb1
prerank,Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.558496901497355,-0.9414516554407514,0.6106983655274889,1.0,1.0,5/40,3.78%,Dusp10;Dusp5;Dusp16;Dusp6;Ppp2r5a
prerank,Signaling By BMP R-HSA-201451,-0.5768543025603419,-0.9414189804639661,0.6022889842632332,1.0,1.0,8/25,9.47%,Bmpr1b;Smurf1;Amhr2;Smad7;Smad1;Smad6;Smad9;Acvr2b
prerank,RAC1 GTPase Cycle R-HSA-9013149,-0.4682982991276709,-0.9413733115233455,0.578042328042328,1.0,1.0,41/175,6.06%,Dock1;Srgap1;Dlc1;Plekhg1;Arap2;Vav2;Dock2;Arhgap22;Farp1;Pik3r1;Wipf1;Vrk2;Arhgap31;Srgap2;Arhgap23;Arhgap45;Dock8;Dock5;Arhgap26;Nckap1l;Mcf2;Vav1;Garre1;Dock6;Ncf2;Arhgap25;Prex1;Arhgap42;Swap70;Arhgef6;Iqgap1;Arhgef19;Arhgap24;Cdc42ep1;Arhgef11;Fgd5;Arap1;Mcam;Ophn1;Arhgef10;Cav1
prerank,RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.5896396039269266,-0.9413352410055745,0.5791788856304986,1.0,1.0,10/23,13.51%,Prkcb;Ncf2;Prkcd;Mapk11;Prkca;Nox3;Ncf1;Rac2;Ncf4;Cyba
prerank,Signaling To ERKs R-HSA-187687,0.5287038261030295,0.9409551696328614,0.5321100917431193,1.0,1.0,8/33,5.81%,Bcl11b;Mapk1;Rit2;Map2k1;Ywhab;Mapk3;Src;Mapk14
prerank,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",0.47462775293412607,0.9389596573024208,0.56,1.0,1.0,6/80,2.30%,Slc2a13;Slc44a5;Slc16a7;Slc39a6;Slc6a15;Slc30a3
prerank,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.584781059247083,-0.9386097345996889,0.5943536404160475,1.0,1.0,1/21,3.46%,Mfn1
prerank,NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.5711196588125714,-0.9383333054350256,0.5997109826589595,1.0,1.0,4/24,9.04%,Wwp2;Egfr;Jag2;Adam10
prerank,Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.5635294433621839,-0.9383023606227041,0.581294964028777,1.0,1.0,2/32,3.93%,Trim25;Usp43
prerank,Signaling By EGFR In Cancer R-HSA-1643713,-0.587379141895142,-0.9381235124683175,0.6150627615062761,1.0,1.0,2/23,5.64%,Pik3r1;Egfr
prerank,CTLA4 Inhibitory Signaling R-HSA-389513,-0.5925830474162573,-0.9372888717192731,0.612184249628529,1.0,1.0,5/21,9.16%,Cd86;Lyn;Ppp2r5a;Cd80;Ppp2r5c
prerank,ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.5990357855740782,-0.9371460704719298,0.620199146514936,1.0,1.0,9/20,28.72%,Tlr3;Dtx4;Ticam1;Irf3;Nkiras1;Ripk1;Nfkbia;Chuk;Rela
prerank,Leishmania Infection R-HSA-9658195,-0.4647204192381116,-0.9371169920648824,0.6085164835164835,1.0,1.0,39/216,8.40%,Dock1;Elmo1;Rxfp1;Itpr2;Vav2;Entpd1;Wipf1;Myo1e;Htr7;P2rx7;Gng4;Nckap1l;Hck;Vav1;Lyn;Prkar1b;Npsr1;Casp1;Gng12;Gnas;P2rx4;Gnai1;Adrb3;Ggt5;Gnb4;Adcy7;Plk2;Hrh2;Lhcgr;C1qtnf1;Gnai2;Adora2b;Syk;Prkca;Adam17;Btk;Crhr1;Txnip;Mapk8
prerank,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.5972387043447647,-0.9366609389642396,0.613603473227207,1.0,1.0,3/18,12.17%,Birc3;Tlr3;Ticam1
prerank,Sialic Acid Metabolism R-HSA-4085001,-0.5656954556053988,-0.9355669406792687,0.6175182481751825,1.0,1.0,6/33,5.28%,St6gal1;St8sia5;St3gal6;St6gal2;Neu4;St8sia6
prerank,"Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",0.576518080005408,0.9340136570574465,0.5625,1.0,1.0,7/16,16.33%,Ywhab;Exosc8;Tnpo1;Dcp1a;Exosc2;Exosc1;Mapkapk2
prerank,Amyloid Fiber Formation R-HSA-977225,0.4852907272694615,0.9338125756294969,0.5654761904761905,1.0,1.0,6/58,3.54%,Snca;Calb1;Sorl1;Tspan5;Sncaip;Tspan33
prerank,TNFs Bind Their Physiological Receptors R-HSA-5669034,-0.5650555580768243,-0.9331052451594685,0.6020558002936858,1.0,1.0,4/25,7.75%,Tnfrsf1b;Tnfrsf13b;Edaradd;Tnfrsf11b
prerank,O-linked Glycosylation R-HSA-5173105,0.4522328253009016,0.9318929366082109,0.5751633986928104,1.0,1.0,14/98,4.06%,Thsd7a;Sema5a;St6galnac3;Adamts17;Spon1;Adamts3;Galnt18;Galnt14;B4galt5;Sema5b;B3gnt2;Large1;Adamts18;St3gal1
prerank,Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.5775496472915261,-0.9318052713406333,0.5923836389280677,1.0,1.0,3/21,10.36%,Tcn2;Acaca;Sp8
prerank,ABC Transporter Disorders R-HSA-5619084,-0.5122687820863919,-0.931613423136042,0.5991253644314869,1.0,1.0,9/77,18.32%,Abca1;Cftr;Psmb8;Abcd1;Psma8;Abca3;Sel1l;Psme4;Psme2
prerank,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.47344686463581537,0.9312519584485712,0.5672131147540984,1.0,1.0,6/72,2.82%,Negr1;Cntn5;Lsamp;Ntng2;Nrn1;Rtn4rl1
prerank,Organelle Biogenesis And Maintenance R-HSA-1852241,-0.44969202621083254,-0.930939800012644,0.6127770534550195,1.0,1.0,26/256,11.59%,Asap1;Tbl1x;Camk4;Sclt1;Prkab2;Smox;Prkaa2;Tubb4a;Smarcd3;Mapk11;Ccp110;Nde1;Nedd1;Cep83;Atat1;Bbs9;Prkca;Plk4;Ift88;Idh2;Bbs2;Alms1;Dync1h1;Ppargc1a;Glud1;Chchd6
prerank,Kinesins R-HSA-983189,-0.5618991746401869,-0.9299272870700293,0.6129496402877698,1.0,1.0,6/36,6.13%,Kif21b;Kif26a;Kif6;Kif5a;Kif13b;Kif16b
prerank,Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,0.532062753945369,0.9294345677908095,0.5585284280936454,1.0,1.0,4/32,7.31%,Nek6;Ndc1;Nup93;Ranbp2
prerank,Cytoprotection By HMOX1 R-HSA-9707564,-0.5353562539576735,-0.9291309793499375,0.6130952380952381,1.0,1.0,8/54,15.01%,Tbl1x;Smarcd3;Nfe2l2;Txnip;Cox16;Nlrp3;Abcc1;Stat3
prerank,Metabolism Of Folate And Pterines R-HSA-196757,-0.6124577884073371,-0.9283976442755656,0.6264367816091954,1.0,1.0,3/15,14.14%,Aldh1l1;Mthfd1l;Folr2
prerank,Glycolysis R-HSA-70171,-0.5273585104948184,-0.9276377795360048,0.6115326251896813,1.0,1.0,5/62,7.75%,Pfkp;Pfkfb3;Map4k2;Pfkfb4;Prkca
prerank,Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.582874131990073,-0.9274401605783648,0.6257225433526011,1.0,1.0,3/19,6.75%,Eps15;Stam2;Sh3gl2
prerank,Signaling By ERBB2 R-HSA-1227986,0.48505615556971315,0.9269264064254056,0.5584415584415584,1.0,1.0,9/48,4.94%,Prkce;Nrg2;Nrg3;Akt3;Diaph1;Fyn;Cul5;Matk;Src
prerank,VLDLR Internalisation And Degradation R-HSA-8866427,-0.5925183972239763,-0.9263048174294534,0.6453900709219859,1.0,1.0,3/16,14.62%,Ap2b1;Mylip;Cltc
prerank,Generation Of Second Messenger Molecules R-HSA-202433,-0.5871540882383971,-0.9262303367911991,0.6223479490806223,1.0,1.0,1/21,1.19%,Lcp2
prerank,Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.43250540994777403,0.9237281135154904,0.5957446808510638,1.0,1.0,10/109,2.43%,Zfpm2;Dock10;Kif26b;Carmil1;Dock4;Dock11;Ehd3;Dock3;Ehd1;Phf21a
prerank,Other Semaphorin Interactions R-HSA-416700,0.5600959267909839,0.9232331474681803,0.5548780487804879,1.0,1.0,3/19,1.27%,Plxna4;Sema5a;Sema6d
prerank,Viral Messenger RNA Synthesis R-HSA-168325,0.5183044906149818,0.9231741394215923,0.5824915824915825,1.0,1.0,11/43,15.52%,Gtf2f2;Ndc1;Nup93;Ranbp2;Polr2e;Gnl3;Nup160;Nup155;Polr2k;Nup210;Gtf2f1
prerank,Signaling By ROBO Receptors R-HSA-376176,0.4075836630821422,0.9228539859344791,0.6254826254826255,1.0,1.0,10/201,3.28%,Slit3;Nell2;Robo2;Nrp1;Lhx9;Dcc;Arhgap39;Nck2;Cap1;Abl2
prerank,Sensory Processing Of Sound R-HSA-9659379,-0.5133454540926397,-0.9228077271041208,0.6059701492537314,1.0,1.0,8/73,2.50%,Pcdh15;Whrn;Epb41l3;Kcnn2;Myo1e;Cacna2d2;Stx1a;Gsn
prerank,Protein Localization R-HSA-9609507,-0.47298123942618425,-0.9228018969914132,0.623249299719888,1.0,1.0,17/151,17.38%,Stx1a;Slc25a13;App;Phyh;Crot;Cyb5a;Pex7;Abcd1;Glyat;Cmc2;Pex13;Idh1;Ide;Ehhadh;Ldhd;Nudt7;Crat
prerank,Regulation Of TLR By Endogenous Ligand R-HSA-5686938,-0.5876122942295752,-0.9223930809535953,0.6294200848656294,1.0,1.0,10/17,37.15%,S100a1;Tlr1;Tlr2;Tlr6;Gsdmd;Tlr4;Ndufa2;Cd36;Fgg;Ly96
prerank,Rab Regulation Of Trafficking R-HSA-9007101,-0.48039164770800746,-0.9215313081518872,0.6157142857142858,1.0,1.0,13/115,12.21%,Rab31;Optn;Dennd1c;Rin3;Dennd3;Rin2;Dennd4a;Tbc1d10c;Dennd5b;Dennd2c;Als2cl;Rab3il1;Chml
prerank,GPER1 Signaling R-HSA-9634597,0.5086765191781564,0.9213218028289201,0.5575757575757576,1.0,1.0,5/41,2.24%,Adcy1;Adcy2;Gng7;Adcy9;Gng2
prerank,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.5042395677555211,0.9204470989105443,0.560126582278481,1.0,1.0,4/36,2.24%,Rgs7;Gng7;Gnaq;Gng2
prerank,HCMV Infection R-HSA-9609646,-0.48944581182623825,-0.9197975440898287,0.6226950354609929,1.0,1.0,5/104,8.24%,Tbl1x;Pcsk1;Kcnh8;Egfr;Itgb1
prerank,NGF-stimulated Transcription R-HSA-9031628,-0.5479082091108357,-0.9191490424584573,0.6229985443959243,1.0,1.0,15/38,19.58%,Kcnh8;Vgf;Egr1;Trib1;Sgk1;Id1;F3;Id4;Arc;Id3;Tph1;Ep300;Rrad;Gdnf;Fosb
prerank,SARS-CoV-1 Infection R-HSA-9678108,-0.5328204512252723,-0.9186191904102337,0.6175182481751825,1.0,1.0,3/50,1.80%,St6gal1;Parp8;Parp4
prerank,Phase 4 - Resting Membrane Potential R-HSA-5576886,0.5576339490313288,0.918047456909261,0.5618729096989966,1.0,1.0,6/18,6.01%,Kcnk10;Kcnk1;Kcnk9;Kcnj4;Kcnj2;Kcnk12
prerank,HIV Transcription Initiation R-HSA-167161,0.49601237364956025,0.9177064704724543,0.5850340136054422,1.0,1.0,6/45,9.84%,Gtf2h2;Gtf2f2;Gtf2h5;Ccnh;Mnat1;Polr2e
prerank,Mitochondrial tRNA Aminoacylation R-HSA-379726,0.5620187205915456,0.9155719476981449,0.5755627009646302,1.0,1.0,4/18,9.44%,Dtd1;Fars2;Rars2;Lars2
prerank,HSF1-dependent Transactivation R-HSA-3371571,0.5173624407913923,0.9147887378605355,0.5836177474402731,1.0,1.0,2/34,0.44%,Camk2a;Camk2b
prerank,Cell-cell Junction Organization R-HSA-421270,0.473269194361123,0.9144315964049547,0.6031746031746031,1.0,1.0,8/56,3.03%,Cdh9;Cadm2;Cdh8;Cdh12;Pard3;Cdh13;Cdh2;Cadm1
prerank,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,0.5164973342758751,0.9142117930559822,0.5675675675675675,1.0,1.0,5/26,3.12%,Nedd4l;Ppp1cb;Smad3;Tgfbr1;Usp15
prerank,Regulation Of TP53 Activity R-HSA-5633007,0.41401308112149676,0.9133152358803489,0.6678200692041523,1.0,1.0,16/143,5.81%,Prkag2;Map2k6;Ppp1r13b;Pdzd2;Akt3;Chd4;Usp2;Chd3;Gatad2b;Cdk5r1;Hdac1;Rad50;Kmt5a;Ehmt1;Smyd2;Mapk14
prerank,SUMOylation Of Intracellular Receptors R-HSA-4090294,0.5422006196706373,0.9131102955115514,0.6006389776357828,1.0,1.0,1/29,0.01%,Nr3c2
prerank,Oncogene Induced Senescence R-HSA-2559585,0.52426364417249,0.9122231798497004,0.5900621118012422,1.0,1.0,5/32,4.88%,Tnrc6c;Mapk1;Ago1;Tnrc6b;Mapk3
prerank,Diseases Of Glycosylation R-HSA-3781865,-0.46920453488015806,-0.9115260344969128,0.6389684813753582,1.0,1.0,19/136,5.96%,Gpc6;Ext1;Adamtsl1;Adamts16;Adamts2;Gpc5;Thsd4;Bcan;B3glct;Cspg4;Vcan;Adamts4;Chst3;Cspg5;Adamts6;Dcn;Notch1;Lfng;Sdc4
prerank,tRNA Aminoacylation R-HSA-379724,0.5413451270619137,0.9114076069809368,0.6222910216718266,1.0,1.0,5/26,9.44%,Dtd1;Fars2;Farsa;Rars2;Lars2
prerank,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.48081163470647126,-0.9113605511581718,0.6385372714486639,1.0,1.0,21/111,9.04%,Fam20a;Fn1;Ltbp1;Igf1;Vcan;Cst3;Sgpp2;Apoe;Igfbp7;Bmp4;Vgf;Eva1a;Cp;App;Mfge8;Igfbp4;Calu;Scg3;Mgat4a;Wfs1;Adam10
prerank,Smooth Muscle Contraction R-HSA-445355,0.4995568927725611,0.9093899183238091,0.58,1.0,1.0,6/40,3.65%,Sorbs1;Cald1;Cacna1h;Anxa6;Calm1;Gucy1b1
prerank,Drug ADME R-HSA-9748784,-0.5268671444885012,-0.9093082507966338,0.6327433628318584,1.0,1.0,6/55,5.23%,Vav2;Slco2b1;Slc22a3;Vav1;Slc38a3;Ggt5
prerank,Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.5780051263063075,-0.9087231211544667,0.65625,1.0,1.0,3/18,13.04%,Lrig1;Pold4;Wrn
prerank,Meiosis R-HSA-1500620,0.4684097074133638,0.908285745114922,0.6072507552870091,1.0,1.0,1/72,0.47%,Syne1
prerank,Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,0.48811128436929935,0.907318216670402,0.6221498371335505,1.0,1.0,9/50,14.08%,Gtf2h2;Gtf2h5;Ccnh;Mnat1;Polr2e;Usp7;Uba52;Gps1;Polr2k
prerank,RNA Polymerase II Pre-transcription Events R-HSA-674695,0.45960954365052753,0.9069287931900439,0.6206896551724138,1.0,1.0,14/74,12.04%,Gtf2h2;Gtf2f2;Gtf2h5;Ccnh;Ssrp1;Ncbp1;Mnat1;Rtf1;Ccnt2;Aff4;Polr2e;Ccnk;Skic8;Cdk9
prerank,Regulation Of Insulin Secretion R-HSA-422356,0.46433568812333004,0.9066345962223544,0.6141479099678456,1.0,1.0,11/74,2.54%,Cacnb2;Cacna1e;Cacna1c;Plcb1;Cacna1d;Gng7;Kcng2;Gnaq;Gng2;Abcc8;Rapgef4
prerank,Endogenous Sterols R-HSA-211976,0.557553417224137,0.9064996395057312,0.6131147540983607,1.0,1.0,3/21,5.26%,Cyp7b1;Cyp11a1;Ncoa1
prerank,Lagging Strand Synthesis R-HSA-69186,-0.5732444412925276,-0.9060082833089057,0.6434782608695652,1.0,1.0,6/20,29.15%,Lrig1;Pold4;Prim2;Rfc2;Dna2;Rfc3
prerank,RAF Activation R-HSA-5673000,0.5289171564159777,0.9058004588775963,0.5777777777777777,1.0,1.0,10/30,4.94%,Camk2a;Camk2b;Map2k1;Ppp1cb;Camk2g;Calm1;Ksr1;Mras;Ywhab;Src
prerank,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.5343267807365342,-0.9057496713724612,0.62,1.0,1.0,2/39,3.93%,Trim25;Usp43
prerank,VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.49321385048001704,-0.9053422033368367,0.637660485021398,1.0,1.0,15/91,6.78%,Dock1;Elmo1;Itpr2;Prkcb;Vav2;Pik3r1;Nckap1l;Vav1;Ncf2;Prr5;Prkcd;Mapk11;Cav1;Ctnna1;Vegfa
prerank,Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.5768116427901661,-0.9048310748632435,0.6428571428571429,1.0,1.0,2/17,14.20%,Casp8;Usp14
prerank,NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,-0.5401725747425351,-0.904828265341062,0.6440177252584933,1.0,1.0,7/41,6.22%,Tbl1x;Arl4c;Abca1;Apoe;Nrip1;Apod;Kdm3a
prerank,RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.5851569378981628,-0.9038391017214661,0.6410256410256411,1.0,1.0,7/17,28.72%,Tlr3;Ticam1;Nkiras1;Ripk1;Nfkbia;Chuk;Rela
prerank,Regulated Necrosis R-HSA-5218859,-0.5244882567362846,-0.9028612006288689,0.6509572901325479,1.0,1.0,9/49,13.21%,Casp1;Casp8;Birc3;Casp4;Irf2;Il1a;Tnfsf10;Il18;Flot1
prerank,Integrin Cell Surface Interactions R-HSA-216083,-0.5097759786953207,-0.9026460763834459,0.6541353383458647,1.0,1.0,21/64,12.01%,Itga9;Fn1;Itgb5;Jam3;Jam2;Itgam;Itga2;Cd44;F11r;Itga6;Col9a1;Col16a1;Vtn;Itgb1;Col4a2;Hspg2;Itga1;Itga3;Col4a1;Itgb2;Vcam1
prerank,Metabolism Of Amine-Derived Hormones R-HSA-209776,-0.5647628759972432,-0.9025527779837401,0.638328530259366,1.0,1.0,4/18,15.60%,Dio2;Chga;Tshb;Tph1
prerank,Transcriptional Regulation By E2F6 R-HSA-8953750,-0.5491043293784149,-0.9022786149396622,0.6418128654970761,1.0,1.0,3/33,10.69%,Rbbp8;E2f1;Pcgf2
prerank,Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.4928284130751879,-0.9020427515137811,0.6402877697841727,1.0,1.0,35/82,19.80%,Gng4;Gng12;Smox;Fzd2;Gnas;Wnt2;Gnb4;Adgre1;Shh;C1qtnf1;Crhbp;Crhr1;Wnt10a;Pth2r;Sctr;Fzd6;Adm;Calcr;Gng3;Wnt3a;Calcb;Gngt2;Calcrl;Wnt7a;Ghrh;Gnb1;Vipr2;Cysltr2;Ucn;Gng11;Wnt5a;Wnt9b;Fzd10;Ptch2;Fzd4
prerank,Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.5420162555125229,-0.9012648088393088,0.6541244573082489,1.0,1.0,11/31,9.27%,Slc7a2;Slc7a11;Slc38a3;Slc7a7;Slc7a10;Slc1a5;Slc38a2;Slc36a1;Slc7a3;Slc38a4;Slc7a1
prerank,RND3 GTPase Cycle R-HSA-9696264,0.5059407059932821,0.9011165573385421,0.5941558441558441,1.0,1.0,6/40,3.95%,Plekhg5;Rasal2;Arhgap21;Pkp4;Vangl2;Nisch
prerank,Activation Of SMO R-HSA-5635838,0.5410357941504567,0.900738553633491,0.5830618892508144,1.0,1.0,4/18,6.19%,Cdon;Ptch1;Efcab7;Csnk1a1
prerank,Opioid Signaling R-HSA-111885,0.4519619121953046,0.9001724931448141,0.6239067055393586,1.0,1.0,21/86,3.72%,Ppp3ca;Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Plcb1;Gng7;Gnal;Gnaq;Mapk1;Pde1b;Adcy9;Camkk1;Gng2;Pde4a;Ppp3r1;Camk2g;Pdyn;Calm1;Itpr1
prerank,Chromatin Modifying Enzymes R-HSA-3247509,0.3879703919708486,0.8989723039287287,0.7622950819672131,1.0,1.0,54/218,11.24%,Kat6b;Arid1b;Kdm7a;Ncor1;Chd4;Phf21a;Chd3;Smarca2;Gatad2b;Hdac1;Dot1l;Rbbp5;Smarca4;Smarcd2;Nsd1;Trrap;Brwd1;Kmt5a;Ncoa1;Elp2;Arid5b;Ehmt1;Smyd2;Hdac8;Ash1l;Mta3;Zzz3;Ncor2;Crebbp;Rbbp7;Tbl1xr1;Suz12;Ezh2;Rcor1;Mta2;Jade3;Setdb1;Setd7;Actl6b;Taf5l;H2bc4;Kat7;Setd2;Kdm4a;Eny2;Dr1;H2az1;H2ac6;H2ax;Epc1;Tada1;Aebp2;Nfkb1;Kdm2b
prerank,RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,0.5352938235511399,0.8981949610653467,0.5728155339805825,1.0,1.0,10/26,19.57%,Gtf3c1;Gtf3c4;Polr2e;Gtf3c2;Polr2k;Polr3gl;Polr3g;Polr3e;Tbp;Polr2f
prerank,Peroxisomal Lipid Metabolism R-HSA-390918,-0.5623554687129704,-0.8977860215634782,0.6476608187134503,1.0,1.0,7/27,21.09%,Phyh;Crot;Abcd1;Ehhadh;Nudt7;Crat;Acox3
prerank,Nucleotide Catabolism R-HSA-8956319,0.5094225687320173,0.897126283881001,0.58,1.0,1.0,4/30,3.00%,Dpyd;Gda;Nt5c2;Upp2
prerank,Signaling By NTRK3 (TRKC) R-HSA-9034015,0.5552053978436533,0.8968830761470854,0.5948905109489051,1.0,1.0,2/16,0.98%,Ntrk3;Ntf3
prerank,L1CAM Interactions R-HSA-373760,0.43304195721715627,0.896434772222005,0.6512345679012346,1.0,1.0,24/95,3.62%,Ank3;Nrcam;Scn3a;Nrp1;Cntn1;Nrp2;Scn2a;Scn8a;Ncam1;Sptb;Scn3b;Mapk1;Map2k1;Sptbn1;Sptbn4;Dnm1;Kcnq3;Ank2;Rps6ka2;Scn9a;Sptan1;Lamc1;Sdcbp;Lamb1
prerank,SARS-CoV-2-host Interactions R-HSA-9705683,-0.4498325210571113,-0.8953949850382721,0.6610878661087866,1.0,1.0,19/166,13.70%,Gja1;Masp1;Irak2;Trim25;Tlr7;Il17ra;Ywhaq;Cav1;Sting1;Traf3;Ifih1;Tlr1;Rnf135;Nlrp3;Rigi;Nod1;Nod2;Irf3;Sec24a
prerank,Telomere Maintenance R-HSA-157579,-0.49266557970860514,-0.8953241321834327,0.6491754122938531,1.0,1.0,6/78,13.04%,Ankrd28;Lrig1;Cdk2;Pif1;Pold4;Wrn
prerank,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,0.451915422043848,0.8930142083630447,0.6193548387096774,1.0,1.0,11/71,8.08%,Hdac7;Herc2;Rad52;Ndc1;Cbx4;Nup93;Sumo2;Phc2;Ranbp2;Parp1;Pias1
prerank,Signal Amplification R-HSA-392518,-0.5368331415477708,-0.8930010875495198,0.6302765647743813,1.0,1.0,9/32,7.15%,Gng4;Pla2g4a;Gna15;Gng12;Gnai1;Gnb4;P2ry12;Gnai2;P2ry1
prerank,Adherens Junctions Interactions R-HSA-418990,0.5272940233549337,0.8927697280267446,0.6143344709897611,1.0,1.0,7/29,3.03%,Cdh9;Cadm2;Cdh8;Cdh12;Cdh13;Cdh2;Cadm1
prerank,Signaling By EGFR R-HSA-177929,-0.516539049047419,-0.892537613634716,0.6624293785310734,1.0,1.0,10/48,9.04%,Pik3r1;Eps15;Egfr;Pag1;Stam2;Sh3gl2;Lrig1;Adam12;Adam17;Adam10
prerank,RHO GTPases Activate ROCKs R-HSA-5627117,0.5326522479095066,0.8925297417081633,0.5657894736842105,1.0,1.0,2/19,2.19%,Ppp1r12b;Ppp1cb
prerank,Glutathione Conjugation R-HSA-156590,-0.5371300618302839,-0.891914776920702,0.6598540145985401,1.0,1.0,8/32,23.21%,Hpgds;Ggt5;Gsta3;Gstt1;Mgst3;Gstm2;Ggt1;Mgst2
prerank,Myogenesis R-HSA-525793,-0.5505946826930442,-0.8916545477904232,0.647887323943662,1.0,1.0,5/26,6.11%,Tcf7l2;Tcf7l1;Cdh4;Mapk11;Ctnna1
prerank,Signaling By ERBB2 In Cancer R-HSA-1227990,-0.5539774362448546,-0.8910579273040813,0.6506364922206507,1.0,1.0,4/24,2.53%,Erbb4;Pik3r1;Nrg1;Erbb3
prerank,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.4077606837484744,-0.8909594848462413,0.7360097323600974,1.0,1.0,85/478,7.83%,Dock1;Kit;Erbb4;Alk;Elmo1;Itpr2;Ptn;Gab2;Prkcb;Vav2;Stat5b;Ptpru;Flrt2;Pik3r1;Lama4;Nrg1;Fgf1;Ngf;Tec;Lama2;Fgfr3;Kcnh8;Flrt1;Nckap1l;Shc3;Gabrg3;Vav1;Pdgfra;Eps15;Col6a2;Erbb3;Igf1;Sparc;Fer;Lyn;Ncf2;Itga2;Apoe;Lama1;Pcsk6;Dusp6;Col6a1;Vgf;Egr1;Col6a5;Esr1;Trib1;Tns3;Prr5;Prkcd;Mapk11;Lamc2;Grb10;Rps6ka5;Dnm3;Egfr;Col9a1;Col4a5;Flt1;Cav1;Ctnna1;Pdgfd;Sgk1;Pag1;Id1;Stam2;F3;Rap1b;Fes;Wwox;Ap2b1;Sh3gl2;Vegfa;Stat6;Jak2;Adap1;Lrig1;Adam12;Mst1r;Atp6v1b1;Ralb;Vegfd;Prkca;Adam17;Spred1
prerank,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,0.5267485034705273,0.8900312508821857,0.5819935691318328,1.0,1.0,10/27,19.57%,Gtf3c1;Gtf3c4;Polr2e;Gtf3c2;Polr2k;Polr3gl;Polr3g;Polr3e;Tbp;Polr2f
prerank,RET Signaling R-HSA-8853659,-0.5308624305792199,-0.8896627706392038,0.6507462686567164,1.0,1.0,10/39,9.32%,Gab2;Pik3r1;Shc3;Grb10;Ret;Clstn1;Prkca;Nrtn;Gfra3;Grb7
prerank,Interferon Gamma Signaling R-HSA-877300,0.463110223314841,0.889055140049606,0.6498516320474778,1.0,1.0,6/64,2.93%,Camk2a;Camk2b;Bcl11b;Ncam1;Camk2g;Trim2
prerank,Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.5552804609025693,-0.8890167366151226,0.653954802259887,1.0,1.0,4/23,2.53%,Erbb4;Pik3r1;Nrg1;Erbb3
prerank,ECM Proteoglycans R-HSA-3000178,-0.5087589554121561,-0.8881390041999249,0.6448863636363636,1.0,1.0,15/54,5.65%,Lama4;Itga9;Bcan;Lrp4;Itgb5;Lama2;Sparc;Vcan;Itga2;Lama1;Dcn;Tgfb1;Hapln1;Tnn;Col9a1
prerank,Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.5371390590137859,-0.8880020005694343,0.6568483063328424,1.0,1.0,10/32,30.79%,Lrig1;Pold4;Wrn;Prim2;Rfc2;Terf1;Dna2;Ctc1;Rfc3;Blm
prerank,HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.5324313354579805,-0.887482812289437,0.6828193832599119,1.0,1.0,6/35,18.54%,Rbbp8;Top3a;Wrn;Artn;Bard1;Rrad
prerank,Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,0.46086880478260456,0.8870028770767514,0.6116504854368932,1.0,1.0,11/50,6.31%,Ralgapa2;Prkag2;Exoc4;Calm1;Ywhaz;Myo5a;Ywhab;Ywhae;Exoc6;Ywhah;C2cd5
prerank,PI3K Events In ERBB2 Signaling R-HSA-1963642,-0.5684911465772522,-0.8868855986362465,0.6817538896746818,1.0,1.0,4/15,2.53%,Erbb4;Pik3r1;Nrg1;Erbb3
prerank,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.5303208369227458,-0.8868844947704557,0.6637554585152838,1.0,1.0,4/36,8.26%,Ccnd3;E2f1;Ccnd1;Cdk2
prerank,G-protein Mediated Events R-HSA-112040,0.48462965236539557,0.8861584434424022,0.6475903614457831,1.0,1.0,12/51,2.09%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Plcb1;Gnal;Gnaq;Mapk1;Pde1b;Adcy9;Camkk1
prerank,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,0.37088654371108204,0.8859305556900159,0.8283261802575107,1.0,1.0,23/298,4.61%,Lmo7;Nedd4l;Cblb;Trim9;Ube2e2;Hace1;Fbxl7;Zbtb16;Rnf217;Hectd2;Rnf19a;Herc3;Rnf182;Btrc;Fbxw11;Fbxo41;Klhl3;Ube2w;Herc2;Nedd4;Cul5;Ube2e3;Huwe1
prerank,Reproduction R-HSA-1474165,0.442027404788163,0.8852948425721133,0.6717791411042945,1.0,1.0,2/90,2.06%,Syne1;B4galt1
prerank,Regulation Of PTEN Stability And Activity R-HSA-8948751,0.4544221260538112,0.8848915136921268,0.6561514195583596,1.0,1.0,4/67,4.49%,Akt3;Prex2;Nedd4;Tnks
prerank,RND1 GTPase Cycle R-HSA-9696273,0.4833532940831682,0.883566095488271,0.6024464831804281,1.0,1.0,5/41,3.60%,Plekhg5;Rasal2;Rras2;Pkp4;Vangl2
prerank,Post-translational Protein Phosphorylation R-HSA-8957275,-0.47370556645583245,-0.8832257527399872,0.6888260254596889,1.0,1.0,20/99,9.04%,Fam20a;Fn1;Ltbp1;Vcan;Cst3;Sgpp2;Apoe;Igfbp7;Bmp4;Vgf;Eva1a;Cp;App;Mfge8;Igfbp4;Calu;Scg3;Mgat4a;Wfs1;Adam10
prerank,O-linked Glycosylation Of Mucins R-HSA-913709,-0.5106394629728185,-0.8831573230771348,0.6793313069908815,1.0,1.0,5/50,4.72%,St6gal1;Galntl6;Galnt9;Galnt6;Gcnt4
prerank,NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,-0.53343569912846,-0.8817804825032796,0.683599419448476,1.0,1.0,6/34,6.22%,Tbl1x;Arl4c;Abca1;Apoe;Apod;Kdm3a
prerank,RNA Polymerase III Transcription Initiation R-HSA-76046,0.5118046552638823,0.8810966667575112,0.6158940397350994,1.0,1.0,12/34,19.57%,Pou2f1;Gtf3c1;Gtf3c4;Polr2e;Gtf3c2;Polr2k;Snapc4;Polr3gl;Polr3g;Polr3e;Tbp;Polr2f
prerank,Processing Of Intronless Pre-mRNAs R-HSA-77595,-0.5481334603856425,-0.8796569486093664,0.6552706552706553,1.0,1.0,1/20,2.68%,Colec12
prerank,Peroxisomal Protein Import R-HSA-9033241,-0.5089483193353677,-0.8794622309194018,0.675187969924812,1.0,1.0,12/58,21.09%,Phyh;Crot;Pex7;Glyat;Pex13;Idh1;Ide;Ehhadh;Nudt7;Crat;Hmgcl;Acox3
prerank,Diseases Of Metabolism R-HSA-5668914,-0.4264401724236555,-0.8787815519176804,0.7315068493150685,1.0,1.0,25/225,6.85%,Gpc6;Ext1;Adamtsl1;Adamts16;Adamts2;Gpc5;Thsd4;Bcan;Tbxas1;B3glct;Cspg4;Vcan;Adamts4;Chst3;Tcn2;Cspg5;Adamts6;Gbe1;Dcn;Notch1;Lfng;Sdc4;Cyp26b1;Cyp27a1;Adamts12
prerank,Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,-0.5565096509804935,-0.878411767771346,0.6771978021978022,1.0,1.0,7/16,30.82%,Traf3;Ticam1;Irf3;Tlr4;Ndufa2;Sarm1;Ubc
prerank,CLEC7A (Dectin-1) Signaling R-HSA-5607764,0.42106997665275614,0.8780695568171706,0.7006369426751592,1.0,1.0,7/98,3.72%,Ppp3ca;Ppp3r1;Btrc;Fbxw11;Plcg2;Calm1;Itpr1
prerank,DNA Double-Strand Break Repair R-HSA-5693532,-0.451903956365374,-0.8775798124607438,0.7108938547486033,1.0,1.0,13/135,13.33%,Rbbp8;Cnksr3;Eya4;Rad51b;Nsd2;Cdk2;Mapk8;Lrig3;Eya2;Pold4;Top3a;Wrn;Artn
prerank,Metabolism Of Non-Coding RNA R-HSA-194441,0.46567067221071057,0.8775548121443995,0.6537216828478964,1.0,1.0,13/48,15.58%,Clns1a;Ndc1;Nup93;Ncbp1;Ranbp2;Gemin8;Snrpd3;Nup160;Snrpb;Nup155;Nup210;Gemin5;Wdr77
prerank,ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.547662279541766,-0.8750626820593435,0.6647314949201741,1.0,1.0,6/21,6.98%,Gng4;Gng12;Gnai1;Gnb4;P2ry12;Gnai2
prerank,Translation R-HSA-72766,0.37247472443278706,0.8744150412917417,0.8253968253968254,1.0,1.0,63/256,16.25%,Dtd1;Fars2;Ssr1;Farsa;Rpl15;Eif4b;Rars2;Eif3a;Eef1a1;Eif5b;Spcs2;Rplp1;Eif4a2;Rpl10a;Eif4a1;Rplp0;Rpl4;Mrps26;Gspt1;Pabpc1;N6amt1;Lars2;Eif4e;Rpl3;Rpsa;Mrpl13;Ptcd3;Rpl36a;Rpl8;Eef1d;Eef2;Rps28;Rsl24d1;Uba52;Eif5;Iars2;Mtif2;Eif3h;Mrps22;Mrpl58;Rpl18;Mrpl37;Mrps15;Eif2b5;Mrps17;Tars2;Mrpl23;Rps21;Mrpl33;Eef1g;Ssr3;Sec61a2;Mrps9;Mrps25;Mrpl21;Rps3;Rps8;Mrpl55;Mrpl53;Mrpl50;Mrpl32;Rpl6;Farsb
prerank,G Alpha (S) Signaling Events R-HSA-418555,-0.45586954584632927,-0.8737556724273293,0.6872309899569584,1.0,1.0,27/133,8.24%,Rxfp1;Pde4d;Pde11a;Pde8a;Pde1a;Htr7;Pde3a;Gng4;Grk3;Prkar1b;Npsr1;Gng12;Gnas;Gnai1;Adrb3;Pde2a;Gnb4;Adcy7;Pde10a;Hrh2;Lhcgr;C1qtnf1;Gnai2;Adora2b;Prkca;Crhr1;Itgb1
prerank,Platelet Homeostasis R-HSA-418346,-0.47340626779188943,-0.8732309745213572,0.6857562408223201,1.0,1.0,19/82,6.40%,Slc8a1;Itpr2;Pde11a;Trpc3;Pde1a;P2rx7;Gng4;Pde5a;Trpc7;Pla2g4a;Prkg2;Ppp2r5a;Gng12;Gnas;P2rx4;Pde2a;Gnb4;Pde10a;Irag1
prerank,Acyl Chain Remodelling Of PC R-HSA-1482788,-0.5423048340618561,-0.8719399304065547,0.6832116788321168,1.0,1.0,8/26,14.29%,Pla2g4a;Lpcat2;Pla2g4c;Plaat3;Pla2g6;Pnpla8;Pla2r1;Lpcat3
prerank,FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.5095670993568124,-0.8706222419882775,0.7021897810218978,1.0,1.0,9/55,2.91%,Dock1;Elmo1;Vav2;Wipf1;Myo1e;Nckap1l;Hck;Vav1;Lyn
prerank,Heme Signaling R-HSA-9707616,-0.5095527033278038,-0.8703380431327207,0.6830357142857143,1.0,1.0,5/42,7.21%,Tbl1x;Npas2;Nrip1;Smarcd3;Nfe2l2
prerank,PLC Beta Mediated Events R-HSA-112043,0.48427541850665534,0.8700752150001441,0.672782874617737,1.0,1.0,14/46,3.72%,Nbea;Camk2a;Camk2b;Adcy1;Adcy2;Plcb1;Gnaq;Mapk1;Pde1b;Adcy9;Camkk1;Camk2g;Calm1;Itpr1
prerank,Lysosome Vesicle Biogenesis R-HSA-432720,0.4917794967085816,0.8691427490056858,0.6507936507936508,1.0,1.0,2/32,3.66%,Clvs2;Clvs1
prerank,Tie2 Signaling R-HSA-210993,-0.5560438388338009,-0.8683441954393664,0.6872309899569584,1.0,1.0,2/17,2.58%,Pik3r1;Angpt1
prerank,Signaling By NODAL R-HSA-1181150,0.5211814499296709,0.8680774753303189,0.6445182724252492,1.0,1.0,5/20,4.88%,Acvr2a;Mapk1;Smad3;Acvr1c;Mapk3
prerank,Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,0.4962073689975451,0.8674291188694445,0.6291390728476821,1.0,1.0,2/26,1.64%,Foxo1;Akt3
prerank,Metabolism Of Cofactors R-HSA-8978934,-0.5444371686318633,-0.8670796591767771,0.6858345021037868,1.0,1.0,6/19,21.91%,Prkg2;Tacr1;Pdss1;Idh1;Coq3;Dhfr
prerank,CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,-0.5605548791167103,-0.8670701482191482,0.6850282485875706,1.0,1.0,2/15,9.16%,Ppp2r5a;Ppp2r5c
prerank,NOD1/2 Signaling Pathway R-HSA-168638,-0.527154105544441,-0.8670619808614014,0.7076700434153401,1.0,1.0,10/32,12.52%,Casp1;Irak2;Casp8;Mapk11;Birc3;Casp4;Cyld;Tnfaip3;Nod1;Nod2
prerank,Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.535918184066799,-0.8669547307353553,0.6873198847262247,1.0,1.0,7/25,30.82%,Lrig1;Lrig3;Pold4;Rfc2;Polk;Rfc3;Ubc
prerank,tRNA Processing In Nucleus R-HSA-6784531,-0.49743873887629475,-0.865378965390054,0.7244897959183674,1.0,1.0,1/51,2.68%,Colec12
prerank,Late Endosomal Microautophagy R-HSA-9615710,-0.5268918794064894,-0.8653333382151017,0.7071742313323572,1.0,1.0,2/29,8.60%,Cftr;Ift88
prerank,RAC3 GTPase Cycle R-HSA-9013423,0.42222836254397184,0.8639465614091068,0.67003367003367,1.0,1.0,13/90,3.28%,Dock10;Tiam1;Wasf1;Abr;Baiap2;Nckap1;Abi2;Arhgap15;Arhgap21;Arhgap39;Abi1;Slitrk3;Abl2
prerank,Regulation Of RAS By GAPs R-HSA-5658442,0.44758077349688946,0.8628455347196406,0.7242524916943521,1.0,1.0,3/65,4.00%,Rasal2;Syngap1;Spred2
prerank,Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.5184612419477184,-0.8623207914897512,0.6872370266479664,1.0,1.0,2/28,7.26%,Colec12;Lsm11
prerank,"PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.4669156614683298,-0.8612849371204472,0.7173295454545454,1.0,1.0,18/99,5.64%,Kit;Erbb4;Gab2;Pik3r1;Nrg1;Fgf1;Pik3ap1;Fgfr3;Vav1;Pdgfra;Erbb3;Cd86;Ppp2r5a;Esr1;Esr2;Clstn1;Pip4k2a;Egfr
prerank,Interleukin-17 Signaling R-HSA-448424,0.44085501529194004,0.8596189998069822,0.6881028938906752,1.0,1.0,15/68,5.94%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Rps6ka2;Mef2c;Btrc;Fbxw11;Mapk10;Ripk2;Map2k4;Mapk3;Mapk14;Dusp4
prerank,Dectin-2 Family R-HSA-5621480,-0.5361027468076907,-0.8592221900691726,0.6824224519940916,1.0,1.0,6/17,16.60%,Lyn;Syk;Muc19;Muc2;Fcer1g;Muc21
prerank,Voltage Gated Potassium Channels R-HSA-1296072,0.4733674625497676,0.8588825852693841,0.6547231270358306,1.0,1.0,13/43,3.55%,Kcnd2;Kcnh1;Kcnab1;Kcnc3;Kcnd3;Kcng2;Kcnc4;Kcnq3;Kcna4;Kcng1;Kcng3;Kcna1;Kcnab2
prerank,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,0.42960211888956,0.8579098201370102,0.7278481012658228,1.0,1.0,2/72,0.50%,Nsf;Kif26b
prerank,DAP12 Signaling R-HSA-2424491,-0.5302070412940988,-0.857259823026388,0.7157142857142857,1.0,1.0,3/26,1.19%,Vav2;Pik3r1;Lcp2
prerank,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.43952384834169994,-0.8566795272283297,0.7235543018335684,1.0,1.0,25/139,8.09%,Rxfp1;Itpr2;Htr7;Gng4;Hck;Lyn;Prkar1b;Npsr1;Gng12;Gnas;Gnai1;Adrb3;Ggt5;Gnb4;Adcy7;Plk2;Hrh2;Lhcgr;C1qtnf1;Gnai2;Adora2b;Syk;Prkca;Adam17;Crhr1
prerank,"Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.510049553700649,-0.8559958115475051,0.717008797653959,1.0,1.0,8/35,10.86%,Slco2b1;Slco1c1;Apod;Slc29a3;Slc35d2;Slc28a1;Nlrp3;Arl2bp
prerank,Aggrephagy R-HSA-9646399,-0.5259491525420967,-0.8546880975088341,0.7076700434153401,1.0,1.0,4/23,13.35%,Cftr;Ift88;Dync1h1;Dync1li2
prerank,RHOF GTPase Cycle R-HSA-9035034,-0.5150494141227497,-0.8542899081526489,0.7155425219941349,1.0,1.0,8/39,6.06%,Farp1;Pik3r1;Srgap2;Akap12;Syde1;Baiap2l2;Mcam;Cav1
prerank,Signaling By Hedgehog R-HSA-5358351,-0.43806845067377703,-0.8534010429126813,0.739612188365651,1.0,1.0,20/134,10.03%,Gpc5;Gpr161;Gli3;Hhip;Prkar1b;Dzip1;Smurf1;Smox;Gnas;Intu;Adcy7;Gli2;Numb;Shh;Prkca;Adam17;Ift88;Psmb8;Kif7;Gas1
prerank,Netrin-1 Signaling R-HSA-373752,0.4431264363482541,0.8530742934798408,0.7071651090342679,1.0,1.0,9/47,2.49%,Slit3;Trpc6;Dscam;Ablim3;Dscaml1;Dcc;Ptk2;Unc5a;Ablim1
prerank,Cellular Response To Hypoxia R-HSA-1234174,-0.47204399668335373,-0.8530329039538289,0.7202295552367288,1.0,1.0,11/71,23.61%,Epas1;Vegfa;Limd1;Psmb8;Psma8;Psme4;Ep300;Psme2;Psma1;Hif3a;Sem1
prerank,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.4873052597886218,-0.8527079634456921,0.7263464337700145,1.0,1.0,11/59,19.85%,Sting1;Stat6;Tlr3;Dtx4;Trim56;Ticam1;Trim21;Irf3;Nkiras1;Ep300;Ripk1
prerank,Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.532208320115307,-0.8523048277233648,0.7173295454545454,1.0,1.0,3/21,16.68%,Idh2;Ldlr;Ldhd
prerank,Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.45790516748468474,-0.8513128817976199,0.7336182336182336,1.0,1.0,18/106,5.64%,Kit;Erbb4;Gab2;Pik3r1;Nrg1;Fgf1;Pik3ap1;Fgfr3;Vav1;Pdgfra;Erbb3;Cd86;Ppp2r5a;Esr1;Esr2;Clstn1;Pip4k2a;Egfr
prerank,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.47180167984600685,-0.8510455244600031,0.7206946454413893,1.0,1.0,6/68,13.33%,Rbbp8;Nsd2;Cdk2;Top3a;Wrn;Artn
prerank,RHOG GTPase Cycle R-HSA-9013408,-0.4700392646727821,-0.8509605038099557,0.7084507042253522,1.0,1.0,15/72,6.06%,Dock1;Vav2;Dock2;Arhgef26;Pik3r1;Vrk2;Dock5;Mcf2;Vav1;Garre1;Prex1;Cdc42ep1;Mcam;Ophn1;Cav1
prerank,Signaling By VEGF R-HSA-194138,-0.4561516586700932,-0.8502760114481465,0.7189265536723164,1.0,1.0,18/100,7.75%,Dock1;Elmo1;Itpr2;Prkcb;Vav2;Pik3r1;Nckap1l;Vav1;Ncf2;Prr5;Prkcd;Mapk11;Flt1;Cav1;Ctnna1;Vegfa;Vegfd;Prkca
prerank,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.4891263652108348,-0.8498355937868961,0.7224606580829757,1.0,1.0,3/54,9.18%,Smurf1;Tgfb1;Psmb8
prerank,Signaling By WNT R-HSA-195721,-0.4077024546451218,-0.8497818417432703,0.7913385826771654,1.0,1.0,45/277,9.18%,Tcf7l2;Sox6;Rspo2;Itpr2;Wls;Prkcb;Cxxc4;Tcf7l1;Nfatc1;Gng4;Ccdc88c;Tle3;Sox2;Gnao1;Prkg2;Smurf1;Lef1;Ppp2r5a;Nlk;Gng12;Plcb2;Prkcg;Fzd2;Sox4;Wnt2;Tle2;Wif1;Gnb4;Lgr5;Cav1;Ap2b1;Ctnnbip1;Rnf43;Bcl9;Prkca;Wnt5b;Dkk2;Ncoa3;Sox9;Sox13;Lrp5;Rspo1;Wnt10a;Ppp2r5c;Psmb8
prerank,Beta-catenin Phosphorylation Cascade R-HSA-196299,-0.5414836880191559,-0.8496743379658845,0.6902404526166902,1.0,1.0,2/17,9.16%,Ppp2r5a;Ppp2r5c
prerank,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,0.4629674307141669,0.8490713511447758,0.6925373134328359,1.0,1.0,1/44,0.39%,Nsf
prerank,DAP12 Interactions R-HSA-2172127,-0.5229593921678948,-0.8482221986297964,0.7409551374819102,1.0,1.0,3/30,1.19%,Vav2;Pik3r1;Lcp2
prerank,Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,0.5010664235608879,0.8464462721598045,0.6793650793650794,1.0,1.0,1/28,0.58%,Cyp7b1
prerank,HDACs Deacetylate Histones R-HSA-3214815,0.4612413577928473,0.8461428648584313,0.7217125382262997,1.0,1.0,13/48,8.01%,Ncor1;Chd4;Phf21a;Chd3;Gatad2b;Hdac1;Hdac8;Mta3;Ncor2;Rbbp7;Tbl1xr1;Rcor1;Mta2
prerank,Deubiquitination R-HSA-5688426,-0.4081881364963982,-0.8461362916707637,0.7864583333333334,1.0,1.0,27/246,12.55%,Cftr;Kat2b;Smad2;Cnksr3;Tgfbr2;Smad7;Trim25;Esr1;Stambpl1;Josd2;Tgfb1;Ccp110;Birc3;Smad1;Stam2;Traf3;Ifih1;Cyld;Psmb8;Rnf135;Nlrp3;Tnfaip3;Rigi;Nod1;Psma8;Nod2;Tnip3
prerank,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.44306734849975005,-0.844843101211757,0.75,1.0,1.0,30/132,14.20%,Ly86;Kcnh8;Itgam;Alpk1;Cd180;Dusp6;Irak2;Casp8;Mapk11;App;Irak3;Birc3;Rps6ka5;Dnm3;Traf3;Map3k1;Btk;Mapk8;S100a1;Ptpn4;Tlr1;Itgb2;S100b;Nod1;Ticam1;Nod2;Irf3;Rps6ka1;Tirap;Usp14
prerank,Signaling By BRAF And RAF1 Fusions R-HSA-6802952,0.4429121196514124,0.8442465143733567,0.7429467084639498,1.0,1.0,16/59,4.94%,Camk2a;Camk2b;Cnksr2;Ap3b1;Mapk1;Kdm7a;Ksr2;Map2k1;Camk2g;Mprip;Fam114a2;Calm1;Ksr1;Ywhab;Mapk3;Src
prerank,Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,-0.5456735262259664,-0.8442260677998985,0.7218259629101283,1.0,1.0,2/15,6.06%,Ddah1;Cav1
prerank,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.45641288907971145,-0.8441131042575917,0.7432624113475177,1.0,1.0,6/79,3.87%,Prkcb;Rasgrp3;Rasgrp1;Nfatc1;Nfatc2;Rel
prerank,Potential Therapeutics For SARS R-HSA-9679191,-0.45507244749096093,-0.8438626953818821,0.7276720351390923,1.0,1.0,15/91,9.91%,Atp1a2;Vav1;S1pr1;Tlr7;Atp1b3;Fxyd7;Ap2b1;Vegfa;Jak2;Nfe2l2;Syk;Btk;Itgb1;Fxyd1;Ifngr1
prerank,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.515659214153953,-0.8436866180917226,0.7032348804500703,1.0,1.0,4/29,19.49%,Tdrd9;Piwil1;Mybl1;Fkbp6
prerank,Removal Of Flap Intermediate From C-strand R-HSA-174437,-0.5423059157375271,-0.8423458203875929,0.7078014184397163,1.0,1.0,4/16,26.29%,Pold4;Wrn;Terf1;Dna2
prerank,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,-0.4850419529553187,-0.8423021765629009,0.727802037845706,1.0,1.0,3/49,4.55%,Tbl1x;Camk4;Smarcd3
prerank,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,-0.5026587282608906,-0.8416660940377972,0.7254038179148311,1.0,1.0,4/34,6.01%,Runx1;Hipk2;Smarcd3;Pcgf5
prerank,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.46365483610380037,-0.8415382651713319,0.7146974063400576,1.0,1.0,16/68,19.64%,Tubb4a;Ccp110;Nde1;Nedd1;Prkca;Plk4;Alms1;Dync1h1;Akap9;Cep43;Csnk1e;Cep164;Cep290;Pafah1b1;Pcnt;Cntrl
prerank,tRNA Processing R-HSA-72306,-0.4543713304814907,-0.8413019308763664,0.7535410764872521,1.0,1.0,2/96,4.10%,Colec12;Trmt9b
prerank,Programmed Cell Death R-HSA-5357801,-0.4159668759073097,-0.8406967809220369,0.7753721244925575,1.0,1.0,30/188,12.56%,Prkcq;Septin4;Bcl2;Unc5b;Gsn;Casp1;Ywhaq;Satb1;Prkcd;Casp8;Bmf;Birc3;Casp4;E2f1;Gas2;Ppp3cc;Tjp2;Casp7;Mapk8;Irf2;Psmb8;Il1a;Oma1;Mapt;Tnfsf10;Il18;Uaca;Ticam1;Psma8;Pkn2
prerank,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.490656600123724,-0.836681888895515,0.7525035765379113,1.0,1.0,7/55,2.34%,Dock1;Elmo1;Vav2;Wipf1;Myo1e;Nckap1l;Vav1
prerank,Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,0.4805135674599417,0.8361496973909238,0.6567656765676567,1.0,1.0,7/28,3.81%,Grik4;Plcb1;Gng7;Ncald;Gng2;Calm1;Grik5
prerank,RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.4191704376903495,0.8359454431440762,0.7707006369426752,1.0,1.0,13/71,10.49%,Rprd1a;Gtf2f2;Pou2f1;Ints6;Ints10;Pou2f2;Ncbp1;Rprd1b;Nabp1;Ccnt2;Ints2;Polr2e;Ccnk
prerank,Intra-Golgi Traffic R-HSA-6811438,0.46966128535819673,0.834751771632049,0.7134146341463414,1.0,1.0,3/35,4.04%,Nsf;Cyth1;Ric1
prerank,EPHA-mediated Growth Cone Collapse R-HSA-3928663,-0.5357127695947753,-0.8332906101123229,0.71045197740113,1.0,1.0,2/15,8.31%,Lyn;Myh14
prerank,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.4663575199089651,-0.8322449242301676,0.7496402877697842,1.0,1.0,9/63,23.61%,Epas1;Limd1;Psmb8;Psma8;Psme4;Psme2;Psma1;Hif3a;Sem1
prerank,Branched-chain Amino Acid Catabolism R-HSA-70895,-0.5205270589222301,-0.8322055211328767,0.6998556998556998,1.0,1.0,6/21,21.98%,Bcat1;Bckdhb;Soat1;Ldhd;Acadsb;Hibadh
prerank,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.4662919489901692,-0.8320616491110001,0.7452966714905933,1.0,1.0,11/80,2.91%,Dock1;Elmo1;Itpr2;Vav2;Pik3r1;Wipf1;Myo1e;Nckap1l;Hck;Vav1;Lyn
prerank,Transcriptional Regulation By Small RNAs R-HSA-5578749,0.4318571944067628,0.8308750169129271,0.7353846153846154,1.0,1.0,15/60,14.57%,Ago1;Ago2;Ndc1;Nup93;Ranbp2;H2bc4;Polr2e;H2az1;H2ac6;H2ax;Nup160;Nup155;H2ac4;Polr2k;Nup210
prerank,Translation Initiation Complex Formation R-HSA-72649,0.44801987163287404,0.8304511912510136,0.7529411764705882,1.0,1.0,13/52,16.71%,Eif4b;Eif3a;Eif4a2;Eif4a1;Pabpc1;Eif4e;Rpsa;Rps28;Eif3h;Rps21;Rps3;Rps8;Rps9
prerank,Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.4925078019021719,-0.8304067815652963,0.7543604651162791,1.0,1.0,4/38,8.26%,Ccnd3;E2f1;Ccnd1;Cdk2
prerank,Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,-0.4681037504700369,-0.8296057505702535,0.746606334841629,1.0,1.0,6/65,2.23%,Pcdh15;Whrn;Epb41l3;Myo1e;Cacna2d2;Stx1a
prerank,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.4721249193844949,-0.828913248127873,0.7436281859070465,1.0,1.0,16/60,17.89%,Trim25;Casp8;App;Traf3;Ifih1;Map3k1;Cyld;Rnf125;Rnf135;Tnfaip3;Rigi;S100b;Irf3;Nkiras1;Tax1bp1;Ep300
prerank,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.4698883523434688,-0.8286758055986068,0.7496402877697842,1.0,1.0,4/58,12.47%,Gli3;Prkca;Psmb8;Psma8
prerank,Hyaluronan Metabolism R-HSA-2142845,0.506694717719196,0.828019480560042,0.6666666666666666,1.0,1.0,1/15,0.91%,Cemip
prerank,Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.4771284850740264,0.8265390294507478,0.6854304635761589,1.0,1.0,10/31,4.34%,Camk2a;Camk2b;Tnrc6c;Ncor1;Camk2g;Ago1;Calm1;Ago2;Tnrc6b;Hdac1
prerank,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.4705257598922321,-0.8263332176940928,0.7585185185185185,1.0,1.0,10/59,6.45%,Kcnh8;Dusp6;Vgf;Egr1;Trib1;Mapk11;Rps6ka5;Sgk1;Id1;F3
prerank,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,0.4044403673016675,0.8257175056814724,0.789308176100629,1.0,1.0,17/90,5.94%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Rps6ka2;Mef2c;Peli1;Btrc;Fbxw11;Mapk10;Peli2;Ripk2;Map2k4;Mapk3;Mapk14;Dusp4
prerank,AURKA Activation By TPX2 R-HSA-8854518,-0.4532626529070298,-0.8255281474762952,0.7363112391930836,1.0,1.0,16/71,19.64%,Tubb4a;Ccp110;Nde1;Nedd1;Prkca;Plk4;Alms1;Dync1h1;Akap9;Cep43;Csnk1e;Cep164;Cep290;Pafah1b1;Pcnt;Cntrl
prerank,Phospholipid Metabolism R-HSA-1483257,-0.407499452086421,-0.8246891718459252,0.8247282608695652,1.0,1.0,43/203,11.62%,Synj2;Cpne7;Pik3r1;Pitpnm3;Inpp5d;Mboat1;Tnfaip8;Pla2g4a;Pik3r5;Enpp6;Pnpla7;Osbpl10;Tnfaip8l3;Lpcat2;Gpat3;Pla2g4c;Clstn1;Inppl1;Sh2d3c;Pip4k2a;Plaat3;Pld4;Pi4k2b;Inpp5f;Pik3cg;Lpgat1;Plekha1;Rufy1;Plaat1;Agk;Ptpn13;Pld2;Pik3r6;Pik3c2b;Chpt1;Ache;Pip4k2c;Osbpl5;Pik3ca;Mtmr7;Pla2g6;Pik3c2a;Pctp
prerank,DARPP-32 Events R-HSA-180024,-0.518307617465526,-0.8246303471341331,0.7339312406576981,1.0,1.0,3/23,3.07%,Pde4b;Pde4d;Prkar1b
prerank,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.4737165659318698,-0.8236459812883865,0.7319277108433735,1.0,1.0,2/60,2.55%,Myo1e;Kat2b
prerank,Na+/Cl- Dependent Neurotransmitter Transporters R-HSA-442660,-0.5235356400915478,-0.8232393658518039,0.7311977715877437,1.0,1.0,4/17,11.66%,Slc6a7;Slc6a9;Slc6a1;Slc6a5
prerank,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.5018581895707545,-0.8231614547727003,0.7314949201741655,1.0,1.0,1/28,1.29%,Fgf1
prerank,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,0.47407168412863987,0.8226480313350938,0.6645569620253164,1.0,1.0,8/31,14.57%,Ndc1;Xpo1;Nup93;Ranbp2;Gnl3;Nup160;Nup155;Nup210
prerank,RHOBTB2 GTPase Cycle R-HSA-9013418,-0.5071570228750143,-0.8214493201166616,0.7578796561604585,1.0,1.0,3/23,7.68%,Myo6;Msi2;Tmod3
prerank,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,0.43763048156666884,0.820998604957244,0.7152317880794702,1.0,1.0,4/54,8.30%,Fbxl7;Cul1;Psmd13;Fbxl18
prerank,Regulation Of Apoptosis R-HSA-169911,-0.4707224131919495,-0.8207991243067313,0.7666666666666667,1.0,1.0,8/52,23.61%,Psmb8;Oma1;Psma8;Pkn2;Psme4;Psme2;Psma1;Sem1
prerank,HIV Infection R-HSA-162906,-0.40112740248192746,-0.8201441075485039,0.8247011952191236,1.0,1.0,4/214,2.22%,Elmo1;Dock2;Ccr5;Hck
prerank,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,0.47233673600838366,0.8195730312349799,0.6930379746835443,1.0,1.0,8/32,14.57%,Ndc1;Xpo1;Nup93;Ranbp2;Gnl3;Nup160;Nup155;Nup210
prerank,PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.516771494931931,-0.8194462509079301,0.7517934002869441,1.0,1.0,2/21,12.61%,Lrig1;Pold4
prerank,Acyl Chain Remodelling Of PI R-HSA-1482922,-0.5192475837318689,-0.8170083416055207,0.7557142857142857,1.0,1.0,3/16,6.29%,Pla2g4a;Pla2g4c;Plaat3
prerank,Cellular Response To Starvation R-HSA-9711097,0.372446427607896,0.8167317586406049,0.8547297297297297,1.0,1.0,32/145,12.98%,Atp6v1a;Fnip2;Rragd;Kptn;Mios;Rpl15;Atp6v0e2;Rptor;Cebpb;Gcn1;Atp6v1c2;Rplp1;Rpl10a;Nprl3;Rplp0;Rpl4;Atp6v1d;Rpl3;Castor2;Rpsa;Slc38a9;Mrpl13;Rragb;Asns;Rpl36a;Rpl8;Rps28;Rsl24d1;Uba52;Atp6v0c;Atf3;Rpl18
prerank,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,0.4644145504625983,0.8165181636482325,0.707395498392283,1.0,1.0,9/33,14.57%,Ndc1;Xpo1;Nup93;Ranbp2;Npm1;Nup160;Nup155;Ranbp1;Nup210
prerank,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,0.4382392471168818,0.8159484193582598,0.7725947521865889,1.0,1.0,13/52,16.71%,Eif4b;Eif3a;Eif4a2;Eif4a1;Eif4e;Rpsa;Rps28;Eif5;Eif3h;Rps21;Rps3;Rps8;Rps9
prerank,Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,-0.5178269223052244,-0.8159075025895667,0.7326732673267327,1.0,1.0,4/18,5.44%,Gng4;Gng12;Gnas;Gnb4
prerank,Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,0.39378801863356927,0.8153580472269372,0.8612903225806452,1.0,1.0,29/107,17.05%,Smg7;Smg1;Rpl15;Ncbp1;Upf1;Rplp1;Rpl10a;Upf2;Rplp0;Rpl4;Gspt1;Pabpc1;Dcp1a;Rpl3;Rpsa;Mrpl13;Rpl36a;Rpl8;Rps28;Rsl24d1;Uba52;Rpl18;Rps21;Rps3;Rps8;Upf3a;Rpl6;Rps9;Rpl31
prerank,Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.5196691542030809,-0.8148805211617629,0.7517934002869441,1.0,1.0,1/16,4.41%,Zfp36l1
prerank,ROS And RNS Production In Phagocytes R-HSA-1222556,-0.4860141523752319,-0.8144797817803757,0.7621776504297995,1.0,1.0,9/34,15.79%,Ncf2;Atp6v1b1;Ncf1;Rac2;Ncf4;Tcirg1;Cyba;Hvcn1;Lpo
prerank,Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.46599399283468973,0.813845172259271,0.7419354838709677,1.0,1.0,8/31,14.57%,Ndc1;Nup93;Ncbp1;Ranbp2;Eif4e;Nup160;Nup155;Nup210
prerank,Nuclear Receptor Transcription Pathway R-HSA-383280,-0.46964438902662137,-0.8137703830538765,0.7601744186046512,1.0,1.0,10/51,5.16%,Nr4a1;Thrb;Rorb;Nr4a3;Nr4a2;Rara;Nr2e1;Rxrg;Esr1;Esr2
prerank,Platelet Calcium Homeostasis R-HSA-418360,-0.49507797467018894,-0.8133707156803681,0.7612994350282486,1.0,1.0,6/26,4.40%,Slc8a1;Itpr2;Trpc3;P2rx7;Trpc7;P2rx4
prerank,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,0.3945797144461983,0.8133062064971966,0.8528528528528528,1.0,1.0,28/102,17.05%,Rpl15;Eif4b;Eif3a;Eif5b;Rplp1;Eif4a2;Rpl10a;Eif4a1;Rplp0;Rpl4;Eif4e;Rpl3;Rpsa;Mrpl13;Rpl36a;Rpl8;Rps28;Rsl24d1;Uba52;Eif5;Eif3h;Rpl18;Rps21;Rps3;Rps8;Rpl6;Rps9;Rpl31
prerank,SUMOylation R-HSA-2990846,-0.41264849314485796,-0.8132221888031353,0.8307692307692308,1.0,1.0,9/163,4.64%,Satb2;Thrb;Nr4a2;Rara;Nrip1;Esr1;Hipk2;Satb1;Hdac4
prerank,PKMTs Methylate Histone Lysines R-HSA-3214841,0.448451804242081,0.8131223003908163,0.752442996742671,1.0,1.0,19/46,13.34%,Dot1l;Rbbp5;Nsd1;Kmt5a;Ehmt1;Smyd2;Ash1l;Rbbp7;Suz12;Ezh2;Setdb1;Setd7;Setd2;Aebp2;Nfkb1;Kmt2c;Kmt5b;Kmt2a;Kmt2d
prerank,Nuclear Import Of Rev Protein R-HSA-180746,0.46626962713965203,0.8125475065300117,0.7333333333333333,1.0,1.0,7/30,14.57%,Ndc1;Nup93;Ranbp2;Npm1;Nup160;Nup155;Nup210
prerank,SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.41425050184464907,-0.812350446999038,0.830028328611898,1.0,1.0,9/157,4.64%,Satb2;Thrb;Nr4a2;Rara;Nrip1;Esr1;Hipk2;Satb1;Hdac4
prerank,"Cell Cycle, Mitotic R-HSA-69278",-0.36749260696739183,-0.8118518771150561,0.9324487334137516,1.0,1.0,44/487,14.25%,Prkcb;Vrk2;Optn;Cdc14a;Lyn;Ppp2r5a;Tubb3;Phlda1;Ccnd3;Tubb4a;Ccp110;Nde1;Nedd1;Ncaph;Mcm10;E2f1;Jak2;Lrig1;Ccnd1;Cdc25b;Prkca;Plk4;Clasp2;Cdk2;Ppp2r5c;Psmb8;Ndc80;Sirt2;Alms1;Dync1h1;Aurkb;Cdt1;Pmepa1;Bub1;Psma8;Pold4;Akap9;Lpin3;Esco2;Dync1li2;Cdkn2c;Cdkn1c;Zwint;Cep43
prerank,Elevation Of Cytosolic Ca2+ Levels R-HSA-139853,-0.5176266324908221,-0.8113247864984058,0.7489481065918654,1.0,1.0,5/15,4.40%,Itpr2;Trpc3;P2rx7;Trpc7;P2rx4
prerank,Presynaptic Function Of Kainate Receptors R-HSA-500657,0.4802711038588821,0.8105880114930182,0.7088607594936709,1.0,1.0,3/20,2.24%,Plcb1;Gng7;Gng2
prerank,DNA Repair R-HSA-73894,-0.3854341235470939,-0.8104492166827132,0.8836601307189542,1.0,1.0,19/288,13.33%,Rbbp8;Cnksr3;Eya4;Trim25;Usp43;Fancc;Lrig1;Rad51b;Nsd2;Cdk2;Mapk8;Mgmt;Lrig3;Eya2;Neil3;Pold4;Top3a;Wrn;Artn
prerank,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.43581542286396086,-0.8102751754650778,0.7849779086892489,1.0,1.0,11/94,7.29%,Chrm2;Syt9;Cftr;Grk3;Eps15;Dab2;Egfr;Stam2;Ap2b1;Sh3gl2;Syt12
prerank,Amino Acids Regulate mTORC1 R-HSA-9639288,0.43148628347906426,0.8089858199243234,0.7581699346405228,1.0,1.0,13/53,11.12%,Atp6v1a;Fnip2;Rragd;Kptn;Mios;Atp6v0e2;Rptor;Atp6v1c2;Nprl3;Atp6v1d;Castor2;Slc38a9;Rragb
prerank,RAC2 GTPase Cycle R-HSA-9013404,-0.4384133259378247,-0.8084288744110991,0.8008658008658008,1.0,1.0,20/86,6.06%,Dock1;Vav2;Dock2;Pik3r1;Vrk2;Arhgap26;Nckap1l;Mcf2;Vav1;Garre1;Ncf2;Prex1;Arhgap42;Swap70;Syde1;Iqgap1;Cdc42ep1;Mcam;Ophn1;Cav1
prerank,Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.45839881366928376,-0.8073499560905241,0.7911931818181818,1.0,1.0,8/55,23.61%,Shh;Psmb8;Psma8;Sel1l;Psme4;Psme2;Psma1;Sem1
prerank,G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,-0.5088303934821141,-0.8067972419511805,0.7445887445887446,1.0,1.0,4/19,5.44%,Gng4;Gng12;Arhgef6;Gnb4
prerank,Oncogenic MAPK Signaling R-HSA-6802957,-0.44587341200191033,-0.8066600531577423,0.7673410404624278,1.0,1.0,14/74,6.94%,Camk2d;Dusp10;Apbb1ip;Fn1;Qki;Dusp16;Dusp6;Nf1;Vcl;Iqgap1;Rap1b;Zc3hav1;Spred3;Jak2
prerank,Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.41015601435541643,0.805763675820296,0.8028169014084507,1.0,1.0,9/74,7.31%,Mapk1;Bag4;Hspa2;Mapk3;Dnajb6;Ywhae;Ndc1;Nup93;Ranbp2
prerank,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.4773753332125051,-0.8056118322612069,0.7635829662261381,1.0,1.0,4/36,8.24%,Wwtr1;Smad2;Smad7;Col1a2
prerank,ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,0.3775918232078803,0.8041481583038644,0.9032258064516129,1.0,1.0,8/111,2.84%,Htr4;Adcy1;Adcy2;Gng7;Adcyap1r1;Adcy9;Gng2;Ramp1
prerank,FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.49680713016994593,-0.8040909570547321,0.7829232995658466,1.0,1.0,8/28,3.06%,Itpr2;Vav2;Lcp2;Nfatc1;Tec;Vav1;Lyn;Nfatc2
prerank,G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,0.4806683087740686,0.8035579881465659,0.717948717948718,1.0,1.0,3/19,2.24%,Plcb1;Gng7;Gng2
prerank,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,0.45347135354494184,0.8033884651788419,0.7692307692307693,1.0,1.0,12/38,4.94%,Camk2a;Camk2b;Cnksr2;Mapk1;Ksr2;Map2k1;Camk2g;Calm1;Ksr1;Ywhab;Mapk3;Src
prerank,Influenza Viral RNA Transcription And Replication R-HSA-168273,0.3786905237501815,0.8030770253968371,0.8852459016393442,1.0,1.0,29/128,15.52%,Gtf2f2;Ndc1;Rpl15;Nup93;Ranbp2;Parp1;Rplp1;Rpl10a;Rplp0;Rpl4;Polr2e;Rpl3;Gnl3;Rpsa;Mrpl13;Rpl36a;Rpl8;Nup160;Rps28;Rsl24d1;Uba52;Nup155;Rpl18;Polr2k;Rps21;Nup210;Rps3;Rps8;Gtf2f1
prerank,Interleukin-12 Signaling R-HSA-9020591,-0.4664341077995023,-0.8026999243448302,0.7710144927536232,1.0,1.0,12/39,24.21%,Rap1b;Jak2;Msn;Rala;Il12rb1;Pkn2;Pitpna;Cdc42;Psme2;Stat4;Anxa2;Lmnb1
prerank,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.4686674185698035,-0.8019798401672671,0.7874818049490538,1.0,1.0,7/46,23.61%,Psmb8;Mrc1;Psma8;Psme4;Psme2;Psma1;Sem1
prerank,Hedgehog Off State R-HSA-5610787,0.3839265677292721,0.8003794269327034,0.8431372549019608,1.0,1.0,12/97,7.20%,Adcy1;Adcy2;Adcy9;Btrc;Dync2h1;Ptch1;Prkar2b;Csnk1a1;Ift57;Prkacb;Cul1;Ift122
prerank,Intrinsic Pathway For Apoptosis R-HSA-109606,-0.4622373373483618,-0.8003127700765464,0.7754491017964071,1.0,1.0,9/49,8.40%,Septin4;Bcl2;Ywhaq;Casp8;Bmf;E2f1;Ppp3cc;Casp7;Mapk8
prerank,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.44555216031141276,-0.7999242403263649,0.8078034682080925,1.0,1.0,12/71,18.76%,Smurf1;Dlx5;Esr1;Psmb8;Ppargc1a;Dlx6;Psma8;Bmp2;Nr3c1;Psme4;Psme2;Esrra
prerank,Signaling By RAF1 Mutants R-HSA-9656223,0.4553112591743491,0.799602582180545,0.7620578778135049,1.0,1.0,12/36,4.94%,Camk2a;Camk2b;Cnksr2;Mapk1;Ksr2;Map2k1;Camk2g;Calm1;Ksr1;Ywhab;Mapk3;Src
prerank,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,0.3859027016164467,0.7983342239545597,0.8685897435897436,1.0,1.0,17/97,5.94%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Rps6ka2;Mef2c;Peli1;Btrc;Fbxw11;Mapk10;Peli2;Ripk2;Map2k4;Mapk3;Mapk14;Dusp4
prerank,BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.4935690551784023,-0.7978088863211981,0.7796610169491526,1.0,1.0,4/23,14.04%,Smox;Bbs9;Bbs2;Bbs5
prerank,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.4316940850940016,-0.797648416111917,0.8102941176470588,1.0,1.0,11/84,12.21%,Rab31;Dennd1c;Rin3;Dennd3;Rin2;Dennd4a;Dennd5b;Dennd2c;Als2cl;Rab3il1;Chml
prerank,Apoptosis R-HSA-109581,-0.40432673200519526,-0.7972647494009716,0.8567454798331016,1.0,1.0,24/161,12.56%,Prkcq;Septin4;Bcl2;Unc5b;Gsn;Ywhaq;Satb1;Prkcd;Casp8;Bmf;E2f1;Gas2;Ppp3cc;Tjp2;Casp7;Mapk8;Psmb8;Oma1;Mapt;Tnfsf10;Uaca;Ticam1;Psma8;Pkn2
prerank,Apoptotic Factor-Mediated Response R-HSA-111471,-0.5081362009154179,-0.7966937974331847,0.7717231222385862,1.0,1.0,3/19,11.96%,Septin4;Casp7;Uaca
prerank,Canonical Retinoid Cycle In Rods (Twilight Vision) R-HSA-2453902,0.46760202176512644,0.7965374151619204,0.6912751677852349,1.0,1.0,2/21,3.23%,Napepld;Stra6
prerank,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,0.3861583413919019,0.7964258037326198,0.8694267515923567,1.0,1.0,17/95,5.94%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Rps6ka2;Mef2c;Peli1;Btrc;Fbxw11;Mapk10;Peli2;Ripk2;Map2k4;Mapk3;Mapk14;Dusp4
prerank,ER Quality Control Compartment (ERQC) R-HSA-901032,-0.499888549518263,-0.7963093717794325,0.7636103151862464,1.0,1.0,2/21,8.81%,Edem1;Uggt2
prerank,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,0.3860483552035977,0.796046561553616,0.8580645161290322,1.0,1.0,17/96,5.94%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Rps6ka2;Mef2c;Peli1;Btrc;Fbxw11;Mapk10;Peli2;Ripk2;Map2k4;Mapk3;Mapk14;Dusp4
prerank,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,0.3826595374910963,0.7959802436245851,0.8709677419354839,1.0,1.0,17/100,5.94%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Rps6ka2;Mef2c;Peli1;Btrc;Fbxw11;Mapk10;Peli2;Ripk2;Map2k4;Mapk3;Mapk14;Dusp4
prerank,RMTs Methylate Histone Arginines R-HSA-3214858,0.44152842721346724,0.7947812083954493,0.7699386503067485,1.0,1.0,5/43,6.83%,Arid1b;Smarca2;Smarca4;Smarcd2;Rbbp7
prerank,Homology Directed Repair R-HSA-5693538,-0.41908085097497116,-0.7943168300331862,0.8368794326241135,1.0,1.0,19/106,23.68%,Rbbp8;Rad51b;Nsd2;Cdk2;Lrig3;Pold4;Top3a;Wrn;Artn;Eme1;Bard1;Rrad;Xrcc2;Xrcc3;H2bc3;Abl1;Rfc2;Sem1;Polk
prerank,trans-Golgi Network Vesicle Budding R-HSA-199992,0.4041111424850267,0.7940795992840333,0.796875,1.0,1.0,7/66,4.47%,Clvs2;Tbc1d8b;Ap3b1;Tpd52l1;Clvs1;Sort1;Pum1
prerank,Cap-dependent Translation Initiation R-HSA-72737,0.3798055994602569,0.7935036141518694,0.8988095238095238,1.0,1.0,30/109,17.05%,Rpl15;Eif4b;Eif3a;Eif5b;Rplp1;Eif4a2;Rpl10a;Eif4a1;Rplp0;Rpl4;Pabpc1;Eif4e;Rpl3;Rpsa;Mrpl13;Rpl36a;Rpl8;Rps28;Rsl24d1;Uba52;Eif5;Eif3h;Rpl18;Eif2b5;Rps21;Rps3;Rps8;Rpl6;Rps9;Rpl31
prerank,Mitotic Anaphase R-HSA-68882,-0.38809653930582333,-0.7928932081056371,0.8950201884253028,1.0,1.0,17/218,14.08%,Vrk2;Ppp2r5a;Tubb3;Tubb4a;Nde1;Clasp2;Ppp2r5c;Psmb8;Ndc80;Sirt2;Dync1h1;Aurkb;Pmepa1;Bub1;Psma8;Dync1li2;Zwint
prerank,Mitotic Metaphase And Anaphase R-HSA-2555396,-0.3877475518011921,-0.7927979999309815,0.8963660834454913,1.0,1.0,17/219,14.08%,Vrk2;Ppp2r5a;Tubb3;Tubb4a;Nde1;Clasp2;Ppp2r5c;Psmb8;Ndc80;Sirt2;Dync1h1;Aurkb;Pmepa1;Bub1;Psma8;Dync1li2;Zwint
prerank,SUMOylation Of SUMOylation Proteins R-HSA-4085377,0.4548890777023604,0.7927974389918249,0.7647058823529411,1.0,1.0,7/31,14.57%,Ndc1;Nup93;Sumo2;Ranbp2;Nup160;Nup155;Nup210
prerank,ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.48792619436060314,-0.7924144973681668,0.7549295774647887,1.0,1.0,6/24,7.15%,Gng4;Pla2g4a;Gna15;Gng12;Gnb4;P2ry1
prerank,C-type Lectin Receptors (CLRs) R-HSA-5621481,0.36935354871599885,0.7918807190226756,0.9193548387096774,1.0,1.0,9/124,4.17%,Ppp3ca;Ppp3r1;Btrc;Fbxw11;Plcg2;Calm1;Itpr1;Arhgef7;Fyn
prerank,Ion Transport By P-type ATPases R-HSA-936837,-0.45544869407714816,-0.7917810003690964,0.7933130699088146,1.0,1.0,10/51,6.71%,Camk2d;Atp13a4;Atp8b1;Atp10a;Atp1a2;Atp2c2;Atp13a5;Atp1b3;Fxyd7;Atp7a
prerank,Cell Junction Organization R-HSA-446728,-0.4349484917422974,-0.7905221969599995,0.8111273792093704,1.0,1.0,16/81,5.22%,Cdh6;Cdh18;Lama4;Sdk1;Nectin3;Cdh19;Cdh10;Cdh4;Cldn1;Lims1;Cldn14;Cldn11;Arhgef6;F11r;Lamc2;Itga6
prerank,DNA Damage Bypass R-HSA-73893,-0.45766967359350036,-0.7897765355515729,0.7896253602305475,1.0,1.0,2/48,3.93%,Trim25;Usp43
prerank,M Phase R-HSA-68886,-0.36822785640142397,-0.7896274374885711,0.9323116219667944,1.0,1.0,49/348,21.37%,Prkcb;Vrk2;Ppp2r5a;Tubb3;Tubb4a;Ccp110;Nde1;Nedd1;Ncaph;Prkca;Plk4;Clasp2;Ppp2r5c;Psmb8;Ndc80;Sirt2;Alms1;Dync1h1;Aurkb;Pmepa1;Bub1;Psma8;Akap9;Lpin3;Dync1li2;Zwint;Cep43;Phf8;Csnk1e;Mastl;H3c7;Cep164;Cep290;Ppp2r5e;H2aj;Psme4;Pafah1b1;Psme2;Pcnt;Cntrl;Ndel1;Cenpn;Cnep1r1;Ska1;Nek7;Rab1a;Anapc11;H2bc3;Knl1
prerank,L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,0.3831445240152069,0.7895629963472499,0.8888888888888888,1.0,1.0,27/101,17.05%,Rpl15;Eif4b;Eif3a;Rplp1;Eif4a2;Rpl10a;Eif4a1;Rplp0;Rpl4;Pabpc1;Eif4e;Rpl3;Rpsa;Mrpl13;Rpl36a;Rpl8;Rps28;Rsl24d1;Uba52;Eif3h;Rpl18;Rps21;Rps3;Rps8;Rpl6;Rps9;Rpl31
prerank,Neddylation R-HSA-8951664,-0.38599846422493034,-0.7884931235480466,0.8821192052980132,1.0,1.0,14/231,9.18%,Socs2;Spsb4;Fbxl19;Epas1;Btbd1;Wsb1;Cish;Asb2;Fbxo7;Nfe2l2;Klhl13;Cul7;Fbxl4;Psmb8
prerank,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.41734637848164546,-0.7870525491555125,0.843441466854725,1.0,1.0,18/101,23.68%,Rbbp8;Rad51b;Nsd2;Cdk2;Pold4;Top3a;Wrn;Artn;Eme1;Bard1;Rrad;Xrcc2;Xrcc3;H2bc3;Abl1;Rfc2;Sem1;Polk
prerank,Centrosome Maturation R-HSA-380287,-0.4291101163234488,-0.7867612979401305,0.8034433285509326,1.0,1.0,16/77,19.64%,Tubb4a;Ccp110;Nde1;Nedd1;Prkca;Plk4;Alms1;Dync1h1;Akap9;Cep43;Csnk1e;Cep164;Cep290;Pafah1b1;Pcnt;Cntrl
prerank,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.4293968945292033,-0.7863744661463651,0.806312769010043,1.0,1.0,16/77,19.64%,Tubb4a;Ccp110;Nde1;Nedd1;Prkca;Plk4;Alms1;Dync1h1;Akap9;Cep43;Csnk1e;Cep164;Cep290;Pafah1b1;Pcnt;Cntrl
prerank,TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.45944135183867835,-0.7855570835238777,0.7935103244837758,1.0,1.0,8/47,13.67%,Plagl1;E2f1;Plk2;E2f7;Cdk2;Rgcc;E2f8;Plk3
prerank,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.4420537868216721,-0.7844892843150479,0.8176638176638177,1.0,1.0,8/58,23.61%,Shh;Psmb8;Psma8;Sel1l;Psme4;Psme2;Psma1;Sem1
prerank,Termination Of O-glycan Biosynthesis R-HSA-977068,-0.48529901680855836,-0.7844372828733586,0.7944606413994169,1.0,1.0,1/19,0.17%,St6gal1
prerank,RHO GTPases Activate PAKs R-HSA-5627123,0.46924488229834854,0.7833815003312782,0.7466216216216216,1.0,1.0,4/21,3.87%,Ppp1r12b;Ppp1cb;Calm1;Arhgef7
prerank,ERK/MAPK Targets R-HSA-198753,-0.49862172681503447,-0.7832651820698133,0.7911764705882353,1.0,1.0,4/21,5.28%,Kcnh8;Dusp6;Mapk11;Rps6ka5
prerank,Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.5023117141811547,-0.7827211565224493,0.7636103151862464,1.0,1.0,3/15,6.27%,Bcl2;Ywhaq;Ppp3cc
prerank,Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.4917532468620566,-0.7822917707870896,0.7718309859154929,1.0,1.0,3/20,2.53%,Erbb4;Nrg1;Erbb3
prerank,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,-0.4944856386744242,-0.7820699097720832,0.7944055944055944,1.0,1.0,4/18,12.52%,Irak2;Mapk8;Nod1;Nod2
prerank,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.49207227375484436,-0.7811331661553158,0.7937853107344632,1.0,1.0,8/21,30.82%,Birc3;Ticam1;Ripk1;Tlr4;Chuk;Ndufa2;Sarm1;Ubc
prerank,Diseases Of Carbohydrate Metabolism R-HSA-5663084,0.4474920190021836,0.7808171538846558,0.7492163009404389,1.0,1.0,3/29,3.51%,Arsb;Lct;Galns
prerank,PI Metabolism R-HSA-1483255,-0.4327165676176788,-0.7807511856502498,0.8259587020648967,1.0,1.0,23/81,11.41%,Synj2;Pik3r1;Inpp5d;Tnfaip8;Pik3r5;Enpp6;Pnpla7;Tnfaip8l3;Clstn1;Inppl1;Pip4k2a;Pi4k2b;Inpp5f;Pik3cg;Plekha1;Rufy1;Ptpn13;Pik3r6;Pik3c2b;Pip4k2c;Pik3ca;Mtmr7;Pik3c2a
prerank,SUMOylation Of RNA Binding Proteins R-HSA-4570464,0.42990290024491373,0.7807422578300726,0.7951807228915663,1.0,1.0,12/42,12.87%,Ndc1;Cbx4;Nup93;Nop58;Sumo2;Phc2;Ranbp2;Hnrnpc;Nup160;Hnrnpk;Nup155;Rnf2
prerank,Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.4474804284717571,-0.7806308304374413,0.7951635846372689,1.0,1.0,6/48,13.33%,Cnksr3;Eya4;Nsd2;Mapk8;Eya2;Artn
prerank,RHO GTPases Activate Formins R-HSA-5663220,0.36699831592450566,0.780354101381127,0.9194630872483222,1.0,1.0,6/114,3.30%,Diaph2;Mrtfa;Cenpp;Dync1i2;Fmnl2;Diaph1
prerank,DNA Double Strand Break Response R-HSA-5693606,-0.4459384593549598,-0.7786753121043505,0.8014184397163121,1.0,1.0,6/49,13.33%,Cnksr3;Eya4;Nsd2;Mapk8;Eya2;Artn
prerank,G2/M DNA Damage Checkpoint R-HSA-69473,-0.4371352479073623,-0.7783404154786328,0.8132183908045977,1.0,1.0,6/64,13.33%,Rbbp8;Ywhaq;Nsd2;Top3a;Wrn;Artn
prerank,G2/M Checkpoints R-HSA-69481,-0.39937979090414183,-0.7769273813636423,0.8688293370944993,1.0,1.0,16/135,19.29%,Rbbp8;Ywhaq;Mcm10;Nsd2;Cdk2;Psmb8;Psma8;Top3a;Wrn;Artn;Psme4;Psme2;Bard1;Mcm3;Rrad;Slc25a2
prerank,Pre-NOTCH Processing In Golgi R-HSA-1912420,-0.4917238380182054,-0.7762941893765007,0.770516717325228,1.0,1.0,4/18,8.87%,St3gal6;Notch1;Lfng;Mfng
prerank,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,0.47695103869771915,0.7755638760151304,0.7220338983050848,1.0,1.0,6/15,15.95%,Exosc8;Nt5c3b;Skic8;Skic3;Exosc2;Exosc1
prerank,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.46927103231484196,-0.7753835854647518,0.7901591895803184,1.0,1.0,5/31,6.56%,Apbb1ip;Fn1;Vcl;Iqgap1;Rap1b
prerank,Metabolism Of Steroid Hormones R-HSA-196071,-0.46750527598479175,-0.775149635981427,0.7968299711815562,1.0,1.0,9/29,27.34%,Stard4;Hsd17b12;Chga;Hsd17b11;Stard3;Hsd11b1;Hsd11b2;Hsd17b2;Cyp11b1
prerank,Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.4662670854815442,0.7746003616159062,0.7227414330218068,1.0,1.0,7/17,6.00%,Tnrc6c;Ago1;Ago2;Tnrc6b;Ccnd2;Src;Cbfb
prerank,Mitochondrial Biogenesis R-HSA-1592230,-0.42835691828434086,-0.7745510013517313,0.8184397163120567,1.0,1.0,6/73,5.01%,Tbl1x;Camk4;Prkab2;Prkaa2;Smarcd3;Mapk11
prerank,G1/S-Specific Transcription R-HSA-69205,-0.475927493983336,-0.7744709103210982,0.8,1.0,1.0,9/29,29.01%,E2f1;Cdt1;Lin54;Rrm2;E2f6;Dhfr;Cdk1;Lin52;Rbl1
prerank,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.411343072605151,-0.7736732491839946,0.8453757225433526,1.0,1.0,21/96,19.64%,Sclt1;Tubb4a;Ccp110;Nde1;Nedd1;Cep83;Prkca;Plk4;Alms1;Dync1h1;Akap9;Cep43;Csnk1e;Cep164;Cep290;Rpgrip1l;Pafah1b1;Pcnt;Cep97;Kif24;Cntrl
prerank,"Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",0.4429953952615945,0.7734068271128748,0.8058252427184466,1.0,1.0,4/36,7.53%,Arsb;Arsj;Tpst1;Fn3krp
prerank,Sphingolipid De Novo Biosynthesis R-HSA-1660661,-0.45057825514740896,-0.7727045568274464,0.8052708638360175,1.0,1.0,4/44,3.04%,Fa2h;Prkd3;Plpp3;Sgpp2
prerank,Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.41658881587786123,-0.7722144147217852,0.8450502152080345,1.0,1.0,11/93,5.50%,Tcf7l2;Runx1;Tcf7l1;Wwtr1;Kat2b;Zfhx3;Smurf1;Lef1;Hdac4;Tgfb1;Notch1
prerank,Tight Junction Interactions R-HSA-420029,-0.47757377690617786,-0.7721779156736681,0.8043795620437956,1.0,1.0,4/25,4.52%,Cldn1;Cldn14;Cldn11;F11r
prerank,G Alpha (Z) Signaling Events R-HSA-418597,-0.4521149674480159,-0.7719291678325381,0.8177777777777778,1.0,1.0,14/46,5.91%,Rgs20;Prkcq;Prkcb;Gng4;Rgsl1;Gng12;Prkcg;Gnas;Gnai1;Prkcd;Gnb4;Adcy7;Rgs16;Prkch
prerank,Nucleotide Salvage R-HSA-8956321,0.4428884961068226,0.7712919371592303,0.7014925373134329,1.0,1.0,4/21,7.86%,Adk;Upp2;Upp1;Ampd2
prerank,Mitophagy R-HSA-5205647,-0.47158955897075794,-0.7711154920601555,0.7967359050445104,1.0,1.0,1/27,3.46%,Mfn1
prerank,Sphingolipid Metabolism R-HSA-428157,-0.4242503299124353,-0.7702647194865196,0.8558823529411764,1.0,1.0,10/80,7.54%,Fa2h;Prkd3;Plpp3;Sgpp2;Neu4;Cerk;Asah2;Gltp;Sptlc2;Asah1
prerank,MAP2K And MAPK Activation R-HSA-5674135,-0.46604398988308915,-0.7701543715272854,0.8058823529411765,1.0,1.0,5/35,6.56%,Apbb1ip;Fn1;Vcl;Iqgap1;Rap1b
prerank,Nuclear Signaling By ERBB4 R-HSA-1251985,-0.46714081778996874,-0.7700474256213794,0.8043478260869565,1.0,1.0,8/31,7.76%,Erbb4;Nrg1;Sparc;Apoe;Esr1;Wwox;Adap1;Adam17
prerank,Formation Of Cornified Envelope R-HSA-6809371,-0.4675740742734974,-0.7693843453005362,0.7988505747126436,1.0,1.0,8/33,19.13%,Pcsk6;Kazn;Dsc3;Rcan1;Klk8;Tgm5;Jup;Klk13
prerank,SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.4319269856642181,0.7684735084556692,0.8133333333333334,1.0,1.0,8/35,14.57%,Ndc1;Nup93;Ranbp2;Pias1;Vhl;Nup160;Nup155;Nup210
prerank,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.44110233022022577,-0.7672346719770012,0.8343023255813954,1.0,1.0,7/51,23.61%,Ccnd1;Psmb8;Psma8;Psme4;Psme2;Psma1;Sem1
prerank,Recycling Pathway Of L1 R-HSA-437239,-0.4762689884649378,-0.7671365069740173,0.7888730385164051,1.0,1.0,8/25,7.87%,L1cam;Rps6ka5;Dnm3;Numb;Ap2b1;Sh3gl2;Msn;Ezr
prerank,Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.47432583657701005,0.766734944288416,0.7508305647840532,1.0,1.0,3/19,5.81%,Map2k6;Ripk2;Mapk14
prerank,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.43551485556499003,-0.7665162909465207,0.8208955223880597,1.0,1.0,16/61,14.62%,Abca1;Lcat;Apoe;Pcsk6;Lipg;Ap2b1;Prkca;Ldlrap1;Mylip;Lpl;Soat1;Npc2;Angptl4;Ldlr;Trnp1;Cltc
prerank,EGFR Downregulation R-HSA-182971,0.4462370389060207,0.7658592158972867,0.7562724014336918,1.0,1.0,6/30,4.21%,Ptprk;Ptpn3;Tgfa;Sh3gl1;Arhgef7;Cbl
prerank,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.4238603978809278,-0.7649446743192851,0.8640350877192983,1.0,1.0,10/77,18.32%,Slc7a11;Notch1;Mafg;Nfe2l2;Psmb8;Gsta3;Idh1;Mafk;Ep300;Psme2
prerank,Elastic Fibre Formation R-HSA-1566948,0.42787242334470693,0.7649442580151719,0.8,1.0,1.0,4/37,3.72%,Itga8;Mfap3;Itgb8;Tgfb2
prerank,Asymmetric Localization Of PCP Proteins R-HSA-4608870,0.39552438125127454,0.764621902241906,0.8498402555910544,1.0,1.0,2/62,3.60%,Prickle1;Vangl2
prerank,Molecules Associated With Elastic Fibres R-HSA-2129379,0.4447159735893121,0.7643381849022658,0.75,1.0,1.0,4/27,3.72%,Itga8;Mfap3;Itgb8;Tgfb2
prerank,Signaling By NTRK1 (TRKA) R-HSA-187037,-0.40382689913292763,-0.7627327702039142,0.8935860058309038,1.0,1.0,17/112,7.62%,Pik3r1;Ngf;Kcnh8;Shc3;Dusp6;Vgf;Egr1;Trib1;Mapk11;Rps6ka5;Dnm3;Sgk1;Id1;F3;Ap2b1;Sh3gl2;Ralb
prerank,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.3596900687234207,-0.7615971188563893,0.9685929648241206,1.0,1.0,26/357,9.18%,Lnx1;Sh3rf1;Hecw2;Trim36;Itgb5;Rnf220;Rnf144b;Herc6;Spsb4;Ncf2;Smurf1;Fbxl19;Ctss;Btbd1;Wsb1;Lonrf1;Asb2;Fbxo7;Herc4;Btk;Klhl13;S100a1;Lrsam1;Cul7;Fbxl4;Psmb8
prerank,Synthesis Of Bile Acids And Bile Salts R-HSA-192105,0.45222904136989367,0.7602904292634667,0.7912772585669782,1.0,1.0,1/28,0.58%,Cyp7b1
prerank,Activation Of Pre-Replicative Complex R-HSA-68962,-0.4585954636859437,-0.759550302333968,0.8168389955686853,1.0,1.0,7/31,23.76%,Mcm10;Cdk2;Cdt1;Mcm3;Slc25a2;Prim2;Orc5
prerank,"mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",0.4097476227943236,0.7588225508134862,0.8567164179104477,1.0,1.0,13/53,16.71%,Eif4b;Eif3a;Eif4a2;Eif4a1;Pabpc1;Eif4e;Rpsa;Rps28;Eif3h;Rps21;Rps3;Rps8;Rps9
prerank,Chaperonin-mediated Protein Folding R-HSA-390466,-0.421667269615672,-0.758780842198844,0.8528571428571429,1.0,1.0,9/81,5.44%,Kif13a;Gng4;Rgs6;Gna15;Tubb3;Fkbp9;Gng12;Tubb4a;Gnb4
prerank,Ub-specific Processing Proteases R-HSA-5689880,-0.3792793817988732,-0.7568236874831452,0.9186991869918699,1.0,1.0,10/171,9.18%,Cftr;Smad2;Smad7;Ccp110;Birc3;Smad1;Stam2;Ifih1;Cyld;Psmb8
prerank,Protein Folding R-HSA-391251,-0.4150779721300536,-0.7562910875951813,0.8587731811697575,1.0,1.0,9/87,5.44%,Kif13a;Gng4;Rgs6;Gna15;Tubb3;Fkbp9;Gng12;Tubb4a;Gnb4
prerank,Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.4368190926805841,-0.7560461543297105,0.8602620087336245,1.0,1.0,17/51,11.41%,Synj2;Pik3r1;Inpp5d;Pik3r5;Clstn1;Inppl1;Pip4k2a;Pi4k2b;Pik3cg;Plekha1;Rufy1;Ptpn13;Pik3r6;Pik3c2b;Pip4k2c;Pik3ca;Pik3c2a
prerank,FCERI Mediated MAPK Activation R-HSA-2871796,-0.4621500158794208,-0.7559677299256404,0.8304597701149425,1.0,1.0,8/28,9.33%,Vav2;Lcp2;Vav1;Lyn;Syk;Map3k1;Mapk8;Grap2
prerank,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.45296202054735435,-0.755346961973605,0.8038067349926794,1.0,1.0,9/33,21.88%,Pla2g4a;Dync1h1;Pla2g6;Pafah1b3;Dync1li2;Rab6b;Pafah1b1;Rab6a;Bicd2
prerank,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.4550711564003105,-0.7550768470672515,0.8128571428571428,1.0,1.0,1/32,1.29%,Fgf1
prerank,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,-0.4483889981723266,-0.7548677880275342,0.8110344827586207,1.0,1.0,2/39,12.85%,Trmt9b;Nsun6
prerank,Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,0.45405183155812756,0.7546700320383434,0.7633333333333333,1.0,1.0,6/21,3.72%,Prkg1;Pde1b;Gucy1b1;Kcnmb4;Kcnma1;Itpr1
prerank,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,0.3616597690078085,0.7546508955347105,0.9665551839464883,1.0,1.0,17/106,5.94%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Rps6ka2;Mef2c;Peli1;Btrc;Fbxw11;Mapk10;Peli2;Ripk2;Map2k4;Mapk3;Mapk14;Dusp4
prerank,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.43450601407310335,-0.7532846237432418,0.8279883381924198,1.0,1.0,7/50,23.61%,Psmb8;Psma8;Slc25a21;Psme4;Psme2;Psma1;Sem1
prerank,"GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",0.458673448613291,0.7528902674296907,0.7534246575342466,1.0,1.0,1/19,0.43%,Rims1
prerank,Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.45759360487729245,0.7521094432079628,0.7959866220735786,1.0,1.0,5/21,3.72%,Prkce;Plcg2;Plpp4;Pik3cb;Itpr1
prerank,Degradation Of Extracellular Matrix R-HSA-1474228,-0.4097216915194524,-0.7503522743931583,0.875748502994012,1.0,1.0,25/95,9.35%,Adamts16;Scube1;Col26a1;Lama4;Bcan;Mmp14;Adamts4;Htra1;Cd44;Ctsd;Ctss;Timp2;Dcn;Lamc2;Capn2;Mmp28;Col9a1;Col16a1;Col12a1;Col19a1;Adam17;Klk7;Hspg2;Adam10;Col14a1
prerank,Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,0.4323199407499291,0.7497781298554824,0.7973856209150327,1.0,1.0,8/31,14.57%,Ndc1;Xpo1;Nup93;Ranbp2;Nup160;Nup155;Ranbp1;Nup210
prerank,RHO GTPases Activate PKNs R-HSA-5625740,0.3995679773000061,0.7494358397306085,0.8388059701492537,1.0,1.0,6/49,6.03%,Ppp1r12b;Ppp1cb;Ywhaz;Ywhab;Ywhae;Ywhah
prerank,Signal Transduction By L1 R-HSA-445144,-0.46920487634912766,-0.7494020032761181,0.8226950354609929,1.0,1.0,4/20,5.64%,Vav2;Itga9;L1cam;Egfr
prerank,SUMOylation Of Transcription Cofactors R-HSA-3899300,0.41599508849085415,0.749203534977796,0.8270440251572327,1.0,1.0,12/40,8.08%,Mrtfa;Uhrf2;Ncoa1;Ddx5;Ncor2;Crebbp;Safb;Cbx4;Sumo2;Phc2;Npm1;Pias1
prerank,FCGR3A-mediated IL10 Synthesis R-HSA-9664323,0.43326210214453614,0.7482135797602751,0.8328173374613003,1.0,1.0,8/32,4.94%,Adcy1;Adcy2;Adcy9;Plcg2;Calm1;Itpr1;Fyn;Src
prerank,MyD88-independent TLR4 Cascade R-HSA-166166,0.3612279192158957,0.7477218934097462,0.9292604501607717,1.0,1.0,15/100,5.94%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Rps6ka2;Mef2c;Btrc;Fbxw11;Mapk10;Ripk2;Map2k4;Mapk3;Mapk14;Dusp4
prerank,Chondroitin Sulfate Biosynthesis R-HSA-2022870,-0.47601338697847795,-0.7475624497109743,0.8208744710860366,1.0,1.0,6/19,4.98%,Bcan;Cspg4;Vcan;Chst3;Cspg5;Dcn
prerank,Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.4645913039585299,-0.7472683169607538,0.8221574344023324,1.0,1.0,6/24,29.15%,Pold4;Prim2;Rfc2;Terf1;Ctc1;Rfc3
prerank,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.4546356783387281,-0.7453698542572611,0.8272327964860908,1.0,1.0,1/30,1.29%,Fgf1
prerank,G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.457363814180695,-0.7452155045518021,0.8045649072753209,1.0,1.0,6/24,9.32%,Gng4;Pik3r5;Gng12;Gnb4;Pik3cg;Pik3r6
prerank,Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.4107730819927099,-0.7449940261022341,0.8888888888888888,1.0,1.0,13/83,13.67%,Rbbp8;Prkab2;Nuak1;Prkaa2;Hipk2;Dyrk2;Mapk11;Cdk2;Aurkb;Top3a;Wrn;Artn;Plk3
prerank,TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,0.4522457120009624,0.7436546190765501,0.7692307692307693,1.0,1.0,2/16,2.53%,Pard3;Tgfbr1
prerank,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.3955930098257363,-0.742795822312491,0.8828451882845189,1.0,1.0,16/86,18.42%,Optn;Tubb4a;Ccp110;Nde1;Nedd1;Prkca;Plk4;Alms1;Dync1h1;Akap9;Cep43;Csnk1e;Cep164;Cep290;Pafah1b1;Pcnt
prerank,G Beta:Gamma Signaling Thru BTK R-HSA-8964315,-0.4707490963550458,-0.7425991150666135,0.8011283497884344,1.0,1.0,4/17,7.94%,Gng4;Gng12;Gnb4;Btk
prerank,Glycerophospholipid Biosynthesis R-HSA-1483206,-0.3837930146732839,-0.7424755281003493,0.9146853146853147,1.0,1.0,26/123,14.29%,Cpne7;Pitpnm3;Mboat1;Pla2g4a;Osbpl10;Lpcat2;Gpat3;Pla2g4c;Sh2d3c;Plaat3;Pld4;Lpgat1;Plaat1;Agk;Pld2;Chpt1;Ache;Osbpl5;Pla2g6;Pctp;Pnpla8;Pla2r1;Lpin3;Pcyt2;Pitpnm1;Lpcat3
prerank,cGMP Effects R-HSA-418457,0.4518024860734424,0.7424048035363263,0.7412587412587412,1.0,1.0,5/15,3.72%,Prkg1;Pde1b;Kcnmb4;Kcnma1;Itpr1
prerank,Regulation Of TP53 Degradation R-HSA-6804757,-0.4420233415804148,-0.7392397396843593,0.8356164383561644,1.0,1.0,5/35,9.16%,Rffl;Prr5;Sgk1;Cdk2;Ppp2r5c
prerank,mRNA 3-End Processing R-HSA-72187,0.382495539128487,0.7391514076358725,0.8858024691358025,1.0,1.0,14/58,11.14%,Cdc40;Srsf9;Cstf3;Thoc2;Srsf11;Nudt21;Srsf1;Papola;Ncbp1;Cstf2t;Fyttd1;Cpsf6;Wdr33;Srsf7
prerank,Bile Acid And Bile Salt Metabolism R-HSA-194068,0.42308979025226867,0.7371838725947015,0.8390092879256966,1.0,1.0,1/36,0.58%,Cyp7b1
prerank,Azathioprine ADME R-HSA-9748787,-0.4648577624117426,-0.7366806946126483,0.8294797687861272,1.0,1.0,2/19,2.34%,Vav2;Vav1
prerank,Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.4520783238805124,-0.7363935418263058,0.8410404624277457,1.0,1.0,3/28,2.53%,Erbb4;Nrg1;Erbb3
prerank,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.42409661821221056,-0.7350901210069378,0.8797101449275362,1.0,1.0,7/49,23.61%,Psmb8;Psma8;Pkn2;Psme4;Psme2;Psma1;Sem1
prerank,HATs Acetylate Histones R-HSA-3214847,0.36507882043412687,0.7339336390031854,0.9389830508474576,1.0,1.0,16/92,10.96%,Kat6b;Trrap;Ncoa1;Elp2;Zzz3;Crebbp;Rbbp7;Jade3;Taf5l;H2bc4;Kat7;Eny2;Dr1;H2ac6;Epc1;Tada1
prerank,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,0.35616951294970184,0.7338792087666106,0.9419354838709677,1.0,1.0,15/97,5.94%,Map2k6;Mapk1;Map2k1;Tnip2;Jun;Rps6ka2;Mef2c;Btrc;Fbxw11;Mapk10;Ripk2;Map2k4;Mapk3;Mapk14;Dusp4
prerank,Calnexin/calreticulin Cycle R-HSA-901042,-0.4519800258666338,-0.7338685730063252,0.844574780058651,1.0,1.0,2/26,8.81%,Edem1;Uggt2
prerank,Intraflagellar Transport R-HSA-5620924,0.4096638802056148,0.733367935841139,0.8618421052631579,1.0,1.0,15/39,14.75%,Dync2h1;Cluap1;Hspb11;Ift57;Ttc26;Ift122;Dynlt2b;Tnpo1;Ift22;Ift80;Dynll1;Wdr19;Wdr35;Ift74;Dync2li1
prerank,Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.4356360741493347,-0.7324113511478091,0.8450920245398773,1.0,1.0,5/36,9.16%,Rffl;Prr5;Sgk1;Cdk2;Ppp2r5c
prerank,Keratinization R-HSA-6805567,-0.42146048000525527,-0.7321010390574743,0.8675595238095238,1.0,1.0,10/60,17.25%,Pcsk6;Kazn;Dsc3;Rcan1;Krt25;Klk8;Krt79;Tgm5;Krt24;Jup
prerank,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.3946983669164281,-0.7297636226982195,0.9172610556348074,1.0,1.0,12/87,24.96%,Cdc14a;Cdk2;Psmb8;Aurkb;Psma8;Psme4;Psme2;Anapc11;Psma1;Anapc5;Sem1;Cdk1
prerank,RNA Polymerase III Chain Elongation R-HSA-73780,0.46501322012438084,0.7292740723787486,0.8093645484949833,1.0,1.0,17/17,53.53%,Polr2e;Polr2k;Polr3gl;Polr3g;Polr3e;Polr2f;Polr3f;Crcp;Polr2h;Polr3a;Polr3b;Polr3k;Polr2l;Polr3h;Polr3c;Polr3d;Polr1d
prerank,Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.3974469580343358,0.7273342074620488,0.8616352201257862,1.0,1.0,9/38,14.57%,Ndc1;Nup93;Ncbp1;Ranbp2;Eif4e;Wdr33;Nup160;Nup155;Nup210
prerank,E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.4526403504807008,-0.7266525814004132,0.8270348837209303,1.0,1.0,5/21,24.96%,E2f1;Slc25a2;Prim2;Orc5;Cdk1
prerank,Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.4155522323326479,0.7260768489752636,0.839344262295082,1.0,1.0,7/31,14.57%,Ndc1;Nup93;Ranbp2;Gnl3;Nup160;Nup155;Nup210
prerank,Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.41595170201092635,-0.7246715522553133,0.8994169096209913,1.0,1.0,6/52,8.06%,Homer2;Hip1r;Tpd52;Dtnbp1;Sh3gl2;Ap3s1
prerank,Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.4348253031955973,-0.7238759932906242,0.8537313432835821,1.0,1.0,4/38,15.56%,Lrig1;Lrig3;Pold4;Nthl1
prerank,Cell Cycle Checkpoints R-HSA-69620,-0.34798172880974343,-0.7233933922568141,0.9883116883116884,1.0,1.0,40/252,23.76%,Rbbp8;Ppp2r5a;Ywhaq;Nde1;Mcm10;Nsd2;Clasp2;Cdk2;Ppp2r5c;Psmb8;Ndc80;Dync1h1;Aurkb;Bub1;Psma8;Top3a;Wrn;Artn;Dync1li2;Zwint;Ppp2r5e;Psme4;Pafah1b1;Psme2;Bard1;Mcm3;Rrad;Slc25a2;Ndel1;Cenpn;Ska1;Anapc11;H2bc3;Knl1;Psma1;Rfc2;Anapc5;Rangap1;Sem1;Orc5
prerank,Dual Incision In TC-NER R-HSA-6782135,0.37620858940245305,0.7231634049548069,0.8964401294498382,1.0,1.0,8/63,11.94%,Gtf2h2;Ercc4;Gtf2h5;Ccnh;Mnat1;Polr2e;Usp7;Uba52
prerank,Selective Autophagy R-HSA-9663891,-0.4106811411544066,-0.7224688332951736,0.8814814814814815,1.0,1.0,5/59,4.36%,Cftr;Mfn1;Prkab2;Epas1;Prkaa2
prerank,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,-0.4275051028991967,-0.7209948580352323,0.8573466476462197,1.0,1.0,10/32,24.21%,Rap1b;Msn;Rala;Pkn2;Pitpna;Cdc42;Psme2;Stat4;Anxa2;Lmnb1
prerank,Miscellaneous Transport And Binding Events R-HSA-5223345,0.4369021237880217,0.7209899841185204,0.8312883435582822,1.0,1.0,1/21,0.80%,Add2
prerank,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.43420732337358403,-0.7185852455708832,0.8437025796661608,1.0,1.0,9/32,13.35%,Trim25;Traf3;Ifih1;Cyld;Rnf125;Rnf135;Tnfaip3;Rigi;Irf3
prerank,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,0.35764869956672946,0.7184618446552955,0.9723926380368099,1.0,1.0,24/87,17.05%,Rpl15;Ncbp1;Upf1;Rplp1;Rpl10a;Rplp0;Rpl4;Gspt1;Pabpc1;Rpl3;Rpsa;Mrpl13;Rpl36a;Rpl8;Rps28;Rsl24d1;Uba52;Rpl18;Rps21;Rps3;Rps8;Rpl6;Rps9;Rpl31
prerank,Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,0.4162330114431453,0.717633846310292,0.8362369337979094,1.0,1.0,6/31,4.94%,Gng7;Gnaq;Mapk1;Gng2;Mapk3;Src
prerank,Glycosphingolipid Metabolism R-HSA-1660662,-0.4314070954247313,-0.7169494462902918,0.8563134978229318,1.0,1.0,6/36,10.81%,Neu4;Cerk;Asah2;Gltp;Asah1;Neu2
prerank,Keratan Sulfate Biosynthesis R-HSA-2022854,0.4302742465595379,0.7144640280116644,0.8181818181818182,1.0,1.0,8/27,5.74%,B4galt1;B4galt5;Chst1;B3gnt2;St3gal1;B4galt4;Ogn;B4galt6
prerank,KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.3791511819509518,-0.714282061651876,0.9316860465116279,1.0,1.0,14/99,18.32%,Slc7a11;Prkcd;Notch1;Mafg;Nfe2l2;Psmb8;Psma8;Trim21;Gsta3;Idh1;Mafk;Psme4;Ep300;Psme2
prerank,ER-Phagosome Pathway R-HSA-1236974,-0.3928452342446726,-0.7135238160004149,0.9051094890510949,1.0,1.0,16/81,24.18%,Btk;S100a1;Psmb8;Tlr1;Psma8;Tirap;Tapbp;Tlr2;Tlr6;Psme4;Vamp8;Psme2;B2m;Psma1;Sem1;Tlr4
prerank,Unfolded Protein Response (UPR) R-HSA-381119,-0.3906697111253606,-0.7124522254888679,0.9161764705882353,1.0,1.0,5/85,9.01%,Creb3l2;Edem1;Crebrf;Cul7;Wfs1
prerank,DNA Replication R-HSA-69306,-0.3656235049074071,-0.7102191212233159,0.9550724637681159,1.0,1.0,22/142,24.07%,Mcm10;Lrig1;Cdk2;Psmb8;Cdt1;Psma8;Pold4;H3c7;H2aj;Psme4;Psme2;Mcm3;Slc25a2;Anapc11;H2bc3;Prim2;Psma1;Rfc2;Anapc5;Sem1;Orc5;Gins4
prerank,G-protein Beta:Gamma Signaling R-HSA-397795,0.4068765779972054,0.710081191620475,0.8507936507936508,1.0,1.0,4/31,2.24%,Plcb1;Gng7;Akt3;Gng2
prerank,Mitotic G2-G2/M Phases R-HSA-453274,-0.3575313623960607,-0.7097480546109759,0.9859747545582047,1.0,1.0,26/178,18.42%,Optn;Phlda1;Tubb4a;Ccp110;Nde1;Nedd1;E2f1;Cdc25b;Prkca;Plk4;Cdk2;Psmb8;Alms1;Dync1h1;Psma8;Akap9;Cep43;Csnk1e;Cep164;Cep290;Lin54;Psme4;Ep300;Pafah1b1;Psme2;Pcnt
prerank,TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.43648331917429256,-0.7073668112958452,0.8813314037626628,1.0,1.0,3/32,3.54%,Ndrg1;Cradd;Casp1
prerank,HCMV Late Events R-HSA-9610379,-0.3934628707227019,-0.7057273008323599,0.922740524781341,1.0,1.0,1/74,2.07%,Pcsk1
prerank,SUMOylation Of Transcription Factors R-HSA-3232118,-0.4511097151631883,-0.7053183778534361,0.8616262482168331,1.0,1.0,3/17,22.07%,Mitf;Pias3;Tfap2c
prerank,Insulin Receptor Recycling R-HSA-77387,0.4182278461155061,0.7052956685862636,0.8327759197324415,1.0,1.0,5/23,9.61%,Atp6v1a;Atp6v0e2;Atp6v1c2;Atp6v1d;Atp6v0a1
prerank,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.43456029066912505,-0.7043672565391444,0.8783592644978784,1.0,1.0,4/23,7.53%,Bcl2;Kcnh8;Egfr;Ccnd1
prerank,Activation Of BH3-only Proteins R-HSA-114452,-0.43410723185311284,-0.7040324715868251,0.87518573551263,1.0,1.0,6/26,8.40%,Bcl2;Ywhaq;Bmf;E2f1;Ppp3cc;Mapk8
prerank,Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.43901485566688986,-0.7034306872468992,0.8666666666666667,1.0,1.0,2/25,12.61%,Lrig1;Pold4
prerank,Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.3730293396207379,-0.703149953496249,0.936231884057971,1.0,1.0,7/105,6.13%,Kif21b;Kif26a;Kif6;Pla2g4a;Kif5a;Kif13b;Kif16b
prerank,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.4052433815535053,-0.7005233986572811,0.8926974664679582,1.0,1.0,8/52,16.68%,Slc16a1;Idh2;Ldhb;Pdk4;Ldlr;Adhfe1;Ldha;Ldhd
prerank,Chromosome Maintenance R-HSA-73886,-0.37266884194985317,-0.7001635317403844,0.9437037037037037,1.0,1.0,7/103,13.04%,Ankrd28;Hjurp;Lrig1;Cdk2;Pif1;Pold4;Wrn
prerank,Dual Incision In GG-NER R-HSA-5696400,0.3904391593764211,0.6986452598572789,0.930379746835443,1.0,1.0,4/41,7.96%,Gtf2h2;Ercc4;Gtf2h5;Parp1
prerank,Response Of Mtb To Phagocytosis R-HSA-9637690,0.42667939768711943,0.6985517878096097,0.8316151202749141,1.0,1.0,2/20,4.88%,Mapk1;Mapk3
prerank,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,0.3534094640320859,0.6983354541086519,0.9365994236311239,1.0,1.0,14/66,11.94%,Mapk1;Jun;Rps6ka2;Mapk3;Ehmt1;Cebpb;Ube2d1;H2bc4;H2az1;H2ac6;H2ax;Nfkb1;Cdc26;Uba52
prerank,Lewis Blood Group Biosynthesis R-HSA-9037629,0.4426466932638487,0.6978456253182757,0.8092105263157895,1.0,1.0,2/15,1.85%,B3galt5;B3galt1
prerank,Ephrin Signaling R-HSA-3928664,0.43169284139833586,0.6967438783041712,0.8157894736842105,1.0,1.0,7/18,5.97%,Nck2;Sdcbp;Arhgef7;Efnb3;Fyn;Src;Ephb2
prerank,UCH Proteinases R-HSA-5689603,0.33946099526614,0.6953586973890338,0.9780564263322884,1.0,1.0,4/90,3.12%,Mbd5;Tgfbr1;Foxk1;Usp15
prerank,Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.4101388667110454,0.6937772247925068,0.8729096989966555,1.0,1.0,8/32,5.74%,B4galt1;B4galt5;Chst1;B3gnt2;St3gal1;B4galt4;Ogn;B4galt6
prerank,Blood Group Systems Biosynthesis R-HSA-9033658,0.4325329019922083,0.6925384210783058,0.8327645051194539,1.0,1.0,2/18,1.85%,B3galt5;B3galt1
prerank,Plasma Lipoprotein Remodeling R-HSA-8963899,0.42057170426456403,0.6920998658846121,0.863905325443787,1.0,1.0,1/26,0.59%,Pcsk5
prerank,Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.4271724766030557,-0.6915587533599099,0.8778409090909091,1.0,1.0,4/23,5.44%,Gng4;Gna15;Gng12;Gnb4
prerank,Circadian Clock R-HSA-400253,-0.3906771076233836,-0.6909835302172219,0.9405646359583952,1.0,1.0,4/65,4.55%,Tbl1x;Npas2;Nrip1;Smarcd3
prerank,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,0.4151962911358445,0.6905452473396826,0.8453947368421053,1.0,1.0,9/26,19.57%,Pou2f1;Polr2e;Polr2k;Snapc4;Polr3gl;Polr3g;Polr3e;Tbp;Polr2f
prerank,Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.41459592011976787,-0.6898328712428111,0.888243831640058,1.0,1.0,7/35,23.76%,Mcm10;Cdk2;Mcm3;Rrad;Slc25a2;Rfc2;Orc5
prerank,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.3949394924058431,-0.6892290335776683,0.9418777943368107,1.0,1.0,7/59,23.61%,Ccnd1;Cdk2;Psmb8;Cks1b;Psme2;Psma1;Sem1
prerank,G2/M Transition R-HSA-69275,-0.34625822288580804,-0.6872768536776145,0.9901823281907434,1.0,1.0,25/176,18.42%,Optn;Phlda1;Tubb4a;Ccp110;Nde1;Nedd1;Cdc25b;Prkca;Plk4;Cdk2;Psmb8;Alms1;Dync1h1;Psma8;Akap9;Cep43;Csnk1e;Cep164;Cep290;Lin54;Psme4;Ep300;Pafah1b1;Psme2;Pcnt
prerank,Base Excision Repair R-HSA-73884,-0.3935724923820635,-0.686241285091132,0.9138972809667674,1.0,1.0,9/59,23.03%,Lrig1;Lrig3;Neil3;Pold4;Nthl1;H2aj;H2bc3;Rfc2;Terf1
prerank,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.41888693840195085,-0.6862030124585683,0.8805755395683453,1.0,1.0,6/26,8.27%,Vav2;Vav1;Prr5;Cav1;Ctnna1;Cdh5
prerank,Interleukin-6 Family Signaling R-HSA-6783589,0.40071083046607564,0.6858621201453038,0.8203389830508474,1.0,1.0,2/22,4.21%,Crlf1;Cbl
prerank,Protein Methylation R-HSA-8876725,-0.4329450487324933,-0.68561211847655,0.8787023977433004,1.0,1.0,1/17,5.11%,Camkmt
prerank,Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.43439639516443473,-0.684136744359092,0.8593314763231198,1.0,1.0,8/18,30.61%,Ap2b1;Pacs1;B2m;Cd28;Ap1m2;Atp6v1h;Ap1b1;Cd4
prerank,Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,-0.4363222276938944,-0.6816551735455855,0.8814285714285715,1.0,1.0,2/16,11.41%,Pi4k2b;Pik3c2a
prerank,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,0.3317026308985413,0.6788873518687062,0.9826388888888888,1.0,1.0,4/93,2.58%,Eml4;Cenpp;Nek6;Dync1i2
prerank,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.40907441699352154,-0.6779299382445532,0.9140401146131805,1.0,1.0,6/29,20.88%,Dhtkd1;Bckdhb;Agxt2;Ldhd;Gldc;Pxmp2
prerank,Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,0.4297667694900506,0.6777889358178062,0.8478964401294499,1.0,1.0,6/17,11.94%,Kmt5a;Ehmt1;Smyd2;Chek2;Atm;Uba52
prerank,Epigenetic Regulation Of Gene Expression R-HSA-212165,-0.3631895387128754,-0.6756880206279247,0.9622093023255814,1.0,1.0,4/102,7.10%,Myo1e;Kat2b;Tet2;Phf1
prerank,Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.3437213288061818,-0.6755544256921612,0.9826338639652678,1.0,1.0,23/145,21.91%,Lyn;Ccnd3;Mcm10;E2f1;Jak2;Ccnd1;Cdk2;Psmb8;Cdt1;Cdkn2c;Cdkn1c;Cables1;Cks1b;Lin54;Psme2;Mcm3;Rrm2;Slc25a2;Abl1;Prim2;E2f6;Psma1;Dhfr
prerank,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.40141445242705825,-0.6746170865790789,0.8928046989720999,1.0,1.0,2/35,8.81%,Edem1;Uggt2
prerank,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.3870979418409839,-0.6732994669187969,0.9190751445086706,1.0,1.0,3/48,8.85%,Rnf152;Rnf144a;Bcl10
prerank,Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,-0.40248825262629356,-0.6728289352821515,0.9141193595342066,1.0,1.0,4/33,6.49%,Arnt2;Tbxas1;Cyp26b1;Cyp27a1
prerank,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.3708323796193464,-0.6714548622368195,0.9576868829337094,1.0,1.0,15/72,32.79%,Cdk2;Psmb8;Psma8;Psme4;Psme2;Anapc11;Psma1;Anapc5;Sem1;Anapc2;Ubc;Anapc10;Ccne2;Psmd11;Anapc1
prerank,Glucagon-type Ligand Receptors R-HSA-420092,-0.4127203135695272,-0.6707098659529134,0.8985714285714286,1.0,1.0,13/29,18.66%,Gng4;Gng12;Gnas;Gnb4;C1qtnf1;Sctr;Gng3;Gngt2;Ghrh;Gnb1;Vipr2;Cysltr2;Gng11
prerank,IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,0.4098519670084098,0.6706182679245553,0.8447653429602888,1.0,1.0,1/16,1.65%,Crlf1
prerank,Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,-0.42617529974706797,-0.6700965551775769,0.894134477825465,1.0,1.0,6/19,29.37%,E2f1;Lin54;Top2a;Lin52;Rbl1;Max
prerank,Cellular Hexose Transport R-HSA-189200,-0.43126630886986483,-0.669538683644034,0.8818443804034583,1.0,1.0,5/15,29.05%,Slc2a8;Slc5a1;Slc2a1;Slc5a2;Slc2a10
prerank,TNF Signaling R-HSA-75893,-0.3986359891826397,-0.6693639871233719,0.9202363367799113,1.0,1.0,5/44,10.76%,Casp8;Birc3;Adam17;Cyld;Tnfaip3
prerank,Eukaryotic Translation Elongation R-HSA-156842,0.33511281413629435,0.6685687244859755,0.984375,1.0,1.0,24/85,17.05%,Rpl15;Eef1a1;Rplp1;Rpl10a;Rplp0;Rpl4;Rpl3;Rpsa;Mrpl13;Rpl36a;Rpl8;Eef1d;Eef2;Rps28;Rsl24d1;Uba52;Rpl18;Rps21;Eef1g;Rps3;Rps8;Rpl6;Rps9;Rpl31
prerank,Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.38158128779856915,0.6681534698524814,0.9137380191693291,1.0,1.0,8/32,14.57%,Ndc1;Nup93;Ncbp1;Ranbp2;Eif4e;Nup160;Nup155;Nup210
prerank,Regulation Of TNFR1 Signaling R-HSA-5357905,-0.40771861562542855,-0.6679736195831052,0.9072164948453608,1.0,1.0,4/35,10.76%,Casp8;Birc3;Cyld;Tnfaip3
prerank,Negative Regulation Of MET Activity R-HSA-6807004,0.3997272972302222,0.6667601724957191,0.852112676056338,1.0,1.0,3/21,4.21%,Ptprj;Sh3gl1;Cbl
prerank,Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,-0.4329589891679495,-0.664927529068908,0.8929577464788733,1.0,1.0,3/15,7.75%,Cckbr;Egfr;Prkca
prerank,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,0.3702491819456631,0.6632827103508876,0.937125748502994,1.0,1.0,9/41,10.57%,Cenpp;Rsf1;Rbbp7;Npm1;H2bc4;Smarca5;H2az1;H2ac6;H2ax
prerank,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.40577221246468265,-0.6622179174786224,0.908695652173913,1.0,1.0,5/29,8.40%,Kcnh8;Dusp6;Mapk11;Rps6ka5;Mapk8
prerank,Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,-0.4225639068844776,-0.6595158855571749,0.8958630527817404,1.0,1.0,5/16,29.01%,E2f1;Lin54;Cdk1;Lin52;Rbl1
prerank,Digestion And Absorption R-HSA-8963743,0.4027176534859513,0.6572302721823715,0.8333333333333334,1.0,1.0,1/17,1.83%,Lct
prerank,Cristae Formation R-HSA-8949613,0.40195888890953635,0.6571779504425046,0.8780487804878049,1.0,1.0,1/15,3.15%,Chchd3
prerank,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,0.37668941252957827,0.6561849703453615,0.9137380191693291,1.0,1.0,9/34,14.08%,Atrx;H2bc4;Polr2e;H2az1;H2ac6;H2ax;Terf2ip;H2ac4;Polr2k
prerank,G-protein Activation R-HSA-202040,-0.40773781928482955,-0.6555883078348826,0.8805120910384068,1.0,1.0,4/23,5.44%,Gng4;Gna15;Gng12;Gnb4
prerank,Iron Uptake And Transport R-HSA-917937,-0.3768516983924448,-0.6521811167384508,0.9328467153284672,1.0,1.0,4/54,8.08%,Steap2;Cp;Atp6v1b1;Hfe
prerank,Macroautophagy R-HSA-1632852,-0.3427436074288449,-0.6501967961962835,0.9759547383309759,1.0,1.0,5/110,4.36%,Cftr;Mfn1;Prkab2;Epas1;Prkaa2
prerank,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.406787699757866,-0.6501622444559457,0.9178885630498533,1.0,1.0,2/24,8.26%,Cdc25b;Cdk2
prerank,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.3552314101003597,-0.6495999425436995,0.9742489270386266,1.0,1.0,16/73,34.76%,Psmb8;Aurkb;Psma8;Psme4;Psme2;Anapc11;Psma1;Anapc5;Sem1;Anapc2;Ubc;Anapc10;Psmd11;Anapc1;Pttg1;Anapc4
prerank,Ovarian Tumor Domain Proteases R-HSA-5689896,-0.3887631839953831,-0.648513154458155,0.9251101321585903,1.0,1.0,10/37,12.55%,Trim25;Esr1;Traf3;Ifih1;Rnf135;Tnfaip3;Rigi;Nod1;Nod2;Tnip3
prerank,DNA Methylation R-HSA-5334118,-0.40959041361402715,-0.6473958291178948,0.9120234604105572,1.0,1.0,5/22,21.46%,H3c7;H2aj;Dnmt3a;H2bc3;Dnmt3l
prerank,DNA Replication Pre-Initiation R-HSA-69002,-0.3369727480699588,-0.644338808401274,0.981021897810219,1.0,1.0,16/114,23.76%,Mcm10;Cdk2;Psmb8;Cdt1;H3c7;H2aj;Psme2;Mcm3;Slc25a2;Anapc11;H2bc3;Prim2;Psma1;Anapc5;Sem1;Orc5
prerank,Interleukin-12 Family Signaling R-HSA-447115,-0.36953824572167887,-0.6439052297455606,0.9413447782546495,1.0,1.0,13/49,18.32%,Rap1b;Jak2;Msn;Ebi3;Il6st;Rala;Il12rb1;Pkn2;Stat3;Pitpna;Cdc42;Il23r;Psme2
prerank,HDMs Demethylate Histones R-HSA-3214842,0.38914667417780546,0.6413982394229542,0.8825396825396825,1.0,1.0,2/21,5.62%,Kdm7a;Arid5b
prerank,DNA Strand Elongation R-HSA-69190,-0.3908109483163051,-0.6404814275009739,0.9275147928994083,1.0,1.0,8/31,29.15%,Lrig1;Pold4;Mcm3;Prim2;Rfc2;Gins4;Dna2;Rfc3
prerank,Peptide Chain Elongation R-HSA-156902,0.3234102161006837,0.6379791591482621,0.9876160990712074,1.0,1.0,22/81,17.05%,Rpl15;Eef1a1;Rplp1;Rpl10a;Rplp0;Rpl4;Rpl3;Rpsa;Mrpl13;Rpl36a;Rpl8;Eef2;Rps28;Rsl24d1;Uba52;Rpl18;Rps21;Rps3;Rps8;Rpl6;Rps9;Rpl31
prerank,Formation Of A Pool Of Free 40S Subunits R-HSA-72689,0.3109512443347396,0.6372104256386203,1.0,1.0,1.0,22/92,17.05%,Rpl15;Eif3a;Rplp1;Rpl10a;Rplp0;Rpl4;Rpl3;Rpsa;Mrpl13;Rpl36a;Rpl8;Rps28;Rsl24d1;Uba52;Eif3h;Rpl18;Rps21;Rps3;Rps8;Rpl6;Rps9;Rpl31
prerank,Synthesis Of DNA R-HSA-69239,-0.33551554570707054,-0.635178446247036,0.9911764705882353,1.0,1.0,18/119,24.07%,Lrig1;Cdk2;Psmb8;Cdt1;Psma8;Pold4;Psme4;Psme2;Mcm3;Slc25a2;Anapc11;Prim2;Psma1;Rfc2;Anapc5;Sem1;Orc5;Gins4
prerank,Transferrin Endocytosis And Recycling R-HSA-917977,-0.3872603188506422,-0.6341832378245859,0.9175108538350217,1.0,1.0,4/28,12.87%,Steap2;Atp6v1b1;Hfe;Tcirg1
prerank,Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,0.3748482289021353,0.6333257962641309,0.9326599326599326,1.0,1.0,6/26,12.81%,Ndc1;Nup93;Tnpo1;Ahctf1;Nup160;Nup155
prerank,Fertilization R-HSA-1187000,0.3852150731747348,0.6324223177807115,0.8854489164086687,1.0,1.0,1/18,2.06%,B4galt1
prerank,Orc1 Removal From Chromatin R-HSA-68949,-0.3522806788223089,-0.6303949480920639,0.9734904270986745,1.0,1.0,11/69,23.76%,Cdk2;Psmb8;Cdt1;Psma8;Psme4;Psme2;Mcm3;Slc25a2;Psma1;Sem1;Orc5
prerank,Attenuation Phase R-HSA-3371568,0.3765862844509232,0.6282485198946549,0.9266666666666666,1.0,1.0,4/24,8.03%,Hspa2;Dnajb6;Crebbp;Hsp90ab1
prerank,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.35984087528615777,-0.6264802249797743,0.9666182873730044,1.0,1.0,6/49,23.61%,Psmb8;Psma8;Psme4;Psme2;Psma1;Sem1
prerank,TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.38489761146637597,-0.6181531574052264,0.9333333333333333,1.0,1.0,3/26,10.76%,Birc3;Cyld;Tnfaip3
prerank,RNA Polymerase I Promoter Opening R-HSA-73728,0.378128077769542,0.6181406716630399,0.9148264984227129,1.0,1.0,6/20,10.57%,Mapk3;Ubtf;H2bc4;H2az1;H2ac6;H2ax
prerank,TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.3926672032092279,-0.6179960105861583,0.9462989840348331,1.0,1.0,4/20,13.67%,Plagl1;Plk2;Rgcc;Plk3
prerank,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.3333804428734679,-0.6174992537612713,0.9788434414668548,1.0,1.0,16/89,21.37%,Ppp2r5a;Nde1;Clasp2;Ppp2r5c;Ndc80;Dync1h1;Aurkb;Bub1;Dync1li2;Zwint;Ppp2r5e;Pafah1b1;Ndel1;Cenpn;Ska1;Knl1
prerank,HSF1 Activation R-HSA-3371511,0.3554842568562879,0.6172014139288967,0.9320987654320988,1.0,1.0,4/27,8.03%,Dnajb6;Ywhae;Eef1a1;Hsp90ab1
prerank,Polo-like Kinase Mediated Events R-HSA-156711,-0.39721302295747074,-0.6167601754093277,0.9144079885877318,1.0,1.0,5/16,32.24%,Lin54;Ep300;Foxm1;Lin52;Ccnb1
prerank,p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.3495556506460691,-0.6149394682570372,0.9730538922155688,1.0,1.0,11/62,32.62%,Cdk2;Psmb8;Psma8;Psme4;Psme2;Psma1;Sem1;Ubc;Cdkn1b;Ccne2;Psmd11
prerank,Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.3742580381067717,-0.6125108442167856,0.9290989660265879,1.0,1.0,8/27,23.94%,Casp8;Birc3;Tnfsf10;Flot1;Mlkl;Ripk1;Cflar;Flot2
prerank,Translesion Synthesis By REV1 R-HSA-110312,0.3757881482070821,0.612161049058335,0.8910256410256411,1.0,1.0,1/16,4.08%,Rev1
prerank,Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,0.33516384721722736,0.6101786896920153,0.9556962025316456,1.0,1.0,8/39,12.81%,Ndc1;Nup93;Ncbp1;Ranbp2;Eif4e;Wdr33;Nup160;Nup155
prerank,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,0.30082638050283106,0.609597397604265,0.9967532467532467,1.0,1.0,24/101,17.05%,Ssr1;Rpl15;Spcs2;Rplp1;Rpl10a;Rplp0;Rpl4;Rpl3;Rpsa;Mrpl13;Rpl36a;Rpl8;Rps28;Rsl24d1;Uba52;Rpl18;Rps21;Ssr3;Sec61a2;Rps3;Rps8;Rpl6;Rps9;Rpl31
prerank,Mitotic Prometaphase R-HSA-68877,-0.3027997689123969,-0.6076406990096885,1.0,1.0,1.0,31/179,20.54%,Ppp2r5a;Tubb4a;Ccp110;Nde1;Nedd1;Ncaph;Prkca;Plk4;Clasp2;Ppp2r5c;Ndc80;Alms1;Dync1h1;Aurkb;Pmepa1;Bub1;Akap9;Dync1li2;Zwint;Cep43;Csnk1e;Cep164;Cep290;Ppp2r5e;Pafah1b1;Pcnt;Cntrl;Ndel1;Cenpn;Ska1;Nek7
prerank,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.3360141351179946,-0.6065871650706292,0.9830985915492958,1.0,1.0,15/67,34.76%,Psmb8;Psma8;Psme4;Psme2;Anapc11;Psma1;Anapc5;Sem1;Anapc2;Ubc;Anapc10;Psmd11;Anapc1;Pttg1;Anapc4
prerank,Translesion Synthesis By POLI R-HSA-5656121,0.37488031554522955,0.6061481743072866,0.9018987341772152,1.0,1.0,1/17,4.08%,Rev1
prerank,Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.3397621209219876,0.6051868550920549,0.9703947368421053,1.0,1.0,9/40,11.69%,Herc2;Babam2;Rad50;Tdp1;Paxip1;H2bc4;Atm;H2ax;Brcc3
prerank,G1/S DNA Damage Checkpoints R-HSA-69615,-0.3417182149526701,-0.6050835052854587,0.9851411589895989,1.0,1.0,7/64,23.61%,Cdk2;Psmb8;Psma8;Psme4;Psme2;Psma1;Sem1
prerank,Phosphorylation Of APC/C R-HSA-176412,-0.37957746367117634,-0.6047925835818454,0.9332386363636364,1.0,1.0,8/20,34.76%,Anapc11;Anapc5;Cdk1;Anapc2;Anapc10;Ccnb1;Anapc1;Anapc4
prerank,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.38229832769969124,-0.6047524148047616,0.9192364170337739,1.0,1.0,4/20,25.37%,Abcd1;Pex13;Pxmp2;Pxmp4
prerank,Eukaryotic Translation Termination R-HSA-72764,0.30183665826780476,0.6038808413845312,0.9936908517350158,1.0,1.0,22/85,17.05%,Rpl15;Rplp1;Rpl10a;Rplp0;Rpl4;Gspt1;N6amt1;Rpl3;Rpsa;Mrpl13;Rpl36a;Rpl8;Rps28;Rsl24d1;Uba52;Rpl18;Rps21;Rps3;Rps8;Rpl6;Rps9;Rpl31
prerank,RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.3658775468278295,-0.6031279376757038,0.9402985074626866,1.0,1.0,8/29,23.94%,Casp8;Birc3;Tnfsf10;Flot1;Mlkl;Ripk1;Cflar;Flot2
prerank,Selenocysteine Synthesis R-HSA-2408557,0.29961089293988663,0.6008811120620211,0.996996996996997,1.0,1.0,23/84,17.05%,Rpl15;Rplp1;Rpl10a;Rplp0;Rpl4;Rpl3;Eefsec;Rpsa;Sephs2;Mrpl13;Rpl36a;Rpl8;Rps28;Rsl24d1;Secisbp2;Uba52;Rpl18;Rps21;Rps3;Rps8;Rpl6;Rps9;Rpl31
prerank,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.3450482653229996,-0.6005550404589319,0.978134110787172,1.0,1.0,6/51,23.61%,Psmb8;Psma8;Psme4;Psme2;Psma1;Sem1
prerank,KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,-0.3870122847932731,-0.599928491494536,0.9361702127659575,1.0,1.0,1/16,5.01%,Mapk11
prerank,PRC2 Methylates Histones And DNA R-HSA-212300,-0.3674504875401856,-0.5948378114877515,0.9462209302325582,1.0,1.0,6/30,21.22%,Phf1;Phf19;H3c7;H2aj;Dnmt3a;H2bc3
prerank,Protein Ubiquitination R-HSA-8852135,0.29756361731086917,0.593780500134721,1.0,1.0,1.0,22/68,12.40%,Ube2w;Ube2e3;Shprh;Ube2g2;Ube2k;Ube2b;Derl1;Ube2r2;Wac;Rad18;Ube2d1;Rtf1;Ube2q2;Ube2d3;H2bc4;Uchl3;Skic8;Usp7;Ube2t;Ube2h;Uba52;Selenos
prerank,TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,-0.3786336866122522,-0.5923800580735751,0.9288824383164006,1.0,1.0,4/16,32.24%,Ep300;Cdk1;Rbl1;Ccnb1
prerank,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.32404246618729804,-0.5915876136281749,0.9943899018232819,1.0,1.0,17/76,34.76%,Psmb8;Psma8;Psme4;Psme2;Anapc11;Psma1;Anapc5;Sem1;Cdk1;Anapc2;Ubc;Anapc10;Ccnb1;Psmd11;Anapc1;Pttg1;Anapc4
prerank,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.32477176149357306,-0.5912296137334873,0.9943820224719101,1.0,1.0,17/75,34.76%,Psmb8;Psma8;Psme4;Psme2;Anapc11;Psma1;Anapc5;Sem1;Cdk1;Anapc2;Ubc;Anapc10;Ccnb1;Psmd11;Anapc1;Pttg1;Anapc4
prerank,Triglyceride Catabolism R-HSA-163560,-0.37645545274319003,-0.5906071066516536,0.9341917024320457,1.0,1.0,3/18,8.69%,Cav1;Prkca;Fabp7
prerank,Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.3657707877961195,-0.5902880364069971,0.9418604651162791,1.0,1.0,7/24,18.78%,Dusp16;Mrc1;Tlr2;Rnf213;Ltf;Eno1;B2m
prerank,Autophagy R-HSA-9612973,-0.3086331133500459,-0.5902878668006134,0.9972067039106145,1.0,1.0,5/124,4.36%,Cftr;Mfn1;Prkab2;Epas1;Prkaa2
prerank,RNA Polymerase II Transcription Termination R-HSA-73856,-0.3307596276892385,-0.5878400963837593,0.9780380673499268,1.0,1.0,3/66,9.08%,Colec12;Lsm11;Srsf5
prerank,Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.3560208339643969,-0.5863950660577145,0.961038961038961,1.0,1.0,1/28,5.94%,Map4k2
prerank,Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.32879465322711937,-0.5828085205334604,0.9914163090128756,1.0,1.0,8/58,23.61%,Numb;Prkca;Psmb8;Psma8;Psme4;Psme2;Psma1;Sem1
prerank,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.2984204415943563,-0.581502617667475,1.0,1.0,1.0,25/146,31.09%,Slc16a1;Cox16;Ucp3;Idh2;Ldhb;Ndufaf2;Pdk4;Ldlr;Adhfe1;Ldha;Coq10b;Ldhd;Pm20d1;Slc25a27;Ldhc;Ppard;Ndufa2;Ndufa1;Cox7b;Sdha;Rxra;Timmdc1;Ndufaf7;Taco1;Slc16a8
prerank,Cytosolic Sulfonation Of Small Molecules R-HSA-156584,-0.3684277034965232,-0.5812043832722772,0.9593267882187938,1.0,1.0,3/18,18.57%,Podxl2;Papss2;Sult6b1
prerank,RHOH GTPase Cycle R-HSA-9013407,-0.3546565734438794,-0.580781652566284,0.9646017699115044,1.0,1.0,10/34,17.29%,Rhoh;Cav1;Slc1a5;Stom;Uaca;Pkn2;Arhgdia;Arhgdib;Jup;Osbpl11
prerank,Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.3289114975743352,-0.579796548651504,0.9857142857142858,1.0,1.0,6/58,18.32%,Gli2;Prkca;Psmb8;Psma8;Psme4;Psme2
prerank,Viral mRNA Translation R-HSA-192823,0.290653589103609,0.5779226212868673,0.9969325153374233,1.0,1.0,21/85,17.05%,Rpl15;Rplp1;Rpl10a;Rplp0;Rpl4;Rpl3;Gnl3;Rpsa;Mrpl13;Rpl36a;Rpl8;Rps28;Rsl24d1;Uba52;Rpl18;Rps21;Rps3;Rps8;Rpl6;Rps9;Rpl31
prerank,Mitotic Spindle Checkpoint R-HSA-69618,-0.30747027387540343,-0.5777468687230153,0.9971671388101983,1.0,1.0,17/106,21.37%,Ppp2r5a;Nde1;Clasp2;Ppp2r5c;Ndc80;Dync1h1;Aurkb;Bub1;Dync1li2;Zwint;Ppp2r5e;Pafah1b1;Ndel1;Cenpn;Ska1;Anapc11;Knl1
prerank,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.3177668541708907,-0.5771176514803167,0.9971711456859972,1.0,1.0,14/72,32.79%,Psmb8;Psma8;Psme4;Psme2;Anapc11;Psma1;Anapc5;Sem1;Cdk1;Anapc2;Ubc;Anapc10;Psmd11;Anapc1
prerank,Cleavage Of Damaged Purine R-HSA-110331,-0.35688955669492306,-0.5741365933226606,0.9599427753934192,1.0,1.0,4/24,23.03%,Neil3;H2aj;H2bc3;Terf1
prerank,Pyruvate Metabolism R-HSA-70268,-0.34756267563336807,-0.5704974046703167,0.9597122302158273,1.0,1.0,5/29,16.68%,Slc16a1;Ldhb;Pdk4;Ldha;Ldhd
prerank,Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,0.27724919217568333,0.569934630661894,1.0,1.0,1.0,8/81,8.58%,Gtf2h2;Ercc4;Gtf2h5;Ccnh;Sumo2;Parp1;Pias1;Mnat1
prerank,Stabilization Of P53 R-HSA-69541,-0.32568576930633353,-0.5676501396427425,0.986764705882353,1.0,1.0,6/54,23.61%,Psmb8;Psma8;Psme4;Psme2;Psma1;Sem1
prerank,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.31237325147147915,-0.566762573836214,0.9971590909090909,1.0,1.0,14/73,32.79%,Psmb8;Psma8;Psme4;Psme2;Anapc11;Psma1;Anapc5;Sem1;Cdk1;Anapc2;Ubc;Anapc10;Psmd11;Anapc1
prerank,APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.35162875825989104,-0.5654857248982273,0.9572649572649573,1.0,1.0,9/24,34.76%,Anapc11;Anapc5;Cdk1;Anapc2;Ubc;Anapc10;Ccnb1;Anapc1;Anapc4
prerank,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.31694148159261193,-0.5569798206352649,0.9898255813953488,1.0,1.0,6/54,23.61%,Psmb8;Psma8;Psme4;Psme2;Psma1;Sem1
prerank,Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,0.2737796912652947,0.5559880689624737,0.9970149253731343,1.0,1.0,24/92,17.05%,Rpl15;Cebpb;Gcn1;Rplp1;Rpl10a;Rplp0;Rpl4;Rpl3;Rpsa;Mrpl13;Asns;Rpl36a;Rpl8;Rps28;Rsl24d1;Uba52;Atf3;Rpl18;Rps21;Rps3;Rps8;Rpl6;Rps9;Rpl31
prerank,Separation Of Sister Chromatids R-HSA-2467813,-0.27684274562642364,-0.5502274220282112,1.0,1.0,1.0,26/166,23.61%,Ppp2r5a;Nde1;Clasp2;Ppp2r5c;Psmb8;Ndc80;Dync1h1;Aurkb;Pmepa1;Bub1;Psma8;Dync1li2;Zwint;Ppp2r5e;Psme4;Pafah1b1;Psme2;Ndel1;Cenpn;Ska1;Anapc11;Knl1;Psma1;Anapc5;Rangap1;Sem1
prerank,Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.298219145747853,-0.5493194110905565,1.0,1.0,1.0,13/90,23.76%,Cdk2;Psmb8;Cdt1;Psma8;Psme4;Psme2;Mcm3;Slc25a2;Anapc11;Psma1;Anapc5;Sem1;Orc5
prerank,Mitochondrial Protein Import R-HSA-1268020,-0.3091033926186266,-0.5477970178105723,0.9970457902511078,1.0,1.0,1/59,3.24%,Slc25a13
prerank,Recycling Of Bile Acids And Salts R-HSA-159418,-0.3488998224771582,-0.5472079742470476,0.9454277286135693,1.0,1.0,6/15,29.74%,Abcc3;Slc51a;Slc10a2;Alb;Slc10a1;Rxra
prerank,Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.3434098441814665,-0.5448342677227931,0.9515669515669516,1.0,1.0,7/17,38.90%,Piga;Pign;Pigz;Pigc;Pigm;Pigq;Pigv
prerank,S Phase R-HSA-69242,-0.27554584628406104,-0.5443221466648114,1.0,1.0,1.0,26/161,24.07%,E2f1;Lrig1;Ccnd1;Cdc25b;Cdk2;Psmb8;Cdt1;Pmepa1;Psma8;Pold4;Esco2;Cables1;Cks1b;Lin54;Psme4;Psme2;Mcm3;Slc25a2;Anapc11;Prim2;Psma1;Rfc2;Anapc5;Sem1;Orc5;Gins4
prerank,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.30849705563570634,-0.5436074908154136,0.9942446043165467,1.0,1.0,10/58,32.62%,Psmb8;Psma8;Psme4;Psme2;Psma1;Sem1;Cdk1;Ubc;Ccnb1;Psmd11
prerank,Translesion Synthesis By POLK R-HSA-5655862,0.32939858433072483,0.538260676647126,0.941747572815534,1.0,1.0,1/17,4.08%,Rev1
prerank,Nucleotide Excision Repair R-HSA-5696398,0.2524435379315546,0.53344339919493,1.0,1.0,1.0,13/105,12.45%,Gtf2h2;Ercc4;Gtf2h5;Ccnh;Sumo2;Parp1;Pias1;Mnat1;Polr2e;Ino80d;Usp7;Uba52;Nfrkb
prerank,Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.28376430869159364,-0.5309537252618823,1.0,1.0,1.0,17/102,21.37%,Ppp2r5a;Nde1;Clasp2;Ppp2r5c;Ndc80;Dync1h1;Aurkb;Pmepa1;Bub1;Dync1li2;Zwint;Ppp2r5e;Pafah1b1;Ndel1;Cenpn;Ska1;Knl1
prerank,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.28996107266311616,-0.5303262592096203,0.9985380116959064,1.0,1.0,9/84,18.32%,E2f1;Ccnd1;Cdc25b;Cdk2;Psmb8;Cables1;Cks1b;Lin54;Psme2
prerank,Fanconi Anemia Pathway R-HSA-6783310,-0.31525459651925947,-0.5281757724005683,0.9821958456973294,1.0,1.0,2/35,14.73%,Fancc;Eme1
prerank,Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.3185597855496169,-0.5263254382863998,0.9795918367346939,1.0,1.0,5/29,23.03%,Neil3;Nthl1;H2aj;H2bc3;Terf1
prerank,"Base-Excision Repair, AP Site Formation R-HSA-73929",-0.3168048530886105,-0.5219150433113873,0.982274741506647,1.0,1.0,5/31,23.03%,Neil3;Nthl1;H2aj;H2bc3;Terf1
prerank,SUMOylation Of DNA Methylation Proteins R-HSA-4655427,-0.32960680564947586,-0.5200576881501483,0.9667149059334298,1.0,1.0,2/15,18.30%,Pcgf2;Dnmt3a
prerank,NS1 Mediated Effects On Host Pathways R-HSA-168276,-0.30398922665363104,-0.5150339761058405,0.9913669064748202,1.0,1.0,1/37,6.00%,Eif2ak2
prerank,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,0.25368548320703577,0.5085491583235712,1.0,1.0,1.0,4/75,5.39%,Gtf2h2;Ercc4;Gtf2h5;Ccnh
prerank,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.28930644571923486,-0.5065233012333158,0.9985549132947977,1.0,1.0,6/52,23.61%,Psmb8;Psma8;Psme4;Psme2;Psma1;Sem1
prerank,G0 And Early G1 R-HSA-1538133,-0.3153464173830936,-0.5062133827942183,0.9812409812409812,1.0,1.0,2/27,8.26%,E2f1;Cdk2
prerank,DNA Damage Recognition In GG-NER R-HSA-5696394,0.2852351494372812,0.5059189614382533,0.9840764331210191,1.0,1.0,36/36,71.51%,Parp1;Ino80d;Uba52;Nfrkb;Gps1;Ino80;Cops7a;Rad23b;Ino80e;Mcrs1;Cops2;Cops6;Cops8;Tfpt;Ino80c;Ino80b;Cops5;Ruvbl1;Actr5;Actl6a;Cops4;Rad23a;Rps27a;Rbx1;Ddb1;Cul4b;Parp2;Cetn2;Yy1;Ubb;Cops3;Actr8;Ubc;Ddb2;Xpc;Cul4a
prerank,XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.29902459858523767,-0.5038682639520004,0.9898843930635838,1.0,1.0,9/45,24.86%,Edem1;Cul7;Wfs1;Shc1;Gfpt1;Tln1;Lmna;Tspyl2;Mydgf
prerank,IRE1alpha Activates Chaperones R-HSA-381070,-0.297669060514091,-0.5033966583698876,0.9897810218978103,1.0,1.0,9/47,24.86%,Edem1;Cul7;Wfs1;Shc1;Gfpt1;Tln1;Lmna;Tspyl2;Mydgf
prerank,G1/S Transition R-HSA-69206,-0.26008142324652544,-0.5027293620120368,1.0,1.0,1.0,19/127,23.76%,Mcm10;E2f1;Ccnd1;Cdk2;Psmb8;Cdt1;Cables1;Cks1b;Lin54;Psme2;Mcm3;Rrm2;Slc25a2;Prim2;E2f6;Psma1;Dhfr;Sem1;Orc5
prerank,Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,-0.3224622431320538,-0.5013450851411798,0.9697386519944979,1.0,1.0,7/15,47.60%,Gale;Gfpt1;Galk1;Gne;Dolk;Srd5a3;Dpm3
prerank,Cyclin E Associated Events During G1/S Transition R-HSA-69202,0.24826703984731005,0.5000186577603024,1.0,1.0,1.0,6/82,8.58%,Akt3;Ccnh;Cul1;Wee1;Psmd13;Mnat1
prerank,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.26683841861108826,-0.4950310859180179,1.0,1.0,1.0,43/97,51.18%,Cox16;Ucp3;Ndufaf2;Coq10b;Pm20d1;Slc25a27;Ndufa2;Ndufa1;Cox7b;Sdha;Timmdc1;Ndufaf7;Taco1;Ndufa3;Nubpl;Tmem186;Cox5a;Sdhb;Ndufa12;Ndufb8;Uqcrc1;Coq10a;Etfa;Cox6b1;Ndufb11;Ndufb3;Sco1;Cox5b;Ndufa7;Cox8a;Ndufa13;Uqcr11;Trap1;Sco2;Uqcrb;Uqcrh;Uqcrq;Uqcr10;Ndufs5;Ndufs2;Ndufb9;Ndufaf3;Ndufaf6
prerank,Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.3051093312194877,-0.4888299478234268,0.9874651810584958,1.0,1.0,7/21,37.19%,Anapc11;Anapc5;Anapc2;Anapc10;Anapc1;Anapc4;Mad2l1
prerank,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.27510896136051044,-0.4878117165658,0.9956204379562044,1.0,1.0,5/58,18.32%,Relb;Psmb8;Psma8;Psme4;Psme2
prerank,SUMOylation Of DNA Replication Proteins R-HSA-4615885,0.2654795485802777,0.47763716671037854,0.9935897435897436,1.0,1.0,5/41,7.31%,Ndc1;Top1;Nup93;Sumo2;Ranbp2
prerank,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.2651260085797061,-0.474473469905282,1.0,1.0,1.0,12/63,34.76%,Psmb8;Psme2;Anapc11;Psma1;Anapc5;Sem1;Anapc2;Ubc;Anapc10;Psmd11;Anapc1;Anapc4
prerank,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.263565368926314,-0.46798168342456264,0.9985250737463127,1.0,1.0,5/61,18.32%,Relb;Psmb8;Psma8;Psme4;Psme2
prerank,"Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",0.25689712089732364,0.46776642458142603,1.0,1.0,1.0,8/45,16.71%,Eif3a;Rpsa;Rps28;Eif3h;Rps21;Rps3;Rps8;Rps9
prerank,Selenoamino Acid Metabolism R-HSA-2408522,0.22502705155391312,0.4672392210135635,1.0,1.0,1.0,17/99,11.94%,Txnrd1;Rpl15;Rplp1;Rpl10a;Rplp0;Rpl4;Rpl3;Eefsec;Rpsa;Sephs2;Mrpl13;Rpl36a;Rpl8;Rps28;Rsl24d1;Secisbp2;Uba52
prerank,Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.29282501082750845,-0.46611613343086156,0.9882525697503671,1.0,1.0,6/20,34.76%,Anapc11;Anapc5;Anapc2;Anapc10;Anapc1;Anapc4
prerank,Respiratory Electron Transport R-HSA-611105,-0.25108829744894245,-0.4618980256477432,1.0,1.0,1.0,40/89,51.18%,Cox16;Ndufaf2;Coq10b;Ndufa2;Ndufa1;Cox7b;Sdha;Timmdc1;Ndufaf7;Taco1;Ndufa3;Nubpl;Tmem186;Cox5a;Sdhb;Ndufa12;Ndufb8;Uqcrc1;Coq10a;Etfa;Cox6b1;Ndufb11;Ndufb3;Sco1;Cox5b;Ndufa7;Cox8a;Ndufa13;Uqcr11;Trap1;Sco2;Uqcrb;Uqcrh;Uqcrq;Uqcr10;Ndufs5;Ndufs2;Ndufb9;Ndufaf3;Ndufaf6
prerank,Degradation Of AXIN R-HSA-4641257,-0.2636804476500748,-0.4615827688979527,1.0,1.0,1.0,6/54,23.61%,Psmb8;Psma8;Psme4;Psme2;Psma1;Sem1
prerank,Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.28440505879679273,-0.4608582157827539,0.9943661971830986,1.0,1.0,1/29,6.45%,Stam2
prerank,Defective Pyroptosis R-HSA-9710421,0.26472900266160954,0.4480846309178364,0.9937304075235109,1.0,1.0,7/30,10.57%,Rbbp7;Suz12;Ezh2;H2bc4;H2az1;H2ac6;H2ax
prerank,Assembly Of Pre-Replicative Complex R-HSA-68867,-0.2389525609235908,-0.44684067723664106,1.0,1.0,1.0,13/98,23.76%,Psmb8;Cdt1;H3c7;H2aj;Psme2;Mcm3;Slc25a2;Anapc11;H2bc3;Psma1;Anapc5;Sem1;Orc5
prerank,Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,-0.27317802367751165,-0.44165707360514467,0.9941775836972343,1.0,1.0,5/26,23.76%,H3c7;H2aj;Slc25a2;H2bc3;Orc5
prerank,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.24054564649368892,-0.440729441895577,1.0,1.0,1.0,16/80,32.79%,Cdk2;Psmb8;Psma8;Psme4;Psme2;Anapc11;Psma1;Anapc5;Sem1;Cdk1;Anapc2;Ubc;Anapc10;Ccnb1;Psmd11;Anapc1
prerank,Influenza Infection R-HSA-168255,-0.22054360138724782,-0.43145755941985126,1.0,1.0,1.0,3/146,9.45%,Tgfb1;Eif2ak2;Rpl3l
prerank,APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.26466428409404574,-0.4299660262427031,0.993006993006993,1.0,1.0,8/26,37.19%,Anapc11;Anapc5;Anapc2;Ubc;Anapc10;Anapc1;Anapc4;Mad2l1
prerank,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,0.23589055394020747,0.42633482594775124,1.0,1.0,1.0,44/44,76.45%,Gemin8;Snrpd3;Rpsa;Rps28;Snrpb;Rps21;Gemin5;Rps3;Rps8;Rps9;Gemin2;Gemin4;Rps15a;Rps15;Rps13;Rps17;Snrpf;Rps10;Rps23;Rps12;Rps19;Rps29;Rps2;Rps20;Rps14;Fau;Snrpg;Snrpe;Rps25;Smn1;Rps27a;Rps5;Rps16;Rps7;Gemin6;Rps27;Snrpd2;Rps6;Rps27l;Rps4x;Ddx20;Gemin7;Rps24;Rps11
prerank,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,-0.2678107834957547,-0.4251605865906019,0.9911111111111112,1.0,1.0,3/25,21.22%,H3c7;H2aj;H2bc3
prerank,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,0.22468380822405407,0.4241113132328546,1.0,1.0,1.0,10/53,15.20%,Ywhaz;Cul1;Psmd13;Psmd2;Uba52;Psmc1;Psmd14;Fbxw7;Psmd5;Skp1
prerank,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,0.21956664135640325,0.4231942086690595,1.0,1.0,1.0,7/62,11.94%,Gtf2h2;Gtf2h5;Ccnh;Mnat1;Polr2e;Usp7;Uba52
prerank,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,0.22292247744493127,0.42077073909912366,1.0,1.0,1.0,7/54,13.42%,Btrc;Cul1;Psmd13;Psmd2;Uba52;Psmc1;Psmd14
prerank,DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.2434726516274207,-0.4109924362509004,1.0,1.0,1.0,6/40,24.21%,Cdk2;Artn;H2aj;H2bc3;Terf1;Lmnb1
prerank,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.24961646935629517,-0.4107945796009523,1.0,1.0,1.0,6/30,30.82%,Pold4;Dtl;Rfc2;Cul4a;Rfc3;Ubc
prerank,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.23573523310300015,-0.4101971144280532,1.0,1.0,1.0,2/51,9.18%,Nfe2l2;Psmb8
prerank,Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,-0.2562578431053137,-0.40013749434376067,0.9971671388101983,1.0,1.0,6/15,38.23%,Pdk4;Ldhd;Ppard;Rxra;Dlat;Plpp6
prerank,Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,-0.24474873046746426,-0.38974703169954816,0.9985207100591716,1.0,1.0,3/23,21.22%,H3c7;H2aj;H2bc3
prerank,Translesion Synthesis By POLH R-HSA-110320,-0.2487870552357544,-0.3871020597479339,0.9971305595408895,1.0,1.0,9/19,49.90%,Rfc2;Rfc3;Ubc;Polh;Vcp;Slc19a1;Polr1b;Ubb;Rpa3
prerank,Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.21666838296105514,-0.3760562294949267,1.0,1.0,1.0,6/51,23.61%,Psmb8;Psma8;Psme4;Psme2;Psma1;Sem1
prerank,Packaging Of Telomere Ends R-HSA-171306,-0.2345794562933119,-0.3737266393965844,0.9985955056179775,1.0,1.0,3/20,23.03%,H2aj;H2bc3;Terf1
prerank,Mitochondrial Translation Initiation R-HSA-5368286,0.1760904657179011,0.3590503510002923,1.0,1.0,1.0,27/82,20.97%,Mrps26;Mrpl13;Ptcd3;Mtif2;Mrps22;Mrpl58;Mrpl37;Mrps15;Mrps17;Mrpl23;Mrpl33;Mrps9;Mrps25;Mrpl21;Mrpl55;Mrpl53;Mrpl50;Mrpl32;Mrpl3;Mrpl51;Mrpl45;Mrpl15;Mrpl1;Mrpl16;Mrpl57;Mrps11;Dlgap3
prerank,Condensation Of Prophase Chromosomes R-HSA-2299718,-0.21686799087280043,-0.3536155286242365,0.9985119047619048,1.0,1.0,5/30,24.96%,Phf8;H3c7;H2aj;H2bc3;Cdk1
prerank,Complex I Biogenesis R-HSA-6799198,-0.1907222712929493,-0.3283179399711623,1.0,0.9998442977894115,1.0,20/50,52.14%,Ndufaf2;Ndufa2;Ndufa1;Timmdc1;Ndufaf7;Ndufa3;Nubpl;Tmem186;Ndufa12;Ndufb8;Ndufb11;Ndufb3;Ndufa7;Ndufa13;Ndufs5;Ndufs2;Ndufb9;Ndufaf3;Ndufaf6;Ndufa9
prerank,Mitochondrial Translation R-HSA-5368287,0.1579120381108134,0.32794634400693207,1.0,1.0,1.0,23/88,18.43%,Mrps26;Mrpl13;Ptcd3;Mtif2;Mrps22;Mrpl58;Mrpl37;Mrps15;Mrps17;Mrpl23;Mrpl33;Mrps9;Mrps25;Mrpl21;Mrpl55;Mrpl53;Mrpl50;Mrpl32;Mrpl3;Mrpl51;Mrpl45;Mrpl15;Mrpl1
prerank,Mitochondrial Translation Termination R-HSA-5419276,0.15880734378620792,0.32425997238862103,1.0,1.0,1.0,26/82,20.97%,Mrps26;Mrpl13;Ptcd3;Mrps22;Mrpl58;Mrpl37;Mrps15;Mrps17;Mrpl23;Mrpl33;Mrps9;Mrps25;Mrpl21;Mrpl55;Mrpl53;Mrpl50;Mrpl32;Mrpl3;Mrpl51;Mrpl45;Mrpl15;Mrpl1;Mrpl16;Mrpl57;Mrps11;Dlgap3
prerank,Mitochondrial Translation Elongation R-HSA-5389840,0.1512566420384543,0.3109326594883605,1.0,0.9999065565201648,1.0,26/82,20.97%,Mrps26;Mrpl13;Ptcd3;Mrps22;Mrpl58;Mrpl37;Mrps15;Mrps17;Mrpl23;Mrpl33;Mrps9;Mrps25;Mrpl21;Mrpl55;Mrpl53;Mrpl50;Mrpl32;Mrpl3;Mrpl51;Mrpl45;Mrpl15;Mrpl1;Mrpl16;Mrpl57;Mrps11;Dlgap3
